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Riassunto  
 
Nuove metodologie per l’analisi Proteomica 
 
Le “Biotecnologie Moderne” sono l’insieme delle tecniche rivolte alla produzione di 
prodotti e servizi mediante l’utilizzo di sistemi biologici e moderne tecniche di biologia 
molecolare. Tipicamente i prodotti finali delle produzioni biotecnologiche sono 
proteine che trovano largo impiego in campo medico, industriale e agrario. La 
maggioranza dei prodotti biotecnologici sono ottenuti mediante l’utilizzo di tecniche di 
DNA recombinante basate su cellule “ospite” geneticamente modificate in sistemi 
biologici come batteri, lieviti ed anche cellule mammifere. Per l’ottimizzazione di un 
sistema di produzione biotecnologico, oltre alla messa a punto dei sistemi di 
fermentazione e crescita cellulare “a monte” del processo, è altrettanto necessario 
realizzare “a valle” efficienti procedure di estrazione e purificazione dei bio-prodotti 
dalle matrici impiegate. Tradizionalmente lo sviluppo di un processo prevedeva la 
progettazione e l’ottimizzazione delle procedure “a monte” e “a valle” mediante 
l’utilizzo di dati empirici e con un’incompleta o limitata conoscenza dei meccanismi 
cellulari a livello molecolare. I recenti progressi nel campo della Genomica e 
Proteomica, tecnologie che permettono di ottenere informazioni sui meccanismi 
cellulari a livello molecolare, hanno fornito nuovi strumenti e conoscenze utili per la 
progettazione dei processi biotecnologici. La Genomica è una branca della biologia 
molecolare che si occupa dello studio della composizione, delle funzioni e 
dell’evoluzione del patrimonio genetico negli organismi viventi. Tuttavia, è apparso 
subito evidente che la staticità dei dati genomici non era in grado di spiegare la 
dinamicità del corrispondente comparto proteico, caratterizzato da eventi di splicing 
alternativo, modifiche post-traduzionali e formazioni di complessi funzionali proteina-
proteina. Per questo motivo negli ultimi anni l’attenzione è stata focalizzata 
maggiormente sui prodotti del genoma: le proteine. L’analisi Proteomica si occupa 
proprio della definizione del comparto proteico di un organismo mediante studi di 
caratterizzazione, variazione dei profili d’espressione, definizione di modifiche post-
traduzionali e ricostruzione delle interazioni funzionali tra proteine. L’approccio 
proteomico ha avuto un forte impatto nel campo delle moderne biotecnologie. Oggi, 
tali metodologie sono comunemente applicate nelle produzioni biotecnologiche 
alimentari, nel controllo qualità e anche nel campo delle fermentazioni, per 
l’ottimizzazione dei bio-processi. La grande innovazione dell’analisi Proteomica è lo 
studio dell’intero comparto proteico come un unico analita. Differentemente dagli 
approcci classici di biochimica, le proteine non sono più separate dall’originale 
contesto di complessità che caratterizza i sistemi cellulari, ma sono piuttosto 
analizzate contemporaneamente, cercando di mantenere invariata la rete 
d’interazioni che esse formano in vivo. Attualmente l’analisi proteomica si avvale di 
numerose tecniche analitiche capaci di fornire una visione globale del comparto 
proteico di un organismo, tra queste sicuramente le più importanti sono l’elettroforesi 
bidimensionale (2DE) e la spettrometria di massa (MS) accoppiata a sistemi 
cromatografici nano-HPLC (LC-MSMS). La versatilità e la sinergia di queste 
tecnologie hanno permesso di raggiungere innumerevoli risultati in tempi brevi, 
rendendo oggigiorno l’analisi Protomica una tappa obbligatoria di qualsiasi studio 
biochimico. Tuttavia, il vasto campo di applicabilità di tale approccio porta 
inevitabilmente ad incontrare diversi limiti connessi sia alle caratteristiche dei 
campioni in analisi sia alle peculiarità delle tecniche analitiche utilizzate. Per esempio 
l’analisi delle proteine di membrana può essere problematica a causa della scarsa 
 2 
solubilità di questa classe di analiti nei tamponi utilizzati per la separazione 
elettroforetica. Inoltre l’ampia gamma dinamica di concentrazione in esame rende 
difficile l’analisi di modifiche post traduzionali sub-stechiometriche anche mediante 
l’utilizzo di tecniche gel-free. Negli ultimi anni sono stati diversi i lavori metodologici 
rivolti a superare questi limiti costituzionali dell’analisi proteomica, permettendo di 
estendere il campo d’analisi perseguibile. Seguendo questa tendenza, lo scopo di 
questo progetto di tesi è l’ottimizzazione di nuove procedure d’analisi per migliorare 
l’analisi Proteomica di importanti modifiche post-traduzionali. Ciò è stato realizzato 
mediante la manipolazione chimica di peptidi e proteine combinata all’impiego di 
avanzate tecniche di spettrometria di massa. 
Il primo studio affrontato in questo lavoro di tesi è dedicato alla ottimizzazione di una 
procedura di analisi per migliorare l’identificazione dei siti di nitrazione nelle proteine. 
La nitrazione dei residui di tirosina è un’importante modifica post-traduzionale che 
può verificarsi in vivo durante fenomeni di stress ossidativo associati alla iper-
produzione di ossido nitrico (1). Essa consiste nella sostituzione di un idrogeno in 
posizione orto nel gruppo fenolico dei residui di tirosina con un gruppo nitro (NO2). 
L’importanza biologica di questa modifica è globalmente accettata sia per le sue 
funzioni di mediatore della transduzione dei segnali cellulari sia come bio-marker di 
diverse patologie (2). Quest’ultima caratteristica è oggetto di numerosi studi, infatti la 
nitrazione delle proteine sembra essere implicata in numerose patologie riguardanti il 
sistema nervoso come il morbo di Parkinson, il morbo di Alzheimer e l’ischemia (3). 
Tuttavia, l’approccio classico di Proteomica presenta numerosi limiti nella rivelazione 
dei fenomeni di nitrazione in vivo. Infatti, anche se l’analisi mediante anticorpi 
specifici permette di identificare la presenza di proteine nitrate frazionate con 
tecniche di 2DE (4), il carattere sub-stechiometrico della reazione di nitrazione in vivo 
rende molto difficile l’identificazione dei siti di modifica. Inoltre, è stato anche 
dimostrato che l’analisi di spettrometria di massa risente enormemente 
dell’incorporazione del gruppo nitro nell’anello fenolico dei residui di tirosina (5). Per 
superare questi limiti sono state realizzate diverse metodologie alternative rivolte ad 
arricchire proteine o peptidi contenenti residui di nitro-tirosina. Questo è stato 
realizzato mediante tecniche di immuno-precipitazione (6) o anche di 
derivatizzazione chimica con reagenti che permettono la purificazione specifica dei 
residui marcati (7). Mediante quest’ultimo tipo di approccio è anche possibile 
migliorare l’analisi di spettrometria di massa, in quanto il gruppo nitro è convertito in 
una specie che favorisce la ionizzazione. Tuttavia le tecniche appena citate 
consistono di molteplici passaggi cromatografici che possono risultare dispersivi in 
termini di materiale, tempo e campione. In questo lavoro di tesi è stata ottimizzata 
una metodologia innovativa che, basandosi sulla modifica chimica dei residui di nitro-
tyrosina, permette di identificare proteine nitrate in miscele complesse evitando 
preventive separazioni cromatografiche. La strategia prevede la riduzione dei gruppi 
nitro ad ammina e la successiva sulfonazione di quet’ultimi con il reagente cloruro di 
dansile (DNS-Cl). Le condizioni di reazione e analisi di spettrometria di massa sono 
state inizialmente ottimizzate utilizzando una proteina modello. A questo scopo è 
stata scelta l’albumina siero bovina (BSA), costituita da 20 tirosine, che è stata nitrata 
in vitro. La selettività della reazione di marcatura è stata controllata dal pH della 
soluzione che è stato mantenuto a 5,0, sfruttando in questo modo il peculiare pKa 
delle ammine aromatiche che è 4,7. L’utilizzo del cloruro di dansile permette di 
effettuare analisi di spettrometria di massa estremamente selettive con strumenti 
dotati di analizzatori ibridi triplo quadrupolo-trappola ionica lineare. Infatti, in 
precedenti studi è stato dimostrato che i peptidi modificati con il dansile generano in 
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esperimenti di massa tandem frammenti peculiari con rapporto massa carica (m/z) 
234 e 170 (8). Inoltre, quest’ultimo frammento può essere anche generato in 
esperimenti di tipo MS3 dal precursore a m/z 234. Tali caratteristiche di 
frammentazione sono state utilizzate per ottimizzare una procedura d’analisi LC-
MSMS in modalità Precursor Ion Scan (PIS) e MS3. In pratica la miscela peptidica 
ottenuta dall’idrolisi delle proteine in esame è frazionata mediante cromatografia a 
fase inversa e analizzata direttamente mediante spettrometria di massa in modalità 
PIS. Questa modalità permette di ridurre l’analisi ad un numero molto ridotto di 
specie poiché sono rivelate solo le specie ioniche che generano frammenti a m/z 170 
a seguito di collisione con gas neutro (CID), peculiarità tipica dei peptidi modificati 
con dansile. E’ stato stimato che in questa modalità operativa, per la BSA nitrata il 
73% dei peptidi non nitrati non è stato rivelato. Combinando all’analisi PIS anche 
esperimenti di tipo MS3, che permettono di determinare quali ioni possono generare 
frammenti m/z 170 da frammenti m/z 234, è possibile definitivamente ridurre l’analisi 
alle sole specie marcate, con delezione del 100% delle specie di non interesse. La 
riduzione della complessità analitica permette di guadagnare enormemente in 
sensibilità, in quanto è incrementato considerevolmente il duty cycle del sistema. Il 
frazionamento in fase gassosa, realizzato dalla metodica di spettrometria di massa, 
può considerarsi dunque equivalente ad un passaggio di arricchimento dei peptidi 
nitrati, senza tuttavia aggiungere ulteriori sistemi cromatografici. L’applicabilità della 
tecnica è stata verificata in miscele complesse come estratti proteici di E.coli e di 
latte bovino, confermando la possibilità di individuare proteine nitrate e i 
corrispondenti siti di modifica anche in campioni di origine biologica. Infine i dati 
ottenuti da questo lavoro sono stati pubblicati da un’importante rivista di Chimica 
Analitica (9).  
La strategia appena proposta tuttavia non permette di effettuare stime quantitative 
per valutare variazioni di concentrazione di proteine nitrate in differenti campioni. 
L’analisi quantitativa di questa modifica post-traduzionale rappresenta un vero limite 
della Proteomica, al punto che attualmente non ci sono procedure che permettono di 
identificare e quantificare allo stesso tempo i siti di nitrazione nelle proteine. Le 
uniche metodologie attualmente disponibili sono il saggio ELISA (10) e il dosaggio 
mediante gas cromatografia della nitrotirosina in forma aminoacidica ottenuta 
dall’idrolisi in HCl delle proteine (11). Tale problematica è stata affrontata in questo 
progetto di dottorato. In particolare sulla base dell’esperienza pregressa è stato 
ipotizzato che l’utilizzo di un criterio di elevata selettività in spettrometria di massa, 
accoppiato ad una marcatura altrettanto selettiva dei residui di interesse con un 
reagente arricchito nella componente isotopica, potesse permettere l’identificazione e 
quantificazione dei siti di nitrazione. Per questo scopo, non essendo disponibili in 
commercio isotopi del cloruro di dansile, è stato scelto come reagente la N-
metilpiperazina-acetato N-idrossisuccinimide estere che è la molecola utilizzata nella 
più nota strategia di analisi quantitativa in Proteomica: iTRAQ (12). Il successo di 
questa metodica è dovuto alla peculiare struttura del reagente iTRAQ che permette 
l’acilazione delle ammine primarie. Esso è commercializzato in 4 forme isobare che 
differiscono tra loro per la composizione e distribuzione degli atomi pesanti del C, N, 
e O, consentendo di modificare i peptidi sempre con lo stesso incremento di massa. 
La strategia prevede la marcatura di fino a 4 profili d’espressione differenti e 
successivamente le miscele peptidiche sono unificate prima dell’analisi LC-MSMS. 
La grande innovazione di iTRAQ è l’indistinguibilità in modalità MS dei peptidi 
provenienti dai differenti campioni di origine, aumentando di fatto l’intensità del 
segnale rivelato e soprattutto non introducendo ulteriori segnali nello spettro di 
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massa. Nei relativi spettri di frammentazione MS/MS sono distinguibili i segnali 
peculiari del reagente iTRAQ utilizzato, rispettivamente a valori di m/z 114, 115, 116, 
117 dalla cui misura dell’intensità è possibile realizzare stime quantitative relative. 
Differentemente dal cloruro di dansile, la chimica degli esteri della N-
idrossisuccinimmide non permette di utilizzare il tipico pKa delle ammine aromatiche 
per realizzare acilazioni selettive dei residui di nitrotirosina a pH 5,0. Per questo 
motivo, prima della riduzione del gruppo nitro e della marcatura, le ammine primarie 
delle lisine e dei residui N-terminali dei peptidi devono essere acetilati. In questo 
modo è possibile successivamente condurre la marcatura a pH 8,0 senza reazioni 
aspecifiche. Anche in questo caso le condizioni di reazione sono state ottimizzate 
utilizzando come proteina modello la BSA. L’analisi di LC-MSMS è stata ancora una 
volta effettuata mediante uno spettrometro ibrido triplo quadrupolo trappola ionica 
lineare realizzando esperimenti in modalità PIS, usando come criterio di selettività 
uno degli ioni frammento peculiari del reagente iTRAQ (114, 115, 116, 117). 
Mediante questo tipo di analisi è stato possibile per la BSA eliminare il 96% dei 
peptidi di non interesse. Da un confronto con i risultati ottenuti mediante l’utilizzo del 
cloruro di dansile, risulta che l’analisi in PIS dei peptidi marcati con iTRAQ è molto 
più selettiva. Questo perchè la regione dello spettro MSMS dei peptidi compreso tra 
114 e 117 è più libera di segnali rispetto a alla regione intorno al valore 170. Tuttavia 
non è stato possibile realizzare la completa rimozione dei peptidi non nitrati mediante 
analisi MS3, in quanto non sono state trovate transizioni efficaci. Basandosi solo 
sull’elevata selettività della PIS la procedura è stata quindi verificata su scala 
proteomica analizzando miscele complesse di estratti proteici di E.coli e di latte 
bovino, caratterizzati da differenti concentrazioni di proteine nitrate. E’ stato in questo 
modo possibile in una singola analisi identificare ed effettuare stime quantitative dei 
siti di nitrazione anche per proteine poco rappresentate. I dati ottenuti sono stati 
accettati e pubblicati da un’importante rivista di Proteomica (13).  
Un altro aspetto affrontato in questo progetto di tesi riguarda il miglioramento 
dell’analisi MALDI-MSMS mediante la modifica chimica delle miscele peptidiche in 
esame. Questa problematica è stata largamente affrontata in altri lavori, dove è stato 
dimostrato che la frammentazione dei peptidi triptici in sorgenti MALDI generalmente 
non permette di ottenere una distribuzione omogenea dei segnali per consentire un 
corretto sequenziamento della regione N-terminale (14). Questo effetto è dovuto alla 
caratteristiche della ionizzazione MALDI che genera ioni mono-carica nella forma di 
addotti MH+. La presenza costante di un residuo fortemente basico di arginina o 
lisina in posizione C-Terminale, ha un effetto di localizzazione della carica in questa 
regione, favorendo la generazione di ioni frammento appartenenti alla serie y. Inoltre 
l’effetto di localizzazione sopra citato, sfavorisce la frammentazione dei legami 
peptidici nella regione N-Terminale come predetto dalla teoria del protone mobile 
(15). Per superare questo limite sono state realizzate diverse strategie che 
prevedono la marcatura chimica dell’ammina N-Terminale inserendo un ulteriore 
“protone mobile” o una carica fissa, capaci di favorire la frammentazione dei legami e 
la ritenzione della carica nella regione N-Terminale dei peptidi (14). Queste strategie 
hanno permesso di migliorare la qualità degli spettri di frammentazione ottenuti con 
spettrometri di massa MALDI, tuttavia diminuendo l’intensità dei segnali in modalità 
MS. Inoltre tali strategie non sono mai state applicate su scala proteomica. In questo 
progetto di tesi è stato valutato l’utilizzo del cloruro di dansile per la marcatura del 
residuo N-Terminale dei peptidi con lo scopo di migliorare l’analisi MS e MSMS. Le 
proprietà in modalità MALDI-MS dei peptidi dansilati sono state già studiante in un 
precedente lavoro (16). E’ stato dimostrato che l’introduzione di un gruppo 
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dimetilammino-naftalenico, che ha un massimo di assorbimento alla lunghezza 
d’onda del laser utilizzato nelle comuni sorgenti MALDI, permette di migliorare il 
rapporto segnale rumore dei peptidi modificati in modalità MS. Inoltre è stato 
osservato che la marcatura degli idrolizzati triptici cambia la tipica “impronta digitale” 
di una proteina ottenuta mediante analisi MALDI-MS. Quest’ultimo effetto è dovuto 
alla natura della modifica introdotta, che cambia la gerarchia dei profili di 
ionizzazione, permettendo l’identificazione di peptidi non rivelati mediante un 
approccio classico, tuttavia a discapito di altri normalmente osservati. Gli autori 
hanno dunque proposto una strategia che prevede l’idrolisi delle proteine in esame, 
la marcatura con DNS-Cl di un’aliquota delle risultanti miscele peptidiche ed infine 
l’analisi in parallelo delle due miscele ottenute mediante Peptide Mass Fingerprint 
(16). La complementarietà dei risultati generati dall’analisi delle miscele marcate e 
non marcate, permette di ottenere considerevoli miglioramenti nell’attendibilità dei 
dati statistici e nella copertura di sequenza. In questo lavoro di tesi sono state 
migliorate le condizioni di reazione avvantaggiandosi dell’utilizzo delle micro-onde. 
Inoltre i dati sopra citati sono stati confermati mediante l’utilizzo di uno spettrometro 
di massa d’ultima generazione MALDI-TOFTOF. E’ stato realizzato uno studio più 
approfondito rivolto a comprendere l’effetto di variazione dei profili di ionizzazione 
dopo la marcatura, mediante l’utilizzo di un numero elevato di peptidi e di dati ottenuti 
da esperimenti MSMS. Da questo studio risulta che la modifica dell’ammina N-
Terminale con un gruppo che assorbe la radiazione UV, aumenta il trasferimento di 
energia dalla sorgente laser al sistema matrice/campione, favorendo il desorbimento 
e la ionizzazione soprattutto dei peptidi dotati di m/z più bassi. Tuttavia la 
sulfonazione dei gruppi amminici causa una netta diminuzione del pKa di questi 
residui, comportando nei peptidi una minore tendenza a formare addotti MH+. Mentre 
questo effetto è irrilevante per la conversione dell’ammina N-teminale (pKa ? 8,0), è 
stato osservato che il 91% dei peptidi non identificati in seguito alla marcatura 
conteneva un residuo di lisina (pKa ? 12,0), in posizione C-Terminale. I dati ottenuti 
spiegano la complementarietà osservata a seguito della marcatura con DNS-Cl, che 
ha permesso di identificare per la BSA 18 peptidi normalmente non osservati. In 
questo studio sono anche state valutate le caratteristiche di frammentazione dei 
peptidi dansilati in modalità Post Source Decay mediante uno spettrometro di massa 
MALDI-TOFTOF. Risulta che la presenza del residuo di dansile in posizione N-
terminale permette di ottenere una migliore copertura della sequenza aminoacidica 
ricavata dall’interpretazione degli spettri MSMS. Infatti in fase di ionizzazione, il 
gruppo dimetilammino-naftalenico assorbe discrete quantità di energia che è 
ridistribuita nei nei vari sottolivelli vibro-rotazionali dei legami chimici lungo la catena 
peptidica. Questo comporta un aumento della probabilità di frammentazione del 
legame peptidico in prossimità del sito di dansilazione, infatti lo spettro MSMS risulta 
essere caratterizzato da una maggiore presenza di segnali relativi alla regione N-
Terminale. In definitiva l’analisi complementare mediante la dansilazione dei peptidi 
triptici è vantaggiosa per aumentare la copertura di sequenza e l’attendibilità dei dati 
statistici anche per l’analisi LC-MALDI/MSMS. Ciò è stato verificato su scala 
proteomica dall’analisi di miscele complesse di estratti proteici di E.coli.  
L’ultimo oggetto di studio affrontato in questo progetto di tesi è rivolto allo sviluppo di 
una procedura in grado di permettere l’analisi dei differenti stati di ossidazione dei 
residui tiolici in vivo. Tale problematica è attualmente di grande interesse in quanto la 
transduzione di importanti segnali biologici è regolata dalla modifica ossidativa 
reversibile dei residui di cisteina (17). Inoltre è stato osservato che diversi fenomeni 
patologici sembrano relazionati a una incorretta ossidazione di tali amminoacidi a 
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seguito di eventi di stress ossidativo (18). I metodi dell’analisi Proteomica classica 
non sono sempre efficaci per la definizione dello stato di ossadazione delle cisteine. 
Questo perchè la più parte delle modifiche è reversibile e quindi fortemente 
suscettibile ai tamponi normalmente impiegati per l’estrazione delle proteine e il 
frazionamento elettroforetico. Per questi motivi sono stati studiati approcci alternativi 
che consistono nell’alchilazione differenziale dei tioli, in tamponi riducenti a selettività 
decrescente (19). La pletora dei reagenti alchilanti impiegati permette oggigiorno di 
valutare le variazioni dello stato ossidativo dei tioli mediante le classiche tecniche di 
Proteomica. Tuttavia i reagenti utilizzati non sempre favoriscono tutti i passaggi 
analitici che caratterizzano l’approccio proteomico. In questo progetto di tesi sono 
stati effettuati studi preliminari per valutare l’applicabilità dei derivati del dansile nella 
caratterizzazione delle modifiche post-traduzionali connesse allo stato d’ossidazione 
dei tioli. Infatti, oltre alle eccezionali caratteristiche di spettrometria di massa 
mostrate nei precedenti studi di questo progetto di tesi, i dansil derivati possono 
essere impiegati per la rivelazione di fluorescenza di proteine frazionate per 
elettroforesi (20). Inoltre in bibliografia sono presenti diverse metodologie che 
prevedono l’utilizzo dei dansil-derivati nelle tecniche di istochimica (21) e citometria a 
flusso (22). Dunque sembrerebbe possibile sviluppare per la prima volta una 
metodologia che prevede l’utilizzo di un unico reagente per la determinazioni dello 
stato ossidativo dei tioli nei tessuti e cellule compatibile con il frazionemento 
elettroforetico e l’analisi di spettrometria di massa. La strategia prevede la marcatura 
dei tioli con il reagente dansil-aziridina (DAZ) e successiva alchilazione con 
iodoacetammide in un tampone riducente. Per raggiungere questo scopo sono state 
ottimizzate le condizioni di reazione ed è stata verificata la selettività del reagente 
utilizzando come proteina standard la BSA, caratterizzata da 34 cisteine ossidate in 
17 ponti disolfuri e una in forma ridotta. Verificata l’efficienza della reazione, la BSA 
modificata con DAZ è stata frazionata mediante SDS-PAGE per valutare la 
sensibilità della rivelazione di fluorescenza che è stata stimata compresa tra 1 e 
10ng di proteina marcata. E’ stata inoltre valutat la possibilità di apprezzare 
ossidazioni delle cisteine mediante variazione dell’intensità di fluorescenza in 
proteine frazionate mediante elettroforesi. Questo è stato realizzato facendo reagire 
la BSA con una soluzione 1 mM di H2O2 e successivamente applicando il protocollo 
di marcatura ottimizzato. E’ stato osservato che la banda corrispondente alla BSA 
ossidata presentava un’evidente diminuzione della fluorescenza dovuta alla minore 
disponibilità di tioli liberi dopo la reazione di ossidazione. Questo tipo di analisi è 
stata anche estesa ad un estratto proteico di E.coli permettendo di confermare la 
specificità e l’applicabilità del metodo su scala proteomica. In questo progetto di tesi 
sono state anche ottimizzate le condizioni di reazione per realizzare la marcatura dei 
tioli intra-cellualre. Questo è stato possibile perchè i dansil derivati sono permeabili 
alla membrana cellulare. E’ stato verificato che la quantità di reagente utilizzato non 
fosse stata nociva per le cellule batteriche ed umane mediante test del blu tripano, 
microscopia in fluorescenza e citometria a flusso. Dunque, cellule batteriche e 
umane sono state sottoposte a stress ossidativo indotto da H2O2 ed inseguito trattate 
con dansil-aziridina. Mediante citometria a flusso è stato possibile discriminare la 
popolazione di cellule sottoposte a stress in quanto presentava una minore 
emissione fluorescenza rispetto al controllo. Inoltre dall’analisi dell’immagine dei gel 
2DE degli estratti cellulari relativi ai campioni sopra citati è stato possibile identificare 
le proteine coinvolte nei processi ossidativi. Allo stato attuale la strategia presentata 
deve ancora essere ottimizzata in alcuni punti. Infatti, devono essere valutate 
eventuali differenze tra la marcatura in vitro ed in vivo, dovute alla differente 
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accessibilità dei residui di cisteina da parte del reagente. In caso affermativo si 
potrebbe considerare la possibilità di estendere la procedura anche a studi 
conformazionali e di interattomica. Inoltre allo stato attuale la strategia, come tutte le 
altre metodologie presenti in letteratura, anche se permette di identificare la proteina 
coinvolta nel processo di ossidazione non consente sempre in maniera univoca la 
determinazione del sito di modifica. Questo scopo sarà raggiunto, nel prosieguo di 
questo progetto, quando saranno sintetizzati analoghi del dansile arricchiti della loro 
componente isotopica. 
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Résumé 
 
Le travail de thèse présenté dans ce mémoire consiste en la mise au point de 
nouvelles méthodologies d’analyse pour les études protéomiques. Le sujet principal 
de ce travail de thèse a été l’optimisation de procédures innovantes qui se basent sur 
la manipulation chimique de mélanges peptidiques et sur l’ analyses avancée par 
spectrométrie de masse MS3, et qui ont pour objectif d’améliorer les capacités 
d’identification et quantification des modifications post-traductionelles par une 
approche protéomique. 
Une nouvelle procédure d’identification des sites de nitration des protéines a été 
mise au point, par le moyen d’une modification sélective des peptides nitrés après 
dansylation et par l’analyse par spectrométrie de masse en modalité Precursor Ion 
Scan/MS3. Une telle stratégie pemet de surmonter quelques unes des limites 
classiques de l’analyse des sites de nitration des protéines, comme la nécessité 
d’utiliser des techniques d’enrichissement chromatographique mais permet aussi de 
surmonter les difficultés d’identification des peptides nitrés par spectrométrie de 
masse. Il a également été optimisé une procédure pour l’identification et la 
quantification des sites de nitration des protéines par le biais d’une modification 
sélective des peptides nitrés avec le réactif iTRAQ et par une analyse successive par 
spectrométrie de masse en modalité Precursor Ion Scan. Cette technique peut etre 
considérée comme étant la première stratégie capable simultanément d’identifier et 
de quantifier les sites de nitration des protéines par spectrométrie de masse. En 
outre, différentes conditions d’analyses pour l’identification des phospopeptides dans 
des mélanges biologiques ont été évaluées par analyse LC-MSMS en modalité 
neutral loss et precursor ion scan. De plus, une nouvelle procédure qui utilise la 
chimie des micro-ondes afin d’améliorer les analyses LC-MALDI-MSMS a également 
été optimisée, par un marquage extensif des mélanges peptidiques analysés avec du 
chlorure de dansyle. Cette étude a également permis de comprendre les 
caractéristiques de la fragmentation des peptides dansylés dans des éxpériences de 
post source decay. Enfin, des expériences préliminaires ont été réalisées afin de 
vérifier la possibilité d’utiliser les dérivés de la dansylation pour développer une 
nouvelle procédure finalisée à l’identification des états d’oxydations des résidus de 
cystéine des protéines séparées par une électrophorèse bi-dimensionelle. Les 
rèsultats obtenus indiquent que les dérivés du dansyle permettent de déterminer les 
variations des états d’oxydation des cysteines par des technniques de cytométrie en 
flux, électrophorèse bidimensionelle et spectrométrie de masse.  
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1. INTRODUCTION 
 
1.1 Proteomics impact on modern Biotechnologies 
 
In modern terms, Molecular Biotechnology has come to mean the use of cells and 
tissue cultures, molecular biology, and in particular recombinant DNA technology, to 
generate unique organisms with new features leading to produce specific products, 
that many times are proteins. On this basis, the fields of the Industrial (white) 
Biotechnology, Medical (red) Biotechnology, Vegetal (green) Biotechnology, can be 
distinguished if these tools are applied to the development of industrial processes, 
molecular studies of the diseases and drug discovery, agricultural and food 
production improvement respectively. Most of the biotechnological products result 
from the use of recombinant DNA technology, where a recombinant production 
system is set up, based on a genetically modified host cell, using either microbial 
fermentation or mammalian cell cultures. In addition to fermentation, the extraction 
and subsequent purification of the desired bio-product from the fermentation broth is 
an important part of the overall production process. These downstream procedures 
form a major part of the overall process development and are important in the 
determination of the final productivity and characteristics of the product. Traditionally, 
process development involves designing and optimizing upstream and downstream 
processes based on empirical data, with only incomplete or limited understanding at 
the cellular level. The advent of Genomic and Proteomic technologies, which can 
provide details at the molecular level, has generated interest in the application of 
these tools for the development of biotechnological processes.  
Genomics is the comprehensive analysis of the genetic content of an organism. It 
also often refers to genome wide studies of mRNA expression (1). Already during the 
“genomic era” that ended with the sequencing of Human Genome in the year 2003, 
the scientific community realized that the identification of coding sequences is 
insufficient to understand the molecular mechanisms of cell activity. Therefore, the 
attention increasingly focused on the products of the genome: the proteins and 
enzymes that determine cellular architecture and function. According to the current 
annotation, the human genome consists of about 25000 genes, scattered among 3 
billions nucleotides of chromosome-based DNA code (2). This represents a huge 
amount of static information, which needs to be correlated with dynamic information 
coming from gene products and their interactions. In contrast to the genome, the 
proteome is dynamic and is in constantly modulated because of a combination of 
factors, which include mRNAs differential splicing, post translational modifications 
(PTMs), as well as temporal and functional regulation of gene expression as well as 
the formation of multi-protein complexes.  
Proteomics provides methods for correlating the vast amount of genomics 
information that is becoming available with the equally vast protein information that is 
being produced through analysis of cells under normal versus altered states (3). In 
the last few years Proteomics has become a powerful tool for the investigation of 
complex biochemical processes and protein-protein interactions (4-5). In medical 
sciences, the discovery and the use of disease biomarkers, especially in cancer and 
neurodegenerative diseases, has became a routine analysis for a better and more 
targeted medical treatment (5–8). Currently, Proteomic methods are widely used in 
food biotechnology as quality control so the terms “industrial process proteomics” (9) 
and “industrial proteomics” (10) are currently used. It has also been shown that 
proteomic technology can be very useful in the development of production processes 
 10 
for therapeutic proteins by using genetically engineered animal cells (11-12) or 
human stem cells (13). In “classical” fermentation industry, Proteomic methods can 
also be used for the identification of targets for bioprocess improvement (14). Unlike 
mammalian cells that are used almost exclusively for production of protein-based 
therapeutics (15), microbial cells are also widely used for production of small 
molecules (14). Microbial fermentation in food processing has been a tradition for 
thousands of years (16). Besides optimization of the fermentation process, 
purification, optimization of yield and purity, the characterization of the final process 
are crucial steps in integral process development.  
In the near future, in parallel with genomics and metabolomics, proteomics will play 
an important role in process development. These technologies will be used to 
enhance productivity of microbial cells or to influence targeted properties of the final 
product. Knowledge of the cell proteomics will be helpful to predict the cellular 
response to environmental change and its adaptation to different substrates. Finally, 
proteomics are important for optimization of downstream processing and for thorough 
analytical investigation of the final products.  
 
1.2 Proteomics analysis 
 
The terms Proteomics is associated to the set of analytical tools used to depict the 
protein compartment of a cell. This innovative “biotechnology” is the natural 
continuation of Genomics approach. It moves away from classical Protein Chemistry, 
also if from the latter, taking advantages of all the heritage of knowledge and 
methods developed from the latter. In fact, the great innovation of the Proteomics 
analysis is the idea that to study the cellular molecular mechanisms, in which 
proteins play a key role, it is necessary to study the entire proteome as a “single 
analyte”. Meaning that, the proteins target of the analysis are no more purified and 
isolated from their highly complexity context found in living systems. Indeed, they are 
analyzed all together in order to obtain a real snapshot of the proteome, related to a 
particular cell state. From this general definition it may distinguish two main area of 
interest: i) “expression proteomics” that is focused to the characterization of the 
change in protein expression levels and definition of PTMs (17), ii) “functional 
proteomics” aimed to understand protein-protein interactions (18), signal pathways 
(19) and structure function relations.  
However, the proteome analysis is hindered by several analytical problems. First of 
all is the large range of protein concentration present in the samples. For example, in 
the human serum the 50 most abundant proteins represent about 99% of the total 
amount of protein mass but only less than 0.1% in number (20). Another important 
challenge is surely the detection of PTMs. In fact only a minor part of the proteins of 
interest are post translationally modified, for instance just 1 in 106  tyrosines are 
nitrated (21). The high sample complexity, in terms of number of analytes, is also a 
feature that has to be taken in account, in fact for about 21000 human protein-
encoding genes are estimated around 106 human proteins (22). For these reasons 
the Proteomics analysis needs a pool of methodologies and technologies that are 
high throughput, sensitive, selective toward the proteins target of the analysis and 
with large dynamic range effectiveness.  
Currently, Proteomics may rely on many chromatographic and electrophoresis tools 
to fractionate the analytes. However, if different approaches are in relation to these 
techniques of separation, all the strategies have a common essential final step: the 
mass spectrometry (MS) analysis of peptides or proteins. 
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-1.2.1 Mass spectrometry tools for Proteomics analysis 
 
a) Principles and instrumentation 
Mass spectrometers consist of three basic components: an ion source, a mass 
analyser, and an ion detector. Molecular mass measurements are carried out 
indirectly, calculating the mass charge ratio (m/z), by the analysis of kinetics 
behaviour of the ionized analytes in the gas phase and in electromagnetic fields. The 
need of a method that transfers efficiently intact molecules from solution or solid 
phase into the gas phase, was the limit that for many years excluded proteins and 
peptides from this powerful technique. With the development and the 
commercialization of mass spectrometers based on the ion source technologies of 
“Matrix-Assisted Laser Desorption/Ionisation” (MALDI) (23) and “Electrospray 
Ionisation” (ESI) (24) the gas phase ionization of polar analytes has also become 
possible. Both MALDI and ESI are considered as soft ionisation techniques with 
which the generated ions undergo minor fragmentation.  
In MALDI technique, samples are co-crystallised with a weak aromatic acid matrix on 
a metal target. A pulsed laser is used to excite the matrix, which causes rapid 
thermal heating of the molecules and desorption of ions into the gas phase in a 
pulsed beam fashion. After the laser activation, the weak acid nature of the matrix 
drives to generate single-charged ions in the form of MH+ adduct. The one-one 
analyte-MS signal relation in MALDI-MS makes possible to analyze also multi-
component mixtures without any interpretation difficulties caused by the peaks 
overlapping. 
ESI creates ions by spraying an electrically generated fine mist of ions into the inlet 
of a mass spectrometer at atmospheric pressure. By creating a potential difference 
between the capillary, through which the liquid flows, and the inlet of the mass 
spectrometer, small droplets of liquid are formed. These are transferred into a heated 
device to induce efficient evaporation of solvent. Once the droplets have reached the 
Rayleigh limit, ions are desorbed from the droplet generating gas-phase ions in a 
continuous beam fashion. The ions produced by ESI sources are multiply charged 
adducts MHnn+, where the number of protons incorporated depends on the statistical 
acid/basic equilibrium of the analytes. This situation complicates the spectra 
interpretation because each analyte may give rise to many signals in the spectrum. 
For this reason it is not possible to analyze complex mixture without a previous 
fractionation. However, because the ionization is carried on a liquid flow, ESI source 
may be simply coupled to liquid chromatography systems. The most notable 
improvement of ESI technique has come from the reduction of the liquid flow rate 
used to create the electrospray to nano-scale level. This device leads to create ions 
more efficiently (25) because the charge density at the Rayleigh limit increases 
significantly with decreasing droplet size (zR ? 8R3/2 where R is the droplet radius). 
Another advantage using separation techniques with low flow rate ESI is the increase 
in the concentration of the analyte as it elutes off the column.  
After ionisation, the analytes reach the mass analyzer, which separates ions by their 
mass-to-charge (m/z) ratios. Ion motion in the mass analyser can be manipulated by 
electric or magnetic fields to direct ions to a detector, usually an electro-mcultiplier, 
which records the numbers of ions at each individual m/z value converting the signals 
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in current. In Proteomic research, four basic kinds of mass analysers are currently 
 
 
Fig.1.1 Main components of Proteomics commonly used mass spectrometers 
 
used: time-of-flight (TOF), ion trap (IT), quadrupole (Q), and Fourier transform ion 
cyclotron resonance (FTICR) analysers (Fig.1.1). All four differ considerably in 
sensitivity, resolution, mass accuracy and the possibility to fragment peptide ions. 
By using a TOF analyzer the mass spectrum is measured by determining the flight 
time of ions after the extraction and the acceleration from the source by an electric 
potential. The ions are separated in a field-free flight tube. The ions time-of-flight is 
related to their m/z values: 
 
m/z= 2Et2/d2,   E= potential of extraction, t= time of flight, d=length of the tube 
 
The experimental arrival times of each ion to the end of the flight tube can be a mass 
spectrum can be acquired. The two main improvements to enhance the resolution of 
this technique were the “delayed extraction” that corrects the initial velocity vectors 
and the “reflectron” (26) that increases the ions path, curving their trajectories. TOF 
based instruments have high resolution and accuracy characteristics and they are 
usually coupled to pulsed beam type sources. 
The simpler mass analyzer is the quadrupole that consists of four precisely straight 
and parallel rods that are aligned in the axial direction of ion beam. A voltage 
combining a DC component and a radio frequency (RF) component is applied 
between adjacent rods but with inverse polarity, opposite rods are electrically 
connected. Once inside the quadrupole the ions will oscillate in the (x) (y) direction as 
a result of the electric field. The differential equation which describes the motion of 
the charged particle along the x or the y-axis is: 
 
d2f /dτ2= - [a-2qcos(2τ)]f     with      a =- 4/ω2ro2(e/m)U,  q =- 2/ω2ro2(e/m)V,  τ=ωt/2 
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(with ω the frequency of RF, r0 the radius between the electrodes, U is the constant 
DC voltage, V the maximum RF voltage, m the ion mass and e its charge). The 
general solution of this differential equation was found by Mathieu and has the form: 
 
f =AeµτF(τ) + B-µτ (-τ),  with  µ  (a, q)=α  +iβ   
 
 
A and B are the constant of integration while α  and β  are real function of a and q 
(27). It is possible to demonstrate that for a given m/z value ion oscillations are stable 
only for a restricted couple of a and q values that are operative depending 
respectively by the DC and RF voltage. Otherwise the ions have very large x,y 
coordinates and strike the rods and dissipate. The family of Mathieu stable solutions 
may be graphically represented in function of RF and DC. The resulting diagram 
helps to understand for a given m/z for what couple of RF and DC values it would 
have stable trajectories (Fig.1.2A). The symmetry around the DC voltage =0 means 
that in only RF mode the quadrupole lets pass all the ions. The mass filtering is 
realized by changing in time the DC voltage and the RF frequency, keeping constant 
their ratio (Fig.1.2B), therefore instantly varying the ions that are in their boundary 
stability condition. 
The three-dimensional ion traps (IT) are composed of three hyperbolic electrodes: 
two end-caps and one ring. The ring electrode defines the radial direction and the 
end-cap electrodes define the axial direction. One end-cap electrode will usually 
have a hole in it to allow ions to enter the trapping volume. The ions are injected 
axially with kinetic energies that lead to pass the fringing field barrier near the end-
cap hole. However, to overcome the exit of the ions, their high kinetic energy is 
dissipated by cooling them by collision with neutral gas by filling the trap with helium 
(28). In the IT ion trajectories undergo the same quadrupole rules and motion 
Fig. 1.2 Panel A shows a RF voltage vs DC voltage diagram of Mathieu stable solution for the ion  
219 m/z in a 9.5 mm diameter quadrupole. All the RF-DC couples of voltage values inside the curve 
give to the ion stable trajectories and may be detected. Panel B shows the effect of the quadrupole 
scanning. In the RF voltage VS DC voltage diagram are represented three stability curves for the ions 
28 m/z, 69 m/z and 219 m/z. The “operative line” starting from the origin represents the RF and DC 
ratio used during the scan in function of the time. When the line crosses the stability region of an ion it 
means that it is actually scanned. By this representation it is showed that with a linear scan line 
through the origin, the peak width increase geometrically with increasing mass. By using higher DC/RF 
ratio the operative line increase its slope and it passes through less stability regions resulting in higher 
resolution scan.  
 
A B 
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equations showed before. However, the geometry of the electric field used gives to 
the ions an elliptical trajectory in the radial plane so they are confined inside the 
volume of the electrodes, and maintains a stable periodic motion in the axial direction 
with a peculiar secular frequency ωz for each m/z (29). By applying a supplementary 
voltage at the frequency ωz, the axial oscillation is increased causing the ions ejection 
from the trap. By timely changing the frequency it is possible to scan the mass range. 
Mass spectrometer equipped with IT technology has good sensitivity but low 
resolution and mass accuracy. 
The most common FTICR analyzer consists of a cell composed of six plates 
arranged in the shape of a cube (30). This cell is oriented in a magnetic field (4,7-13 
Tesla) so that one opposing pair of plates is orthogonal to the direction of the 
magnetic field lines. It is common for trapping electrodes of cubic cells to have 
openings that permit electrons or ions to enter the cell along the magnetic field lines. 
The four remaining plates are used for ion excitation and ion detection. When the 
ions pass into the magnetic field they are bent into a circular motion in a plane 
perpendicular to the field by the Lorentz Force. The cyclotron frequency of the ions 
rotation is dependent on their m/z ratio 
 
ωc=eB/2πm,  ωc, secular frequency, B=magnetic field 
 
At this stage, no signal is observed because the radius of the motion is very small. 
The excitation of each individual m/z is achieved by a RF pulse across the plates of 
the cell. Each individual excitation frequency, corresponding to the peculiar ωc value, 
will excite the ions natural motion to a higher orbit inducing an alternating current 
between the cell plates. When the RF goes off resonance for that particular m/z 
value, the ions relax to their natural orbit and the next m/z packet is excited. Although 
the RF sweep is made up of a series of stepped frequencies, it can be considered as 
all frequencies simultaneously. This results in the measurement of all the ions 
together producing a complex frequency vs. time spectrum containing all the signals. 
The deconvolution of this signal by Fourier transform methods results in a frequency 
vs intensity spectrum, which is finally converted to the mass vs. intensity spectrum. 
FTICR mass spectrometers are the most accurate and the highest resolving power 
instruments currently available. (31)  
 
b) Tandem Mass Spectrometry 
Conventional MS produces ions that are separated by m/z and analyzed directly. If a 
soft ionization method is used, the mass spectrum will lead to calculate the molecular 
weight values of compounds present in the analyte but with little or no structural 
information. In a tandem mass spectrometer, ions of a particular mass (parent or 
precursor ion) are selected by the first mass analyzer (MS1) can be subjected to 
collisions with neutral gas atoms or molecules. This process is known as Collision 
Induced Dissociation (CID). The ionic fragments (daughter ions) are then separated 
in a second analyzer (MS2), giving structural information such as the amino acid 
sequence of a peptide. Therefore, to realize the multi-stage MS analysis many mass 
spectrometers equipped with hybrid combinations of analyzer were commercialized. 
Triple quadrupole (QqQ) (32), quadrupole/ time of flight (QqTOF) (33) and time of 
flight/ time of flight (TOFTOF) (34) may perform “space separated” tandem MS. Ion 
trap analyzer by itself may realize tandem MS experiments. This is accomplished by 
the expulsion of the ions trapped in MS mode, isolating the parent ion. This one is 
further fragmented by collision and the produced ions are first accumulated, then 
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scanned and detected. This “time separated” operative mode allows to realize very 
sensitive MSn experiments with simple equipments. However, the usage of a unique 
quadrupole trap analyzer leads to record MSn spectra with low mass range cut-off. In 
fact, during their generation the daughter ions have experience of the RF and DC 
values used to trap the precursor ion.  
 
These couple of potential values are in the stable region of Mathieu graphic for ions 
with m/z within 60% of the parent ion m/z, thus resulting in the complete loss of the 
smaller fragments (28). The chemistry of the fragmentation depends on many factors 
as the energy transferred to the ions, the time elapsing between the activation and 
the dissociation, the distribution of the internal energy (35). The amount of energy 
that can be deposited in an ion depends on the relative collision energy of the 
colliding ion/neutral pair under the classical impact rules. Considering that the neutral 
gas molecules have no velocity component the maximum centre-of-mass energy is: 
  
Ecom= (N/N+m) Ekin    
 
with N the neutral gas the mass, m the ion mass, Ekin the parent ion kinetic energy 
(36-37). It results that heavier ions are more difficult to fragment and, by using 
heavier neutral gas, higher amount of energy are transferred to the parent ion. The 
Ekin value depends on the mass spectrometer optics and the operative mode. It is 
also related to the energy transfer kinetics and to the distribution in internal degrees 
of freedom. CID experiments of peptides and proteins are realized in three different 
modes: “High Energy”, “Low Energy” and “Very Low Energy”. High Energy CID 
processes involve keV kinetic energy of the parent ion and they are carried out by 
sector-based instruments (38). The gas pressure inside the spectrometer is kept low, 
thus 1-5 collisions take place between the fragmentation events. Consequently a 
large part of ion population increments the internal energy of few eV while the 
remaining has high energy favouring only a restrict number of critical sequential 
dissociation (Fig.1.3A). Therefore the efficiency of the process is low (10%) and the 
spectra consist principally of d and w ions characterized by side chain fragmentations 
Fig.1.3 Panel A shows the internal energy distribution for an ion population after a rapid activation 
High Energy CID (7keV). In these condition the collision are rare and high energetic. Thus, it 
appears that only a restricted number of ions increases their internal energy with high increment 
resulting in poor sample utilization and drastic fragmentation. Panel B shows the ions internal 
energy distribution after a slow activation Low Energy CID (28 eV). In these conditions the collisions 
are more probable and the ions are cooled by the higher operative pressure (0,5 mtorr). Thus, it 
results that a large number of ions increases their internal energy favoring peptide bn,, yn and 
immonium ions generation. Panel C shows the ions internal energy distribution after a slow 
activation Very Low Energy CID (26 eV). The higher operative pressure (2 mtorr) and the lower ions 
kinetic energies lead to a very slow activation compatible with the formation of a reaction 
intermediate. It results in a Gaussian curve without high energy tail. Thus, the fragmentations follow 
the Arrhenius theory producing mainly bn,, yn ions 
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only useful to discriminate 
isobaric amino acids (38). 
Low Energy and Very Low 
Energy CID processes 
involve 1-100 eV kinetic 
energy realized by using 
QqQ and QTOF and Ion 
Trap instruments 
respectively. Higher gas 
pressures are applied 
leading to 10-100 
collisions between 
dissociations events. 
Under multiple collision 
conditions, energy is 
deposited in small 
increments, thus such 
activation effectively gives 
rise to a statistical internal 
energy distribution without 
higher component 
(Fig.1.3B and C). 
Consequently, no d or w 
ions or sequential 
dissociation is observed. 
The difference between 
Low Energy and Very Low Energy CID is essentially due to the “beam type” and “no 
beam type” features of the spectrometers. In fact the ions in QqQ and QTOF 
instruments have higher kinetic energy that may causes with the classical b and y 
ions also internal fragments as immonium ions (Fig.1.4) or a and x ions generated by 
the cleavage of α-C and carbonyl-C. On the contrary in the Ion Trap the ions are 
“cooled” resulting in lower energy fragmentations with enhanced efficiency (50-
100%)(39). The peptide bond cleavage is the principal event using Low and Very 
Low Energy CID, giving rise to b and y ions if the charge is retained on the N-
Terminal or C-Terminal containing moiety respectively (Fig.1.4). It is commonly 
accepted that the cleavage occurs predominantly through charge-directed pathways. 
In practice the fragmentation is initiated by a charge that is transferred to the vicinity 
of the cleavage site after the hydrogen rearrangement as described by the mobile 
proton model (40). This interaction of the charge and the heteroatoms is more 
important in the gas phase because the solvent molecules that typically stabilize the 
molecules in the solution phase are not present in the gas. However, a charge-
remote component is also observed in peptides CID fragmentation by which the 
acquired proton is localized on the more basic sites and takes no part to the 
fragmentation mechanism. In this pathway the peptide bond cleavage takes place by 
internal proton rearrangements, with charge retention on the initial protonated moiety. 
During this hybrid fragmentation pathway, singly-charged tryptic peptides give rise 
predominantly to y ions, by the presence of a strong basic lysine or arginine in C-
Terminal position. The ions of b series are better visualized in multiply-charged 
peptides where the probability to have a N-Terminal charge retention is higher. The 
resulting Low Energy CID fragmentation spectra recorded with the common mass 
Fig.1.4 Principal fragmentations of Low and Very Low Energy 
CID 
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spectrometer consist of a large number of peaks related mainly to the b and y series 
ions and also to eventual neutral loss of NH3, CO and H2O. By the interpretation of 
these spectra it is very simple to reconstruct the peptide sequences calculating the 
difference between the mass values relative to the ions belonging at the same series. 
This procedure may be also automated by using special algorithms (41-42) leading to 
the de novo sequencing or the protein database searching (43-44).  
 
-1.2.2 The first generation of the Proteomic analysis 
 
Proteomic analysis is aimed to analyze the whole proteome as a single analyte. 
However, the high complexity of the mixture examined imposes to use fractionation 
procedures in order to simplify the analysis without losing a global view of all the 
protein component of the samples. Bidimensional electrophoresis was the first 
technique leading to study the proteins on Proteomic scale and it is currently the 
leader technique in this field. Although 2DE development was realized many years 
before the post-genomic era (O’farrel et al. 1975) (45) the usage of this technique is 
still of high value because it allows to separate protein with high resolution (up to 
10000) (46) giving rise at the same time to protein maps of the biological matrix 
examined. 2DE consists of a first fractionation step by Iso-Electric Focusing (IEF) 
leading to separate proteins by their typical iso-electric point. In the second step, co-
focalized proteins are orthogonally separated by their hydrodynamic volume by SDS-
PAGE. 2DE conversion from only-imaging technique to Proteomic leader technique 
was favoured both by the commercialization of the first MALDI-MS instruments and 
by the enrichment of sequence database using genomic data. Thus, the synergy 
between 2DE separation features, MALDI-TOF accurate and sensitive mass 
measurement, the sequencing database software versatility, lead to develop in 1993 
the Peptide Mass Fingerprinting (PMF) (47-49) strategy that may be considered the 
first Proteomic high throughput methodology. PMF is based on the idea that a protein 
digested by an enzyme with known specificity produces a peptides pool that may be 
used as discriminatory for its identification. MALDI-TOF analysis produces a unique 
spectrum giving the accurate monoisotopic mass of all the peptides produced by the 
protein digestion, producing peculiar molecular masses map for each protein. This 
map is then compared to the ones generated in silico by the virtual digestion of all the 
protein sequences present in the genomic database. The results are statistically 
analyzed to find the best match. Therefore, such gel based strategy consists of six 
analytical steps: I) protein recovery from biological matrix II) 2DE fractionation III) 
Image analysis IV) in gel protein digestion V) MS analysis VI) Data base searching. 
The statistic nature of the protein identification, without any information about the 
amino acid sequence, implies a high hydrolysis yielding optimize the sequence 
coverage. In addition, in order to avoid misunderstanding results high protein 
purification and high mass accuracy of the mass measurements is also important. 
While the last two features are achieved by coupling 2DE and MALDI-TOF, it must 
be considered that the in gel hydrolysis leads to poor sequence recovery. This 
characteristic was the most important limitation of the first generation Proteomic 
analysis. The introduction of MS2 This problem was in part overcome with the 
introduction of nanoLC-MS2 technique in 1996, leading to determinate peptide amino 
acid sequence (50-51). So, the association of molecular weight and amino acid 
sequence for each given peptide is a milestone of Proteomic evolution. The statistic 
relevance of the sequence data coupled to the mass measurement allows to the un-
ambiguous protein identification, even if a reduced number of peptides is detected. In 
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the last 10 years many technological progresses have changed the materials and 
methods of the gel-based Proteomics. New gel dyes were introduced in order to 
enhance the 2DE sensitivity (Brillant Blue Coomassie, Sypro, DIGE) (52-53) and the 
selectivity toward the post-translational modifications (Pro Q diamond, Pro Q 
emerald) (54-55). Mass spectrometry analysis has been improved by using new 
instruments with higher resolution power and faster scan rates. The electrophoresis 
techniques are radically changed with the introduction of the first dimension gel strip 
with pre-formed gradient. Also research algorithms were powered and protein 
database were enriched, in particular considering the complete human genome 
sequencing in 2003. This overall evolution of modern Proteomic is driven by the 
methodological revolutions in the protein analysis over the years 1993-1995. This is 
particularly true if we consider that the six steps procedure is still currently un-varied 
in many Proteomic applications of the more recent research lines (56-57). 
 
-1.2.3 The second generation of the Proteomic analysis 
 
The great results reached by the coupling of the 2DE high resolution power and MS 
flexibility were the driving force for the development of modern technologies and high 
throughput strategies. In fact, the analysis carried out by 2DE-MS presents many 
constitutive limitations for the study of some kinds of Biological aspects. For example, 
the analysis of membrane proteins is still a challenge, because of the poor solubility 
of the sample and the low recovery after the extraction procedures. To avoid 2DE 
high conductivity, that may induce the gel over-warming, low quantity of sample must 
be analyzed. Under this condition a high percentage of less abundant proteins never 
reaches the detection limits and remains un-analyzed. For the same reason the 
PTMs identification is a challenge because of the sub-stoichiometric characteristics 
of the biological modifications. In addition the 2DE-MS strategy is not a high 
throughput approach. To identify the detected proteins a large number of spots have 
to be processed, however the method is time consuming and it requires an intensive 
work of skilled operators. This is very limiting because the modern Proteomic studies 
relies on reproducible analysis of large numbers of proteins and samples that is 
realizable only with a high automation of the procedures. Moreover, the 2DE has also 
low reproducibility and triplicates of the analysis are required. In order to overcome 
this problem and make accessible all the fields of analysis, a new generation of 
Proteomic strategies was implemented. It consists in the extensive hydrolysis of 
protein extracts without gel-based separation. By this “shotgun” method, theoretically 
all the proteins present in the sample may be identified, also the ones with low 
solubility, if enzymes capable to achieve heterogeneous phase digestion as trypsin 
are used. However, the resulting peptide mixtures are too complex to be directly 
analyzed by RP/LC-MS2 (58). The optimization of the multidimensional 
chromatography techniques followed by improved MS methods makes possible to 
realize this approach. The most common one employs µLC column packed with 
strong cationic exchange (SCX) and RP materials. Peptides are separated first by 
their electrostatic charge features then by their hydrophobicity followed by online MS2 
analysis. In parallel the evolution of the MS technique played a key role in the 
achievement of the gel free approach. In fact the introduction of high scan rate mass 
spectrometers, the realization of routinely data dependent methods to survey the LC 
separations make possible to manage a large number of samples and to analyze 
large amount of peptides in a full automated mode, resulting in a definitive high 
throughput strategy. However the large dynamic range of protein concentration in 
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biological samples is a major concern in gel free approach. The routine strategy 
combines a succession of one survey MS scan, the selection of the most intense 
precursors and the MS2 fragmentation of the selected ions. When applied to complex 
peptide mixtures the shotgun approach is limited by the LC co-elution effects. A large 
number of redundant peptides can be repetitively fragmented leading to the 
identification of the more abundant proteins. To overcome this problem Aebersold’s 
group introduced an innovative strategy called ICAT (Isotope Coded Affinity Tag) 
(59). It is based on the consideration that the modern database software leads to un-
ambiguous protein identifications by using accurate peptide mass measure and just 
short primary sequence passage. Thus to lower the complexity of the peptide 
mixtures they based the analysis on a reduced number of peptides per protein 
containing cysteine residue. This amino acid was chosen by the evidence that it is 
present in 92% of Saccharomyces cerevisiae proteins and by their hydrolysis with 
trypsin only 10% of the resulting peptides contain a cysteine residue (60). The global 
strategy consists in a three dimensional chromatography. To enrich the mixture with 
cysteine containing peptides, they are labelled with a thiol reactive biotin and purified 
by streptavidin affinity chromatography before the bidimensional LC-MSMS. On this 
basis many other labelling strategies are available aimed to enhance both the global 
protein identification and more specific PTMs. Despite 2DE is still a standard 
proteomic tool, the shotgun approach is the higher throughput approach for the 
extensive Proteomic analysis.  
 
-1.2.4 Quantitative Proteomics 
 
The estimation of protein expression changes is one of the main aims of Proteomics 
analysis. Therefore, more than an absolute quantification of peptides and proteins it 
is interesting to evaluate the relative variation of concentration. 
The different techniques introduced in the last years follow the parallel development 
of the analytical tools cited above. Gel-based strategy allows to obtain quantitative 
data because stained 2DE spot intensity can be directly related to the protein 
amount. Coomassie or silver stained gel images of different samples are digitized 
and aligned to be further compared spot by spot. There are many software 
consenting to carry out the spot alignments and the quantification. With the dual 
channel visualization (61) two gel images are discharged of their colours leaving 
respectively only the red and the green channel. By superposing the images the 
common spots appear orange, which tonality leads to calculate the relative 
contribution of the original base colour and so to obtain the relative quantitative 
estimations. However, Coomassie and silver stained spots have short range of 
chromatic linear variation in function of the concentration. In addition the low 
reproducibility of the 2DE technique makes it problematic to compare different gels. A 
solution to this problem was proposed by the Differential Gel Electrophoresis (DIGE) 
(53). It consists in the differential labelling of up to three protein extracts with MS 
compatible chromophore molecules. Then the extracts are pooled and analyzed by a 
unique 2DE gel. In this way the problems related to the migration reproducibility are 
overcome and the differential visualization of the samples is realized by using a 
scanner that acquires images at different wavelength. From the resulting three 
component colours it is possible to obtain quantitative information as discussed 
above. Also in this case the 2DE resolution limits affect the analysis: in particular the 
presence of overlapping protein species in the gel spots may invalidate the correct 
quantitative measure.  
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The shotgun approach allows 
the quantitative analysis by 
using MS. The signal intensity 
recorded by a mass 
spectrometer is directly related 
to the amount of ion species 
analyzed. However, the 
amount of ionized analytes 
detected depends on the 
ionization efficiency that is 
specific to each chemical 
species and that is also related 
to the instantaneous 
conditions of the source and 
the buffers. For these reasons 
it is possible to compare the 
MS signal intensity just 
between isotope molecules in the same mass spectra. This is realized in different 
proteomic approaches by labelling the protein or the peptide of different samples with 
isotope enriched tags. In fact by this modification the differentially labelled species 
have an identical chemical and chromatographic behaviour but are distinguishable by 
MS analysis using their isotopic composition. ICAT reagent for example is 
commercialized in two different isotopic forms with a different distribution of 12C/13C 
atoms that consents the relative quantitative estimation between two samples in MS 
mode (62). Major impact has had the iTRAQ strategy (63) that by a combination of C, 
N, and O isotope makes possible a peptide isobaric labelling consenting the MS2 
quantification without any complication of MS spectra. Isotope dilution may be also 
achieved by enzymatic reaction, in vitro introducing two 18O atoms in the peptide C-
Terminus by trypsin hydrolysis in H218O (64) or in vivo by SILAC (Stable Isotope 
Labelling with Amino acids in Cell cultures) (65) strategy based on the cell growth in 
isotope enriched amino acid medium. Although, each method has its strong and 
weak points in terms of flexibility, efficiency of the labelling, mass difference 
introduced, SILAC is considered the most powerful strategy. Because the reactions 
are quantitative and driven into the cell, the samples are pooled by the protein 
extraction minimizing systematic errors, the ∆M are high (9 Da) and no tag is linked 
to proteins or peptides. The wide application of this strategy is just limited by the 
relevant cost of the kit. Some alternative methods have been recently proposed to 
avoid the expensive costs of isotopic enriched reagent. The use of Rare Earth 
Elements (REE) was demonstrated (66) a valid alternative. In fact the peptides 
coordinating different REE have identical LC retention times. In addition the metallic 
centre allows to perform the analysis by Inductively Coupled Plasma (ICP) MS, which 
sensitivity and signal independence by the chemical structure make it the best tool 
for the quantitative analysis. Despite the important advances in the chromatographic 
and MS techniques, the “quantitative identification” of all the proteins in a biological 
system remains still a challenge, in particular for the bad data quality relative to the 
less abundant species (Fig.1.5). 
 
 
 
 
Fig. 1.5 Estimated Serum Proteomics capacity. More than 
50% of the less abundant proteins rests not identified and 
the quantification is realizable just on a restrict number of 
more concentrated proteins   
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1.3 Oxidative stress 
 
Disturbances in the intracellular redox equilibrium are often associated with disease 
(67). Oxidative stress, for instance, is an imbalance of the intracellular redox status 
that is found in many human diseases, such as rheumatoid arthritis, 
autoinflammatory and neurodegenerative diseases, and cancer (68-70). However, in 
most disorders, oxidative/nitrosative stress is a consequence and not a cause of the 
primary disease process. Oxidative stress is associated with a significant increase in 
the level of intracellular oxidising species, such as hydrogen peroxide, lipid 
peroxides, superoxide, peroxyl radicals (reactive oxygen species, ROS) (71). 
Mitochondria are the main cellular producers of ROS (72). Low concentrations of 
these metabolites in vivo have a key role in many physiologic functions as signal 
transduction, regulation of genetic expression and defence action against pathogen 
agents (73-75). It was estimated that in normal conditions 1% of the mitochondrial 
electron flow leads to the formation of the superoxide anion (O2-) (Fig.1.6, reaction a). 
Interfering with this mechanism may influence the production of O2- and increase its 
cellular concentration (76). In these cases O2- is rapidly converted in hydrogen 
peroxide H2O2 and oxygen O2 by the action of Superoxide Dismutase (SOD) action 
(Fig.1.6, reaction b), that is the main cellular O2- concentration regulator (77). 
However, H2O2 by reaction with transition metals may give rise to the hydroxyl radical 
(·OH) (Fig.1.6, reaction c) that is a very reactive and toxic species (78). The main 
H2O2 removal mechanism consists in the conversion in water by Catalase and 
Peroxidase activity (Fig.1.6. reaction d) (76). Reactive nitrogen species (RNS) as the 
nitric oxide (NO·) and the nitrite (NO2-), have many physiological roles (79). However, 
it must be considered that these species can induce strong modifications in many 
biological macro-molecules (80). Nitric oxide is an ubiquitary inter-cellular messenger 
Fig.1.6 Main in vivo ROS/RNS pathway   
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deputed to the blood flux regulation, of the neural activity and it also has an important 
role in the un-specific immune defence against the tumours. Nitric oxide is 
synthesized in vivo by the oxidation NADPH-dependent of the L-arginine catalyzed 
by the Nitric Oxide Synthetase (81). A large part of NO·signaling functions are 
accomplished by its reaction with Heme prosthetic group or by cysteine S-
nitrosilation. However, in contrast with these important functions the NO cytopathic 
nature is increased when this molecule reacts with ROS producing a class of 
derivatives that are very reactive toward proteins, lipids, and DNA (82). For instance, 
when NO· concentration in the tissues makes comparable the rate of the reactions 
with O2- and SOD, it is produced a relevant amount of peroxinitrite (ONO2-) (Fig1.6, 
reaction e). In fact, O2- and NO· reaction has a constant about three folds higher the 
one with SOD (76):     O2- + NO· → ONO2-  K =  6,7  x  109 M-1s-1   
                                    O2- + SOD → O2 + H2O2  K = 2,0  x  109 M-1s-1 
 
The ONO2- pKa is 6.8, so at physiological pH only the 20 % is protonated and 
converted to peroxinitrous acid (ONO2H) (Fig. 1.6, reaction f) (83). The last one is a 
high oxidative species that rapidly undergoes to homolytic rupture of N-O bond 
yielding to the nitrogen dioxide (·NO2) and the oxyhydril radical (·OH), two species 
directly involved in the in vivo protein nitration (83). The ONO2- toxicity is mainly due 
to its physiologic stability in the cis form (Fig.1.7) that may not isomerize to less 
reactive species as the nitrate (NO3-) (84) (Fig.1.6, reaction g). High quantity of ·NO2 
may also be generated by the reaction of the H2O2-dependent Myeloperoxidase in 
presence of low concentration of nitrite (NO2-) (85) or also by the reaction between 
NO· e O2 (Fig.1.6, reaction h). Peroxinitrite reactivity may be increased in presence 
of carbonic anhydride (CO2) (Fig.1.6, reaction i) rapidly producing peroxycarbonate 
(ONO2CO2-) that is considered the main 
cellular nitrating agent (83). However, 
ONO2CO2- has a short life-time (3 ms) 
and it is rapidly converted (Fig.1.6, 
reactions j and k). Obviously both the 
enzymatic and un-enzymatic systems 
protect the cells and the tissues by the 
toxic effects of ROS/RNS produced by the metabolism. However, in inflammatory 
pathologic states the concentration of such species may exceed the cell antioxidant 
faculties making relevant the effects showed above. 
  
1.4 Oxidative stress related PTMs 
 
The posttranslational modification of proteins by reactive oxygen and nitrogen 
species is associated with a large number of pathologies and also with biological 
aging (68-70). There is no question that some of these PTMs affect the structural and 
functional integrity of specific proteins. Most of such oxidants will react with several 
amino acids yielding to multiple products. However, only a few of these reactions will 
lead to stable and specific products, characteristic for a selected oxidant, which can 
then be used as a signature for the reaction of one specific individual reactive 
species with a protein in vivo. 
 
 
 
 
Fig.1.7 Cis-Trans peroxynitrite conformation 
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-1.4.1 Protein nitration 
 
Protein nitration consists in the addition of a nitro group (NO2) moiety to the side 
chain of the amino acids. The more susceptible substrate is the aromatic amino acids 
and most of all the tyrosine whose phenolic ring is activated toward such type of 
aromatic substitution. There are two more probable in vivo mechanisms (Fig.1.11) 
both involving the formation of a tyrosyl radical (·Tyr) (86). The generation of this 
specie seems to be the steady state of the reaction yielding 3-nitrotyrosine (NO2Tyr) 
and it is mediated by the presence of some ROS (CO3.-, OH.) mainly formed by 
ONO2- reactions (cfr.par.1.3)(86). The tyrosyl radical reacts with NO2. with the 
reaction rate controlled just by the diffusion of the two reagents (K = 3 x 109 M-1s-1) 
finally generating NO2Tyr. The dimerization of two ·Tyr equivalents producing the 
3,3’-diyirosine is a competent process. However, this kind of inter-molecular 
stabilization is limited by diffusional and steric effects, leaving the tyrosine nitration 
the main process (Fig.1.8). An alternative, less probable, way to NO2Tyr formation is 
the reaction between ·Tyr and NO. generating the intermediate 3-nitrosotirosine 
(NOTyr) that it is further oxidized to NO2Tyr by transferring two electron with the 
formation of the imminoxyl radical (Fig.1.8)(87). 
The NO2 tyrosine ortho-substitution implies the oxydryl pKa decreasing from 10.1 to 
7.2 (88). Therefore, at physiological pH about 50% of NO2Tyr groups are 
deprotonated so a negative charge is introduced also in hydrophobic regions 
inducing protein conformation modification and altering its biological activity. Protein 
tyrosine nitration exhibits a certain degree of selectivity, and not all tyrosine residues 
are nitrated. Tyrosine nitration sites are localized within specific functional domains of 
Fig. 1.8 In vivo 3-Nitrotyrosine generation main pathway 
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nitrated proteins (89). The factors that control site- and protein-specificity in tyrosine 
nitration are the proximity to the site of nitrating agent, the abundance of the protein 
and the number of tyrosine residues within a single protein (90), finally it may be the 
amino acid sequence or a specific nitrating environment (91). Tyrosine nitration 
occurs at inflammatory sites within specific cell types (92), suggesting that the 
proximity to the sites of nitrating agent formation is critical in inducing site- and 
protein-specific tyrosine nitration. Protein tyrosine nitration usually occurs near acidic 
residues in loop regions (89, 90) in areas free of steric hindrances. The location of 
tyrosine residues in favourable environments for nitration within the secondary and 
tertiary protein structure may also influence site-specific nitration. Tyrosine nitration is 
one of the not-abundant PTMs related to ROS/RNS that is stable in vivo and its 
generation it is increased directly with the incurring of inflammatory events 
associated to the iper-production of nitric oxide (92). For these reasons NO2Tyr is 
currently considered the best biomarker for the identification and quantification of 
stress oxidative event related to the RNS (93).  
 
-1.4.2 Thiol oxydation 
 
The redox chemistry of thiol in cysteine involved typically its anionic state (94). The 
features of the protein microenvironment controls thiol reactivity and the stability of 
the resulting modifications (95). For many proteins the first product of cysteine 
oxidation by ROS is the cysteine sulfenic acid (R-SOH) (Fig. 1.9). It undergoes a 
rapid condensation either with another protein thiol by an intramolecular or 
intermolecular interaction or with a small molecule thiol-like as glutathione or cysteine 
 
Fig.1.9 Stress oxidative related thiol PTMs 
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to form a disulfide bond. Then, thiol-based reductants may also return these species 
to the fully reduced thiol state (Fig. 1.9). Disulfide bonds can stabilize extracellular 
proteins, protect against irreversible inactivation, stabilize associations within protein 
complexes, modify structures to create, destroy or modulate functional sites, and also 
regulate enzymatic or transcriptional activity of proteins. Under conditions where 
ROS/RNS are generated, in addition to the typical ROS-generated products, 
reversible S-nitrosation may also play an important signaling role (96). In certain 
cases, the initial sulfenic acid may be stabilized by the protein microenvironment. 
However, in this case the protein sulfenic acid is vulnerable to the hyper-oxidation to 
the irreversible sulfinic or sulfonic acids (Fig. 1.9). These further modifications could, 
in spite of their typically irreversible status, also provide a signaling role analogous to 
a ‘fire alarm’ regarding cellular redox status (97). Sulfenamide (sulfenyl-amide) has 
recently been recognized as another stabilized oxidation product generated by the 
condensation of the sulfenic acid with a neighbouring backbone amide nitrogen (Fig. 
1.9). The resulting 5-membered ring structure appears to represent a form of 
oxidized cysteine resistant to the hyper-oxidation (98). A functional role for the 
generation of the sulfenamide was related to the changes in structure imparted to the 
tyrosine phosphatases active site, changes that may enhance the access by 
reductants and/or modulate interactions with other domains (99-100). Several studies 
have shown that cysteine oxidation is involved in several neurodegenerative 
diseases. Changes in the thiol/disulphide status were evaluated in ischemia events 
(101). Parkinson's disease protective proprieties of protein DJ-1 were demonstrated 
to be carried out by the correct oxidation of cysteine 106 to sulfinic acid (102). 
Recently, S-glutathionated proteins were found related to Alzheimer’s disease (103) 
and the thiol-protease oxidation was implicated in Alzheimer’s disease of the 
hippocampus and cerebellum (104). As far as the first aspect is concerned, oxidation 
of cysteine within proteins may result in various changes of the protein’s structure 
and function, not all of which are detrimental. There are many examples of oxidative 
activation as well as inactivation, some of which are based on modifications to active-
site residues, while others are the result of conformational changes. For instance, 
activation of a protein may be the result of the oxidative removal of an undesired 
thiolate ligand, as observed for matrix metallo-proteinases (105-106). From a 
structural point of view, thiol oxidation may lead to covalent disulfide bridges between 
cysteine residues or more highly oxidised sulfur species with distinct negative 
charges and steric requirements. These changes may be introduced by ‘random’ thiol 
oxidation during oxidative stress, or as part of a controlled enzymatic process 
involving thiol oxidases or thiol/disulfide oxido-reductases, (107). Such structural 
changes induced by oxidation are particularly beneficial in the context of the folding, 
oligomerisation and associated redox activation of proteins able to counteract 
oxidative stress.  
It is increasingly clear that a major component of the ROS-linked modulation of cell 
signaling pathways is the dynamic regulation of protein function by thiol modification. 
Redox signaling is known to affect gene transcription, at least four well-known 
transcription factors are known to be modulated by NO through S-nitrosylation (108-
109). For example, irreversible oxidation of certain cysteine residues to sulfinic or 
sulfonic acid might inhibit enzyme activity or serve as a signal for protein 
degradation. According to the ‘N-end rule’ pathway for protein degradation in 
mammalian cells, oxidation of N-terminal cysteine residues in certain proteins to a 
sulfinic or sulfonic acid is required for arginylation and subsequent degradation (110).  
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2. BIDIMENSIONAL TANDEM MASS SPECTROMETRY FOR SELECTIVE 
IDENTIFICATION OF NITRATION SITES IN PROTEIN 
 
2.1 Introduction 
 
In this chapter is reported the development of a new high throughput method to 
detect nitration sites in proteins. The biological relevance of this PTMs identification 
(see section 1.4.1) makes extremely important the study of new tools that can 
enhance the Proteomics analytical efficiency toward this subject. 
The strategy proposed may be classified as belonging to a class of general 
derivatization methods defined, by Amoresano et al. (1), with the acronym RIGhT 
(Reporter Ion Generating Tag). This approach is based on the labelling of the target 
residues with reagents capable to generate reporter ions in MS2/MS3 experiments. 
The detection of the reporter is a very restricted selectivity criterion that is used to 
reduce the analytical complexity to a few numbers of species, resulting in an 
improved duty cycle and enhanced dynamic range achievable by the MS analysis. In 
operative terms, the use of a high selective MS replaces the off-line chromatographic 
steps (affinity and/or bidimensional chromatography) aimed at isolating the labelled 
peptides with the advantage of avoiding the time consuming analysis and the 
tremendous decreasing in sensitivity. For these features, considering that the 
analysis of nitrated protein has followed the history of Proteomics evolution, we can 
define the strategy presented in this chapter as a third generation of the Proteomics 
analysis. 
 
2.1.1 Proteomic identification of nitrated proteins: the state of the art 
 
Proteomics approach is largely applied to the identification of nitrated proteins in 
tissues (2-6). After that in 1996 Ye et al. set up the first immuno-detection method 
(7), many works were realized using the visualization of nitrated proteins by Western 
blotting, followed by the MS analysis of the in situ digested proteins, positive to the 
immuno-assay. However, by this approach un-equivocally localization of nitration 
sites may be achieved just obtaining the 3-nitrotyrosine-containing peptide 
sequences by MS2 data. For 2DE fractionated proteins, the identification based on 
the fragmentation spectra was presented in only a limited number of works (8-9). 
This lack of data may be caused by the classical limitations of the 2DE technique 
(see 1.3.1), in particular the low quantity of protein extract analysable by iso-electric 
focusing (IEF), considering the sub-stoichiometrc characteristic of such PTMs. In 
addition of the common 2DE limitations, also the MS and MS2 analysis of nitrated 
peptides suffer from some technical hindrances that have to be considered. In fact, 
MALDI-TOF analysis, that is the main technology of the PMF strategy of the first 
generation Proteomics, was demonstrated to be useless in low-abundance nitrated 
proteins analysis. This because the photochemical decomposition of the 3-
nitrotyrosine (NO2Tyr), induced by MALDI UV laser, causes the loss of one or two 
oxygen atoms from the nitro group and also the formation of 3-aminotyrosine (10). 
The post-source decomposition splits in more satellite peaks the MS signal, 
decreasing dramatically the analysis sensitivity. The nitration of tyrosine residues 
may also compromise an efficient MS2 fragmentation. It was demonstrated that the 
neutral amino acid losses from the N- and C- termini (11) depends on the number 
and nature of basic amino acid residues in a given peptide ion. Moreover the 
rearrangement of doubly or higher charged peptide ions can lead to the neutral loss 
 31 
of internal amino acids (12). These processes may give rise to complex MS2 spectra 
with peaks that are not automatically assigned by common MS software, thus the 
manual interpretation of the MS2 spectra may be necessary in order to obtain 
unambiguous assignment of peptide sequences. This problem become real when 
sub-stoichiometric modified peptides do not generate the traditionally expected bn 
and yn fragments in yields too low for satisfactory assignment. This situation was 
observed during the MS2 analysis of 3-nitrotyrosine/Cu2+ complexes (13). In fact, 
collision induced dissociation leads to the neutral loss of H2CO3. A mechanism was 
proposed by which CID leads the intra-molecular reduction to amino group of the 
aromatic nitro group with oxygen transfer to the carboxylate group.  
The development of gel free methods is more appropriate for the identification of 
nitrated protein because it allows working with much higher amounts of nitrated 
proteins or peptides. By using multidimensional chromatography (SCX-RP)-MS2 
approach the rat neuroproteome was explored, identifying 31 sites of nitration in 29 
different proteins (14). However, although this approach allows to overcome many 
limits of previously reported gel-based methods, the detection of lower abundant 
nitrated proteins remains problematic. For proteome analysis of these PTMs, a 
specific enrichment step before the MS analysis is highly advised. The unique 
method to directly enrich nitro-protein uses anti-nitrotyrosine based affinity 
Fig.2.1 Panel A shows the procedure suggested by Nikov et al. consisting in the conversion of 3-
nitrotyrosine residue to its amine and the selective functionalization with a disulfide containing biotin 
tag using the peculiar 3-aminotyrosine 4.7 pKa. Panel B shows the procedure suggested by Zhang 
et al. also consisting in the 3-nitrotyrosine reduction to amine followed by the selective acylation with 
a thiol containing tag always using the peculiar 3-aminotyrosine 4.7 pKa 
B 
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chromatography. However this strategy does not find good agreement, considering 
the quantity of papers published (15-16). This is probably due to the nitrotyrosine 
antibody lack of specificity and the difficulty related to the manipulation of proteins 
instead of peptides solutions. There are no effective enrichment methods for nitrated 
peptides, probably because of the poor chemical reactivity of the nitro group. 
However, different strategies were introduced based on the conversion of NO2Tyr 
nitro group in amine group, which is chemically reactive and hence can be used as a 
chemical handle to employ tagging groups. Nikov et al. reported a novel method for 
the identification of peptides containing nitrotyrosine residues in complex mixture 
(17). Before the reduction of nitrotyrosine to aminotyrosine free thiols were blocked 
with iodoacetamide. Then cleavable biotin tags were selectively anchored to the 
aminotyrosines, and the protein sample was digested. The biotinylated peptides were 
purified on a solid support, which presented streptavidin. Further, the elution with 
DTT consents to recover the nitrated peptides from the solid support and to directly 
analyze them by MALDI-TOF mass spectrometry. Zhang et al. introduced an 
improved enrichment strategy by hooking thiol group to nitropeptides (18). In 
practice, they reduced nitrotyrosine to aminotyrosine, which was derivatized with N-
succinimidyl S-acetylthioacetate (SATA). Then by treatment with hydroxylamine the 
thio-esther group is converted to free thiol and this makes possible the purification 
using thiopropyl-sepharose beads. The enriched peptides were released and 
analyzed by LC-MS2, showing 6-10 times more nitrotyrosine-containing peptides than 
the global analysis of original samples. The nitro group reduction to 3-aminotyrosine 
was demonstrated to be useful also to improve MS analysis realizing LC-MS2 method 
based on the Precursor Ion Scan of the 3-amino-tyrosine immonium ion (m/z 181.06) 
(19). 
The state of the art traced in this paragraph shows the main problems related to the 
protein nitration analysis and how the technological improvements allow to enhance 
the performance of Proteomic approach. It emerges that, because of the high 
variability of matrices analyzed, it is not possible to define a general strategy allowing 
to detect nitrated proteins in any kind of biological samples. However, the availability 
of many tools, using different technologies and analytes physical-chemical 
proprieties, surely enhances the success probability of the research. Making a 
comparison between the strategies discussed above, it appears that the major 
problem is related to the sub-stoichiometric characteristic of the modification. In fact, 
the major improvements are achieved by the passage from gel-based techniques to 
nitro-peptides enrichment strategies using antibody or chemical derivatizations. 
However, it must be considered that many chromatographic steps are material and 
time consuming. Moreover, in the case of immuno-enrichment procedures, only SDS 
PAGE resolves the co-elution of the anti-body with the enriched protein mixture. Thus 
to avoid this problem, it may be interesting to develop a new strategy, using the 
chemical labelling features, not based on the chromatographic proprieties of modified 
peptides.  
By a general view of the recently proposed Proteomics methods, it appears that 
scientific community tends to underestimate the separation features of the mass 
spectrometers, relegating them just to instruments for the peptides sequencing. In 
fact, just in a reduced number of works it is underlined that a mass spectrometer has 
discriminatory faculties that may be addressed to avoid the multi-chromatographic 
techniques (20-21). In addition atto-molar sensitivity of modern mass spectrometers 
is compatible with in vivo concentration of sub-stoichiometric PTMs, avoiding the 
enriching procedures.  
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2.1.2 The hybrid Triple Quadrupole/ Linear Ion Trap mass spectrometer  
 
Triple-quadrupole (QqQ) analyzer consists in two resolving quadrupole mass filters 
(Q1 and Q3) separated by another one that is a collision cell (Q2). Instruments 
equipped with this technology are called ‘beam-type’”mass spectrometers because 
they are usually used with a continuous ion beam source. The beam-type feature is 
both the strength and the weakness of these instruments. In fact, when the mass 
filters are in scan mode, most of the ions are rejected, thus resulting in poor sample 
usage and low sensitivity (22). However, when the mass filters are not scanning, but 
they are set to transmit a single pre-selected ion, the efficiency and the sensitivity are 
very high. This characteristic, coupled with a high dynamic range, are the reasons 
that make the triple quadrupole system one of the most powerful tools for the 
analysis of complex mixtures (23). Moreover, QqQ optics also allow to perform very 
selective analysis such as precursor ion (PIS) and neutral loss (NL) scans that are 
not realizable with other mass spectrometers (24) (Fig.2.2). These specific scan 
modes lead to improve the detection of peptides with posttranslational modifications. 
For example in PIS mode, the Q3 is set to transmit a fragment ion, produced into the 
Q2, that is specific to a class of molecules while the first mass filter is scanning. By 
this approach it is possible to reduce the analysis only to the species of interest. A 
Proteomic application of this technique is achieved by tuning Q3 to the fragment m/z 
-79 from phosphorylated peptides MS2 loss of PO3−. This method has been 
demonstrated to enhance the identification of phosphorylated peptides about 100 
folds if compared with more sensitive but less specific scan modes (25). The space 
separated MS2 characteristic of the triple quadrupole leads to record high quality 
fragmentation spectra. However, switching from the MS to MS2 mode changes the 
duty cycle from 100% to about 0.1 – 0.01% per m/z, drastically reducing the 
sensitivity. In addition the main limit of this optic is also the low resolution and the 
inability to perform MSn experiment. 
The ion-trap analyzers are fundamentally different from the beam-type instruments. 
Three-dimensional ion traps (IT) do not allow performing the selective scans 
discussed above. A single pulse of ions is introduced into the device, and trapped 
radially by an RF field. Mass spectrometers using an ion trap technology are more 
Fig.2.2 Schematic operative representation of a triple quadrupole NL and PIS scan mode. Q1 scans in 
“DC/RF mode” the mass range, filtering sequentially the ions that are transferred to the q2. The 
second quadrupole is in RF only mode” and filled with neutral gas, thus the selected precursor ion is 
fragmented and the generated daughter ions are collimated and transferred by the RF field to 
successive analyzer. Q3 is fixed on a constant DC/RF value, with Unit resolution, consenting to reveal 
just the daughter ions having a given m/z. The fragment monitored during the analysis may be either 
constant following the same diagnostic moiety (PIS) or variable in function of the selected precursor 
following a fixed mass defect (NL) 
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sensitive instruments in comparison with triple quadrupole, because a full mass 
 
 
spectrum can be generated for each pulse of ions admitted. Moreover, several 
experiments of MSn may be performed, providing detailed structural information of 
the analytes. However, IT has a limited number of ions trapping capacity, mainly for 
the three dimensional nature of the RF field, which confines trapped ions to a point at 
the center of the device, causing space charge effects. In addition to this limitation, IT 
has low ion injection efficiency caused by the interference generated by the RF 
alternating field around the end-cap hole. The development of linear ion trap (LIT) 
has opened to a new generation of mass spectrometer. LIT consists in a classical 
quadrupole at which is applied a stopping potential DC at the entrance and at the 
exit. In a different way from the IT, in the LIT ions are not confined axially by the RF 
potentials. Thus a linear oscillatory motion results along the axis of the quadrupole 
that leads to enhance ion storage and capacity. In addition the axial ion injection 
avoids the interference with the RF field improving the trapping efficiency. By using 
an auxiliary voltage the trapped ions are ejected radially (e.g.Thermo-Finnigan LTQ) 
through two slots cuts in the quadrupole rods. The presence of two detectors doubles 
the sensitivity of the analysis (26) (Fig.2.3). However the presence of two slots cuts 
long the z axis imposes to fabricate extremely precise devices. The storage space 
ion capacity is 7x106, resulting 10 folds greater than the IT. These features make the 
radial ejection LIT a stand-alone analyzer (27). Trapped ions may also be ejected 
axially (28). This is realized by the deformed fringing RF field near the quadrupole 
Fig.2.3 Different types of LIT produced by Applied Biosystems and Thermo. Both the devices are 
characterized by the axial injection of the ions avoiding the end-cap interference found in the 3D-IT. 
Applied Biosystems equips their QTrap with an axial ejection LIT that may be rapidly converted in a 
classical quadrupole consenting to insert it in a triple quadrupole optic. Thermo-Finnigan equips their 
FT-ICR and Orbitrap with the more sensitive radial ejection LIT. The double detection and the 
emptying efficiency makes the ThermOo LTQ a stand-alone analyzer 
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exit, that converts the x, y motion, of the ions that are for a given RF at boundary 
stability conditions of Mathieu diagram, in axial motion. Thus the enhanced axial 
component of the motion leads ions to cross the DC barrier at the end of the 
quadrupole. Selective ion ejection is realized by changing RF potential that brings 
different m/z values at the boundary conditions. However, because the fringing field 
has short-range effect, just 20% of ions are ejected. The axial ejection, also if less 
sensitive than the radial ejection, makes possible to switch rapidly the LIT in a 
classical quadrupole. These features were used to project a hybrid mass 
spectrometer, commercialized by Applied Biosystems with the name QTrap, 
consisting in a triple quadrupole optic with the Q3 that is an axial ejection LIT (29). 
With this combination it is possible to perform all the selective scan modes of the 
triple-quadrupole instruments with the LIT sensitivity and high scan rate, allowing to 
carry out PIS and NL analysis at Proteomics scale. QqLIT geometry leads to improve 
MS2 quality of both the optics because the product ions scan is performed in hybrid 
manner. In practice the ions pass through Q1, which is tuned to transmit only the 
precursor ion of interest, and are accelerated into a high-pressure Q2 for the 
fragmentation. The fragments are then trapped in the LIT and then are scanned 
selectively. The lower sensitivity of the classical triple quadrupole MS2 analysis is 
improved by the higher LIT capacity. In addition the triple quadrupole space 
separated MS2 gives no peculiar ion traps low-mass cut off and enhances the 
dynamic range of the analysis. QTrap equipment and in particular the version 
4000QTrap, that reaches LIT scan rate of 4000 amu/sec, also allows to perform 
chromatography compatible MS3 experiment. It is performed as the MS2 fashion but 
the useless fragments trapped in the LIT are discharged by the application of a radial 
RF, thus isolating the second precursor that is further fragmented. The space 
separated and high scan rate features of 4000QTrap lead to very rapid MS3 scan 
(0.3-0,5 sec) allowing to carry out this experiment in a LC/MS2 method. 
 
2.1.3 Dansyl-Chloride: the RIGhT reagent 
 
RIGhT approach is based on the 
analytes separation using the 
molecular structure features of 
selectively labelled peptides and 
the MS2/MS3 fragmentation 
characteristics introduced by the 
reagent chosen. 
RIGhT reagents have a peculiar 
structure consisting in a Reactive 
group toward the interesting 
residues, a Linker group that is 
loss as neutral moiety in MS2 
experiment and a Reporter group 
that leads to generate stable 
fragment ions selectively 
detectable in MS2 experiment. For 
the development of a RIGhT 
strategy to improve the identification of nitrated proteins, Dansyl Chloride was chosen 
as marker molecule. It is a primary amines reactive with all the structural features of 
a RIGhT reagent (Fig. 2.4). Once again, one of the ancient protein chemistry 
Fig 2.4 Dansyl-chloride has the peculiar RIGhT 
reagent structure 
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methods is used for the modern Proteomic techniques. In fact Dansyl Chloride 
chemistry was largely used for its fluorescence characteristics to detect proteins and 
peptides. Currently, we inherit from the past a relevant experience in the usage of 
Dansyl derivatives, in particular because by this class of reagents it was possible to 
set up methods compatible 
with the biological 
concentrations, before the 
commercial availability of the 
mass spectrometers. After the 
introduction of these 
instruments at the end of the 
sixties, MS characteristics of 
dansyl derivatives were 
studied. In a work of 1968 
Marino et al. showed the 
impact electronic 
fragmentation features of the 
dansyl derivatives (30). This 
knowledge was recently used 
by Amoresano et al (1) to set 
up a method to detect 
phosphoserine/threonine 
residues consisting in the 
selective modification of target residues with dansyl cysteamine followed by the 
detection and identification of the labelled peptides by exploiting the characteristic 
fragmentation pathway of derivatives. In fact in MS2 fragmentation, dansyl peptides 
give rise to two peculiar ions with 170 m/z and 234 m/z, in addition the last ion may 
be further fragmented in a diagnostic MS3 transition 234-170 m/z (Fig. 2.5). These 
features were exploited by the use of an Applied Biosystems 4000QTrap mass 
spectrometer. By the coupling of this instrumentation and of the dansyl-derivatives 
characteristics, it was set up a high throughput LC-MS2 method that it is based on 
Precursor Ion Scan (PIS) and MS3 experiments. PIS was chosen as survey scan for 
its selectivity and high scan rate characteristics. It consists in a Q1 scan across the 
full mass range, the ions separated are fragmented in the collision cell (Q2), finally 
the Q3 is set to transmit only the mass of the diagnostic fragment m/z 170. Then the 
selected precursor ions  
 
 Scheme 2.1 3-dansyl-amino-tyrosine synthesis. 
 
are submitted to a combined MS2 and MS3 experiment to specifically detect only 
those producing the transition 234-170 in MS3 mode, leading to the selective 
detection of the dansyl-peptides. This MS based “depletion” of un-desired peptides 
substitutes others chromatographic steps making the mass spectrometer a second 
dimension of the RP-LC separation. 
Fig.2.5 Typical Dansyl-peptides CID fragmentations 
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Once again a look at the past allows to develop a new Proteomic strategy. In fact a 
dansyl chloride labelling procedure of nitrated proteins was developed by McIntyre in 
1990 in order to selectively detect by fluorescence this post translational modification 
(scheme 2.1)(31). The most interesting feature of the proposed strategy is to perform 
at pH 5.0 the labelling reaction of 3-aminotyrosine formed by the precedent reduction 
of 3-nitrotyrosine residues. In fact in these pH conditions the newly generated 
aromatic amine is deprotonated (pKa=4.7) while the collateral reactions with N-term 
and Lysine primary amines are un-favored by the protonation. Moreover, the acid pH 
decreases the competitive aqueous hydrolysis of Dansyl chlorides (32). However, the 
strategy proposed by McIntyre was not optimized at Proteomics scale and the MS 
analysis was not afforded. 
 
2.2 Materials and methods 
 
Chemicals. Tri(hydroxymethyl)aminomethane (Tris), 5-N,Ndimethylaminophtalene-1-
sulfonyl chloride (dansyl chloride, DNSCl), ammonium hydrogen carbonate (AMBIC), 
and iodoacetamide, were purchased from Fluka, Tetranitromethane (TNM), bovine 
serum albumin (BSA), ethylenediaminetetraacetic acid (EDTA), sodium dithionite 
(Na2S2O4), guanidine, sodium acetate, trypsin, and dithiothreitol (DTT) were from 
Sigma (St. Louis,MO), Acetonitrile (ACN) was purchased from Baker (Phillipsburg, 
NJ). SDS-PAGE and western blot chemicals were purchased from Bio-Rad. 
Nitrotyrosine antibody was from Alexis. Trifluoroacetic acid HPLC grade was from 
Carlo Erba. All solvents were of the highest purity available from Baker. All other 
reagents and proteins were of the highest purity available from Sigma. 
 
In Vitro Nitration of BSA. A BSA solution (10 mg/mL) in 200 mM Tris buffer (pH 8,0) 
was nitrated by addition of 350 mM TNM in acetonitrile using a Tyr/TNM ratio of 1/1 
(mol/mol). The reaction mixture was stirred at room temperature for 30 min as 
previously described.15 Nitrated BSA (N-BSA) was rapidly desalted by size exclusion 
chromatography on a Sephadex G-25M column (Amersham). Protein elution was 
monitored at 280 and 350 nm. The fraction containing the protein was manually 
collected, lyophilized, and stored at -20 °C.  
 
Tryptic Digestion. Aliquots of the BSA and N-BSA mixture were dissolved in 
denaturant buffer (guanidine 6 M, Tris, EDTA pH 8.0), reduced with DTT (10-fold 
molar excess on the cysteine residues) for 2 h at 37 °C and then alkylated with 
iodoacetammide (5-fold molar excess on the thiol residues) for 30 min at room 
temperature in the dark. Protein samples were desalted by the size exclusion 
cartridge PD-10 (Amersham), the elution was performed in AMBIC 10 mM. Protein 
elution was monitored at 280 and 350 nm. The fractions containing the protein were 
reunited, concentrated and digested by trypsin. Trypsin digestion was carried out 
using an enzyme/substrate ratio of 1/50 (w/w) either at 37 °C for 18 h. 
 
Reduction of Nitrotyrosine to Aminotyrosine. Reduction of 3-nitrotyrosine to 3-
aminotyrosine was carried out on aliquots of the modified peptide mixtures by using 
Na2S2O4 as previously reported (33). Before MALDI-TOF analysis, cleaning of the 
samples was performed using reversed-phase Zip-Tips C18 from Millipore (Billerica, 
MA).  
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Synthesis of 3-Dansyl-amino-tyrosine. The mixture of reduced BSA tryptic 
peptides was desalted by RP-HPLC on a reversed-phase C18 column (100 × 4.6 
mm, 5 µm; Phenomenex). Peptide fractions were lyophilized and then dissolved in 
100 mM sodium acetate pH 5.0 buffer, 0.9% sodium chloride. Samples were treated 
with a 18.5 ng /µL solution of DNS-Cl in ACN (1000-fold molar excess), and the 
buffered solutions were allowed to react at 65 °C for 16 h.  
 
Labelling of Bovine Milk Protein Extract. A sample of commercially available 
bovine milk was reacted with a 100 mM solution of TNM for 30 min at room 
temperature. Modified milk proteins were purified by precipitation with the Amersham 
Clean Up kit and dissolved in denaturant buffer. Reduction of both the SH and nitro 
groups of the protein mixture was carried out in “one pot” using 20 mM DTT, 40 mM 
iodoacetamide, and a 200 mM solution of Na2S2O4 in the dark for 30 min. The protein 
mixture was purified by size exclusion chromatography on a Sephadex G-25M 
column equilibrated and eluted with 50 mM AMBIC. Protein fractions were 
concentrated and then digested with trypsin as already described. The resulting 
peptide mixture was reacted with DNS-Cl as described above.  
 
Mass Spectrometry. MALDI-MS experiments were performed on a Voyager DE-
STR MALDI-TOF mass spectrometer (Applied Biosystems, Framingham, MA) 
equipped with a nitrogen laser (337 nm). Typically, 1 µL of the total mixture was 
mixed (1/1, v/v) with a 10 mg/mL solution of -cyano-4-hydroxycinnamic acid in 
acetonitrile/50 mM citrate buffer (2/3, v/v). 
NanoLC-MS2 and MS3 experiments were performed on a 4000 QTrap mass 
spectrometer (Applied Biosystems) coupled to an 1100 nanoHPLC system (Agilent 
Technologies). Peptide mixtures were loaded onto an Agilent reversed-phase 
precolumn cartridge (Zorbax 300 SB-C18, 5 × 0.3 mm, 5 µm) at 10 µL/min with 
solvent A (0.1% formic acid, loading time 7 min). Peptides were then separated on a 
Agilent reversed-phase column (Zorbax 300 SBC18, 150 mm × 75 µm, 3.5 µm), at a 
flow rate of 0.2 µL/min using 0.1% formic acid, 2% ACN in water as solvent A 0.1% 
and formic acid, 2% water in ACN as solvent B. The elution was accomplished by a 
5-65% linear gradient of solvent B in 60 min. A micro-ionspray source was used at 
2.5 kV with liquid coupling, with a declustering potential of 50 V, using an uncoated 
silica tip (o.d. 150 µm, i.d. 20 µm, tip diameter 10 µm) from New Objectives (Ringoes, 
NJ). Spectra acquisition was based on a survey precursor ion scan for m/z 170,1. 
The Q1 quadrupole was scanned from m/z 400 to 1400 in 2 s with resolution “low”, 
and the precursor ions were fragmented in q2 using a linear gradient of collision 
potential from 30 to 70 V. Finally, Q3 was set to transmit only ions at m/z 170 with 
resolution “unit”. This scan mode was followed by an enhanced resolution experiment 
for the ions of interest and then by MS3 and MS2 acquisitions of the two most 
abundant ions. MS2 spectra were acquired using the best collision energy calculated 
on the basis of m/z values and charge state (rolling collision energy). MS3 spectra 
were performed on the fragment ion at m/z 234 and acquired using Q0 trapping, with 
a trapping time of 150 ms and an activation time of 100 ms, scanning from m/z 160 to 
210. The entire cycle duration is 5.3 s. 
 
2.3 Results and discussions 
 
BSA (1 mg) was nitrated with TNM, and the excess reagent was rapidly removed by 
size exclusion chromatography as described in the Materials and Methods 
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paragraph. TNM-induced modifications were determined by MALDI mapping 
analyses. Aliquots of the BSA and N-BSA mixtures were reduced with DTT and 
alkylated with iodoacetamide. Proteins were then digested by trypsin, and the 
resulting peptide mixtures were directly analyzed by MALDI mass spectrometry. 
Spectral analyses led to the 85% of BSA sequence coverage, and more important, 
95% of tyrosine residues could be verified. Two mass signals recorded at m/z 972.5 
and 1524.8, respectively, did not correspond to any peptide within the BSA 
sequence. These values occurred 45 Da higher than the signals corresponding to the 
peptides 137-143 and 396-409, respectively, suggesting that they originated from the 
nitrated derivatives of these fragments. This hypothesis was corroborated by satellite 
peaks at -16 and -32 Da, revealing the typical photodecomposition pattern of nitrated 
peptides previously described to occur during the MALDI analysis of nitropeptides 
(10) (Figure 2.6 A). This finding indicated that Tyr137 and Tyr399 were partially 
converted into the corresponding NO2Tyr residues following TNM treatment. These 
data were in perfect agreement with previous results on in vitro BSA nitration (10, 
19). However, signals occurring at m/z 927.5 and 1479.7 were attributed to the 
theoretical fragments, m/z 137-143 and 396-409, respectively, were detected thus 
indicating that the nitration reaction was not quantitative.  
 
Fig.2.6 In the panel A it is showed the MALDI-TOF spectrum enlargement of the nitrated BSA 
peptides 137-143  (972.5 m/z) and 396-409 (1524.8 m/z). The characteristic NO2Tyr post source 
decomposition is observed by the presence of the satellite peaks at -16Da and -32Da. Panel B shows 
that the NO2Tyr reduction by Na2S2O4 is complete, no NO2Tyr signals are present in the MALDI-TOF 
spectrum enlargement. Panel C shows the MALDI-TOF spectrum enlargement of the newly formed 3-
dansylamino tyrosine peptides. 
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Synthesis of 3-Dansyl-Amino-tyrosine. Conversion of nitropeptides into their 3-
dansyl-amino derivatives was accomplished as indicated in Scheme 2.1. First, nitro 
groups were reduced by Na2S2O4 treatment, the peptide mixture was desalted by 
HPLC, and the extent of reduction was monitored by MALDI-MS. Mass spectral 
analysis showed the disappearance of the classical 3-nitrotyrosine 
photodecomposition pattern, indicating nearly quantitative reduction, and its 
replacement by two new signals at m/z 942.4 and 1494.8, attributed to peptides m/z 
137-143 and 396-409, respectively, containing an amino-Tyr residue (Figure 2.6B). 
Aminotyrosine residues were chemoselectively labelled with DNS-Cl following the 
reported procedure. The reaction was carried out at pH 5.0 exploiting the different 
pKa value of the 3-aminotyrosine (4.7) (33) which is partly deprotonated and is 
therefore amenable to react with DNS-Cl at variance with aliphatic (10.4-11.1) and N-
terminal amino groups (6.8-8.0), which are largely protonated. The extent of reaction 
was monitored by MALDI-MS analysis showing the presence of two new signals at 
m/z 1175.6 and 1727.8 occurring 233 Da higher than the 3-aminotyrosine-containing 
peptides (Figure 2.6C). These signals corresponded to the expected dansyl 
derivatives of the 3-aminotyrosine peptides. No modification at the N-terminus or Lys 
residues was detected.  
 
Fig.2.7 In the panel A it is showed the total ion current of a full scan LC-MS2 of a nitrated BSA/BSA 
trypsin digest. Panel B: PIS of nitrated BSA/BSA peptide mixture after dansyl labelling. About 73% 
of un-desired peptides are not analyzed. The MS3 chromatogram in panel C shows that by the 
double selection criteria 100% of un-desired peptides are removed by the spectrometer. 
Full scan MS2 
PIS 170 
MS3 234-170 
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LC-MS/MS Analysis of 3-Aminodansyl-Tyr Peptides. The exact location of the 
original nitro groups was assessed by LC-MS2 analysis of the peptide mixture using a 
linear ion trap 4000 Q-Trap instrument and an experimental procedure that combines 
precursor ion scan with MS3 scan mode as already described (1). In the precursor 
ion scan mode, only the precursor ions producing the m/z 170 fragment were 
detected. The selected precursor ions were then subjected to a combined MS2 and 
MS3 experiment to specifically detect only those ions originating the dansyl-specific 
m/z 234-170 transition in MS3 mode as indicated in Figure 2.3. Figure 2.7 shows the 
LC-MS2 traces corresponding to the various experiments. The chromatographic 
profiles reported in Figure 2.7B and 2.7C for the m/z 170 precursor ion scan and for 
the transition m/z 234/170 in MS3 mode, respectively, showed a lower number of 
signals compared to the LC-MS2 full scan profile (Figure 2.7A). Moreover, a 
significant increase in the signal/noise ratio could be achieved as the higher 
selectivity MS criteria were applied (Figure 2B and C). However, the precursor ion 
TIC exhibited a number of ions that are very unlikely related to 3-dansylamino-Tyr 
peptides (Figure 2.5B). In fact, the PIS of the fragment 170 m/z was realized with the 
Q3 in “unit” resolution characterized by a width of about 1 Da. Thus by this analysis a 
restrict number un-dansylated peptides may be also detected as that containing the 
N-Term couple Gly-Ile/Leu, Ala-Val, by the detection of their b2 ions. However by this 
analysis 73% of unlabelled BSA peptides remain un-detected. The MS3 selection 
criterion is more restrictive than the PIS. In fact, the MS3 TIC (Figure 2.7C) showed 
the presence of only three peaks related to doubly charged ions at m/z 588.2, 792.9, 
and 986.8, resulting in 100% MS depletion of un-desired species. However the MS3 
is too slow to be used as unique survey scan, thus PIS is necessary for a first gas 
phase “fractionation” of the sample making the MS3 scan compatible with 
chromatography. The corresponding MS2 fragmentation spectra of peptides positive 
analysis led to the determination of the entire sequence of these species, identifying 
the fragments 137-143, 396-409, and 445-458, respectively, all of which contain 3-
aminodansyl-Tyr residues. Moreover, modified Tyr residues could easily be detected 
at the level of Tyr137, Tyr399, and Tyr451, allowing for the exact identification of the 
original nitration sites. As an example, Figure 2.8B shows the MS2 spectrum of the 
peptide m/z 396-409 carrying a dansyl moiety. The modified ion is stable during 
collision-induced dissociation, providing easily interpretable daughter ion spectra. 
Both the y and b fragment ions still retained the modifying group linked to the amino 
Tyr residue, thus denoting original nitration. As indicated in the spectrum, the mass 
difference between the b4 and b3 fragment ions is 411 Da corresponding to the 3-
dansylaminotyrosine residue. It should be noted that the LC-MS2 analysis revealed 
the occurrence of a further nitration site within the peptide m/z 448- 458 at level of 
Tyr451, which escaped previous MALDI analysis. Moreover, the daughter ion spectra 
of 3-dansylamino-Tyr-containing peptides showed some peculiar features. Besides 
the signals at m/z 170 and 234, typical of dansyl derivatives, a further signal at m/z 
384 was always observed and assigned to the immonium ion of 3-dansylamino-Tyr. 
This stable fragment could then be used either as an alternative diagnostic fragment 
in the precursor ion scan or simply to confirm the presence of a 3-dansylamino-Tyr 
residue in the peptide sequence. Finally, a fragment ion related to the loss of the 
dansyl moiety as neutral group was always observed in the daughter ion spectra 
when the 3-nitrotyrosine residue is located at N-terminal position. In fact, the 
fragment ion at m/z 942.5 in Figure 2.8A belongs to the y series and occurs 233 Da 
lower than the molecular mass of the dansylated peptide m/z 137-143, showing the 
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neutral loss of the dansylated moiety. This kind of behavior is observed when the 
peptide N-Terminal amino acid is labelled. 
 
 
 
Location of BSA 3-Aminotyrosine-Containing Peptides in Complex Protein 
Mixtures. The feasibility of the developed procedure to identify 3-nitrotyrosine 
Fig.2.8 MS2 spectra relative to the nitrated BSA peptides 137-146 (panel A) and 396-409 (panel B) 
B 
A 
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peptides in proteomics analysis was probed by mixing 100 µg of the mixture of BSA 
and nitrated BSA with 10 mg of the entire cellular extract from Escherichia coli. An 
aliquot of the modified proteome was fractionated by SDS-PAGE to demonstrate that 
BSA was indistinguishable from and in similar amount to other E. coli proteins. The 
total protein extract was then submitted to the procedure described above. 
 
Nitrotyrosines were reduced with dithionite, and the modified protein mixture was 
digested with trypsin. The newly generated amino-Tyr-containing peptides were 
labelled with dansyl chloride at pH 5.0, and an aliquot of peptide digest containing" 
50 fmol of nitropeptide mixture was submitted to the bidimensional tandem mass 
spectrometry procedure described above. Figure 2.7 shows the reconstructed ion 
chromatogram for the precursor ion scan (A) and the selective dansyl transition in 
MS3 mode (B). As clearly indicated in the figure, the precursor ion scan mode still 
showed the occurrence of a large number of signals, most of which are not related to 
NO2Tyr -containing peptides. The further selection based on the MS3 scan removed 
a large number of false positives leading to a simple ion chromatogram essentially 
dominated by six intense signals. Identification of nitrated tyrosine residues was 
carried out by taking advantage of the flexibility of the MASCOT software, a database  
search utility available on the net. First, a variable modification of 411.0 Da 
corresponding to 3-aminodansyltyrosine residues was introduced into the 
Fig.2.9 Total ion current of PIS (panel A) and MS3 (panel B) of E.coli protein extract spiked with 
nitrated BSA 
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Modification File within the MASCOT software. Second, the peak list used for 
database search only consisted in the MS2 spectra of the peptide species that had 
generated a signal both in the precursor ion TIC and in the MS3 ion scan. The MS2 
fragmentation spectra of the six signals observed in the MS3 scan reported the 
occurrence of three NO2Tyr-containing peptides originated from the BSA sequence. 
In addition the other three signals detected correspond to nitrated E.coli peptides 
(Table 2.1).  
 
Labelling and Analysis of a Nitrated Protein Extract of Bovine Milk. The 
proposed strategy was finally employed to identify 3-nitrotyrosine residues in a more 
complex sample, the entire bovine milk. Bovine milk was in vitro nitrated with TNM, 
and an aliquot of milk proteins were 
fractionated by SDS-PAGE and submitted 
to a western blot analysis using 3-
nitrotyrosine antibody to confirm the extent 
of nitration. The presence of nitrated 
proteins was essentially detected in the 
regions between 20 and 35 and 45-60 kDa 
as indicated in Figure 5. The entire milk 
protein extract was dissolved in denaturant 
buffer, and then cysteine alkylation and 
nitro groups reduction were performed in 
“one pot” as described above. The protein 
sample was then desalted and digested 
with trypsin. The resulting peptide mixture was selectively labelled with dansyl 
chloride and directly submitted to LC-MS/MS 
analysis using the double selectivity criteria. 
Identification of nitrated milk proteins was 
carried out using the modified MASCOT 
software as described above. As an 
example, Figure 2.10 (panels A-C) reports 
the MS, MS/MS, and MS3 spectra for the 
peptide fragment m/z 108-117 of !-
lactoglobulin. The results of the identification 
procedure are reported in Table 2 together 
with the modified Tyr residues and MASCOT 
scores. Besides the high-abundant milk 
proteins (α-casein and β-lactoglobulin), this 
procedure was also able to assess the 
nitration sites occurring in low-abundant proteins, such as Vimentin and Claudin 2. 
 
2.4 Conclusion 
 
The major problem in the proteomic analysis of nitroproteins is the need to 
discriminate modified proteins, usually in very low concentrations, from the large 
amount of un-modified proteins. Moreover, biological relevant PTMs often occur at 
sub-stoichiometric level making even more difficult the identification of the 3-
nitrotyrosine-containing proteins in the presence of a larger percentage of the 
corresponding non-nitrated form. Finally, precise localization of the nitration site is 
often required to fully describe the biological process. Existing methodologies 
Table 2.2 nitrated milk protein 
Table 2.1 E.coli nitrated peptides 
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essentially rely on immunochemical techniques, whereby nitrated proteins can be 
detected by alignment of the western blots with the 2DE gels of the entire cellular  
Fig.2.10 In the panel A is showed the MS spectrum of β-lactoglobulin nitrated peptide detected in PIS 
mode as triply charged ion. In the panels B and C are showed respectively its MS2 and MS3 spectra 
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 proteome (8-9). Alternatively, specific capture of 3-nitrotyrosine-containing proteins 
by immuno-affinity procedures (15-16) can also be employed. However, neither of 
these approaches completely fulfills the analytical requirements for nitro proteome 
analysis. However, the peptide mixture from the tryptic digest of the whole enriched 
nitroprotein bulk is still too complicated to be analyzed in a simple one-step process 
and 2D-HPLC, typically consisting of ion exchange and reversed-phase separations, 
in conjunction with tandem mass spectrometric methods had to be used (14). The 
strategy described in this chapter is based on a totally different approach involving 
dansyl chloride labelling and relies on the huge potential of MSn analysis. According 
to the so-called “gel-free procedures”, the analysis is carried out at level of peptides 
following tryptic digest of the whole protein mixture. However, discrimination between  
nitropeptides and un-modified peptides is achieved by taking advantage of the 
instrumental features of a hybrid (triple quadrupole/linear ion trap) mass 
spectrometer. Peptide analysis is carried out by LC-MS/MS, and the peptide ions of 
interest are discriminated by two selectivity criteria based on two subsequent tandem 
MS experiments, a precursor ion scan followed by MS3 scan mode. This procedure 
can then be considered as a sort of “instrumentally driven” bidimensional selection. 
The proposed strategy consists in two simple chemical manipulation steps, namely, 
reduction of 3-nitrotyrosine residues to the corresponding NH2-Tyr derivatives and 
the chemoselective labelling with DNS-Cl at pH 5.0, exploiting the lower basicity of 
aromatic amines compared to the aliphatic ones. 
Analysis of chemically nitrated BSA following tryptic digestion confirmed the ability of 
the bidimensional selection to simplify the peptide ion chromatogram, leading to 
selective identification of 3-nitrotyrosine-containing peptides. This experiment 
underlined the usefulness of the two selectivity criteria in that the precursor ion scan 
still showed the presence of non-nitrated peptide ions that were completely ruled out 
in the MS3 scan mode. Moreover, since this combined MS approach provides only 
the daughter ion spectra of the nitrated peptides, this procedure always leads to the 
unambiguous localization of the nitrated Tyr residues. Because of its operational 
simplicity, avoiding long-lasting and time-consuming fractionation procedures, this 
new strategy seems to be well suited for large-scale proteomic profiling of nitration 
sites. Moreover, the general rationale of the method can in principle be extended to 
the detection of other PTMs. The high impact of the innovative “RIGhT” strategy 
presented in this chapter, is confirmed by the publication of the data showed above 
on a first class analytical chemistry journal (Amoresano A, Chiappetta G, Pucci P, 
D'Ischia M, Marino G., Bidimensional tandem mass spectrometry for selective 
identification of nitration sites in proteins, Analytical Chemistry (2007), 79(5):2109-
17). 
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3. QUANTITATIVE IDENTIFICATION OF PROTEIN NITRATION SITES BY USING 
iTRAQ REAGENTS 
 
3.1 Introduction 
 
Patho-physiological events often alter the protein expression, including the 
posttranslational modifications status as for example tyrosines nitration in cells, 
tissues, or biological fluids. The ability to make relative quantitative estimations about 
protein abundance and their modification differences according to different 
conditions, is essential for identifying key molecular targets or candidate biomarkers 
involved in different diseases. However, the limitations of mass spectrometry based 
approach for protein nitration identification (see chapter 2) have even more impacts 
when quantitative estimations have to be performed. For this reason Proteomics 
approach is lacking of strategies to make the protein nitration profiling in different cell 
states. The results, discussed in the precedent chapter, showed that a very selective 
MS analysis may improve the dynamic range achievable by a mass spectrometer 
and enhance also the signal/noise ratio. However, dansyl chloride is not 
commercially available in C, N, O, S isotopic forms which prevents the development 
of a quantitative method. So far, the iTRAQ chemistry has been limited to primary 
amines. In this chapter it is reported a new strategy based on the use of iTRAQ 
reagents coupled to mass spectrometry analysis for the selective labelling and the 
“quantitative detection” of NO2Tyr residues. This method was proved to lead to the 
simultaneous localisation and quantification of nitration sites both in model proteins 
and in biological systems. 
 
3.1.1 Protein nitration quantification: state of the art 
 
Protein nitration quantification in biological samples is an analytical challenge. The 
main problem related to this kind of analysis is the low percentage of modified 
tyrosine residues that was measured to be NO2Tyr: tyrosine ≈ 1 ppm (1-2). This 
feature, coupled to the low mass increment of the modification (+45Da) and the 
diluted effect of protein iso-electric point decrease induced by Tyr nitration (3), makes 
it difficult to distinguish nitrated protein from the respective wild type by 2DE. Thus 
direct quantitative estimation based on spot intensity is not possible. In addition, the 
low quantity of nitrated peptides in biological samples leads to record low quality 
spectra. Therefore, if an accurate mass measurement coupled with short sequence 
coverage may sometimes allow to identify the nitration site, the quantitative analysis 
based on the MS signal intensity needs good quality of the peaks in terms of 
sharpness, signal/noise ratio and overlapping with isotope pattern of other signals. 
For these reasons, procedures allowing simultaneously to identify and quantify 
nitrated protein by classical Proteomics techniques, are not yet proposed. In fact the 
most important quantitative studies were addressed to the absolute estimation of the 
global level of NO2Tyr amino acid. Because NO2Tyr is considered as the best 
biomarker to detect oxidative damage in vivo, the first quantitative studies were 
addressed to develop clinical methods capable to correlate pathological states and 
concentration changes of basal free amino acidic NO2Tyr in biological fluids by 
absolute quantification. This was first accomplished by gas chromatography (GC) 
based techniques, performing analyses in Selected Ion Mode (SIM) and using an 
isotopically enriched 3-nitrotyrosine as internal standard (1, 2, 4). For the first time it 
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was possible to quantify NO2Tyr at biological levels with femto-nano molar sensitivity. 
Moreover it was also possible to estimate the ratio modified/unmodified free tyrosine 
in vivo. Further, the analysis was also extended to quantify the level of nitrated 
protein in biological samples (5). This was realized by the HCl hydrolysis of proteins 
to amino acid followed by the GC analysis of released tyrosine and nitrated tyrosine. 
For the sensitivity GC is considered as the “Gold standard” for the absolute 
quantification of NO2Tyr in biological fluids and tissues. Problems with the generation 
of NO2Tyr during sample processing, particularly during acid hydrolysis of proteins 
and derivatization of amino acids before the chromatographic separation, have been 
identified (6). Thornalley et al. (7) proposed the enzymatic hydrolysis of proteins with 
a cocktail of enzymes, however the recovery yield slightly decreased compared to 
acid hydrolysis (8). Although GC-MS analysis is a corroborated method to quantify 
NO2Tyr concentration, the required extensive silylation of amino acid enhances the 
complexity of the assay. Nitrated peptides and proteins were also detected by HPLC 
separation using different detectors. For example, derivatization of reduced NO2Tyr 
with fluorophore was used in order to make possible the selective detection by 
fluorescence (9). However, this approach is less sensitive and specific. Best results 
are obtained using an HPLC equipped with an electrochemical detector. In fact, 
NO2Tyr amino acid is detected in plasma with sensitivity comparable to that of GC, 
using the oxidation potential of 0,88V relative to the acetylated 3-aminotyrosine 
oxidation (10-11). Mass spectrometry was also coupled to HPLC for the absolute 
quantification of the global nitration extent in biological samples. In particular realizing 
ESI-MS2 experiments based on the Multiple Reaction Monitoring (MRM) scan, using 
a triple quadrupole, or on the Single Reaction Monitoring (SRM), with an ion trap (12-
13). MRM and SRM scans allow to detect only the parent ions that give peculiar MS2 
transitions, resulting in a very high duty cycle MS method improving the sensibility of 
the technique. Tyrosine (182 Da), nitrotyrosine (227 Da) and their isotopic internal 
standards (respectively 192 Da and 233 Da) were detected using the MS2 neutral 
losses of ammonia (-17 Da) and formic acid (-46 Da). If all these methods for the 
global nitrated tyrosine estimation in biological fluids may be useful diagnostic tools, 
no functional information is provided by these strategies. In fact, more than NO2Tyr 
absolute measures, in order to understand the biological effect of the nitration, it is 
important to perform nitrated protein expression profiles in healthy/disease samples 
by using strategies leading to “quantitative identification”. Immunological approaches 
have been used to identify cellular sources of reactive nitrogen species and specific 
protein targets for modification (14-17). The use of 3-nitrotyrosine antibodies to 
perform ELISA analysis or western blot imuno-detection of 2DE fractionated protein, 
theoretically may allow at the same times to identify and to quantify the nitrated 
proteins. However, by using more accurate GC MS analysis, it was demonstrated 
that the imuno-detection based quantitative estimations were 10-100 folds 
overestimated (18). Isotope stable labelling techniques coupled to MS analysis would 
be an interesting approach that could lead to the quantification of identified nitro-
peptides. However, none of the enrichment strategies summarized in the precedent 
chapter have proposed a “heavy” version of the tag used (19-20). As already cited in 
this paragraph (12-13) and demonstrated in the chapter 2 (21), high selective MS 
methods (MRM, SRM, PIS/MS3) allow to enhance the signal-noise ratio of free or 
peptide-bound nitrated tyrosine in low concentration. On this basis, we tried to set up 
a quantitative method based on the dansyl chloride strategy showed before. This was 
performed by using a deuterated heavy form of DNS-Cl. However a high percentage 
of modified peptides showed a deleterious deuterium effect causing a not perfect co-
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elution of heavy and light forms. This problem, coupled to difficult synthesis of C, N, 
O, S isotope enriched form of DNS-Cl, makes not realizable the “Bidimensional 
tandem mass spectrometry quantification“ of nitrated protein on Proteomics scale.  
 
3.1.2 iTRAQ strategy  
 
Isobaric Tag for Relative and Absolute Quantification (iTRAQ) is probably the most 
innovative methodology for the quantitative analysis by mass spectrometry (22). It 
consists in the modification of peptide primary amines (lysine and n-terminal) by a 
reagent isotopically enriched, commercialized in four different forms called iTRAQ 
114.1, 115.1, 116.1 and 117.1. The great innovation of this methodology is in the 
structural characteristics of the labelling reagent used, that is a methyl-piperazine 
acetic acid N-hydroxysuccinimide ester. This molecule has the peculiar structure of a 
RIGhT reagent. In fact, it is possible to recognize the N-hydroxysuccinimide as the 
“reactive group” toward the primary amines, the carbonyl group as “balance group” 
the methyl piperazine group that is stable as mono-charged ion in MS2 experiments. 
When iTRAQ is reacted with a peptide, the tag forms an amide bond with any peptide 
amine group. The overall mass of the reporter and the balance components of the 
molecule are kept constant using differential isotopic enrichment with 13C, 15N, and 
18O atoms, thus avoiding problems with chromatographic separations as seen with 
the isotopic enrichment involving deuterium substitution. The reporter group ranges 
in mass from m/z 114.1 to m/z 117.1, while the balance group ranges in mass from 
m/z 28 to m/z 31, therefore for each of the four reagents the combined mass remains 
constant (145.1 Da). The isobaric features of iTRAQ reagent allow to perform the 
following workflow: I) four protein mixture are digested by trypsin II) four obtained 
peptide mixtures are labelled with the four different iTRAQ forms IV) four labelled  
 
Fig. 3.1 iTRAQ workflow. It is also evidenced that the iTRAQ reagent has the peculiar structure of a 
RIGhT reagent. 
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peptide mixture are pooled and analyzed in the same LC-MS2 run. 
All the peptides with the same sequence, but carrying different versions of the tag will 
be chromatographically indistinguishable and identical in mass. Labelled peptides 
with the same sequence are also identical in MS mode, thus enhancing the 
sensitivity of the analysis because the MS signal is generated by the contribution of 
four samples. In addition because for any peptide a unique MS signal appears, the 
resulting spectra is not complicated by the analysis of four samples in the same time 
and this feature is very important for the duty cycle of LC-MS2 method. Upon 
fragmentation, the reporter group is detached, creating signals in the “quite” low 
mass range region (114-117 Da) of the MS2 spectrum. The balance group is lost as 
neutral moiety, so the remaining peptide backbone is unmodified and can generate 
backbone fragments that are identical in m/z for all samples, resulting in improved 
S/N ratios because all differentially coded samples contribute to MS2 spectrum. 
Quantitative estimations are done calculating the peak area of the reporter ions, 
which ratios respect the original contribution of each peptide from the starting 
sample. Recently, an octu-plex iTRAQ kit has been proposed thus allowing the 
simultaneous analysis of eight different samples (23) Moreover, iTRAQ labelling 
coupled with pulsed Q dissociation technique has been recently proposed for protein 
quantification by ion traps avoiding the classical low mass cut off (24). 
 
3.2 Materials and Methods 
 
Chemicals 
Bovine serum albumin (BSA), tetranitromethane (TNM), ammonium bicarbonate 
(AMBIC), guanidine, dithiothreitol (DTT), trypsin, iodoacetamide (IAM) and triethyl 
ammonium carbonate (TEAB) were purchased from Fluka. 
Tris(hydroxymethyl)aminomethane, sodium dithionite as well as the MALDI matrix α-
ciano-4-idrossicinnamic acid were purchased from Sigma. iTRAQ reagents were 
furnished by Applied Biosystems. Methanol, trifluoroacetic acid (TFA) and acetonitrile 
(ACN) are HPLC grade type from Carlo Erba, whereas the other solvents are from 
Baker. Gel filtration columns PD-10 are from Pharmacia, the HPLC ones from 
Phenomenex, whereas the pre-packed columns Sep-pak C-18 are from Waters. 
 
BSA nitration.  
An aliquot of 200 µg BSA was dissolved in Tris 200 mM pH 8.0 buffer and was added 
to a 830 nmol/ml solution of TNM in ACN in a molar ratio 1:10 BSA/TNM. The 
reaction was carried out under agitation for 30 min at room temperature. The mix of 
BSA and nitrated BSA (N-BSA) was then desalted by size exclusion chromatography 
on a SEPHADEX G-25M column; the elution was carried out with Tris 300 mM and 
the fractions analyzed through UV spectrometry at 220 and 280 nm wavelength. 
Positive fractions were collected and dried. 
 
Reduction and carboxamido-methylation of BSA.  
BSA and N-BSA mixture were dissolved in denaturation buffer (guanidine 6 M, Tris 
0.3 M, EDTA 10 mM, pH 8.0). Reduction was carried out by using a 10:1 
DTT/cysteine molar ratio. After incubation at 37°C for 2 h, iodoacetamide was added 
to perform carboamidomethylation using an excess of alkylating agent of 5:1 respect 
to the moles of thiolic groups. The mixture was then incubated in the dark at room 
temperature for 30 min. The alkylation reaction was stopped by addition of formic 
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acid, in order to achieve an acidic pH. The product was purified by size exclusion 
chromatography. The elution was performed with TEAB 50 mM pH 8.0. 
 
BSA digestion. Protein digestion was carried out in TEAB 50mM pH 8.0 buffer using 
trypsin at a 50:1 protein : trypsin mass ratio. The sample was incubated at 37°C for 
16 h. Then the sample was dried.  
 
Acetylation of peptide mixture. Peptide mixture was dissolved in 30% TEAB 
500mM pH 8.0, 70% ACN. Acetylation was performed by using acetic acid N-
hydroxy-succinimide esther in molar ratio 500:1 reagent / peptides. The reaction was 
carried out for 1 h at room temperature.  
 
Nitro groups reduction.Reduction of nitro groups to amino groups was performed 
by adding. Na2S2O4 at 100:1 Na2S2O4/NO2Tyr molar ratio. The reaction was carried 
out at room temperature for 10 min under stable stir. The product was purified by 
SEP-PAK RP-LC with C18 column. Peptides were eluted using 80% ACN, 20% 
formic acid 0.1%. Fractions were collected and lyophilized. 
 
Bacterial strains, growth conditions and protein extract preparation Escherichia 
coli K12 strain was grown in aerobic conditions at 37°C in LB medium. After 16 h, 
bacteria were harvested by centrifugation and resuspended in Buffer Z (25 mM 
HEPES pH 7.6, 50 mM KCl, 12.5 mM MgCl2, 1 mM DTT, 20% glycerol, 0.1% triton) 
containing 1 µM phenyl methyl sulfonyl fluoride. Cells were disrupted by sonication. 
The suspension was centrifuged at 90,000 x g for 30 min at 4°C. After centrifugation 
the protein concentration of the extract was determined with Bradford assay. 
 
iTRAQ selective labelling. Sample was dissolved in TEAB 500mM pH 8.0 and then 
was divided in two tubes and each of these was differentially labelled with 
alternatively iTRAQ reagent 114 and iTRAQ reagent 117, following iTRAQ protocol 
furnished by Applied Biosystem. 
 
Labelling of Bovine Milk Protein Extract. A sample of commercially available 
bovine milk was reacted with a 10 mM solution of TNM for 30 min under agitation at 
room temperature. Modified milk proteins were purified by precipitation with the 
Amersham Clean Up kit and dissolved in denaturant buffer. Reduction was carried 
out by using a 10:1 DTT / cysteine molar ratio. After incubation at 37°C for 2 h, 
iodoacetamide was added to perform carboxamido methylation using an excess of 
alkylating agent of 5:1 respect to the moles of thiolic groups. The mixture was then 
incubated in the dark at room temperature for 30 min. The alkylation reaction was 
stopped by addition of formic acid, in order to achieve an acidic pH. The protein 
mixture was purified by size exclusion chromatography on a Sephadex G-25 M 
column equilibrated and eluted with 50 mM TEAB. Protein fractions were 
concentrated and then digested with trypsin as already described. The resulting 
peptide mixture was acetylated and the nitro groups were reduced using a 200 mM 
solution of Na2S2O4 for 30 min. The protein mixture was then reacted with ITRAQ as 
described above. 
 
nanoLC Mass Spectrometry. Peptide mixture, obtained as previously described, 
was analysed by LCMS2 analysis using a 4000Q-Trap (Applied Biosystems) 
equipped with a linear ion trap coupled to an 1100 nano HPLC system (Agilent 
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Technologies). The mixture was loaded on an Agilent reverse-phase pre-column 
cartridge (Zorbax 300 SB-C18, 5x0.3 mm, 5 µm) at 10 µL/min (A solvent 0.1% formic 
acid, loading time 7 min). Peptides were separated on a Agilent reverse-phase 
column (Zorbax 300 SB-C18, 150 mm X 75µm, 3.5 µm), at a flow rate of 0.2 µL/min 
with a 5 to 65% linear gradient in 60 min (A solvent 0.1% formic acid, 2% ACN in 
water; B solvent 0.1% formic acid, 2% water in ACN). Nanospray source was used at 
2.3 kV with liquid coupling, with a declustering potential of 20 V, using an uncoated 
silica tip from NewObjectives (O.D. 150 µm, I.D. 20 µm, T.D. 10 µm). Spectra 
acquisition was based on a survey Precursor Ion Scanning for the ion m/z 114 and 
117. It was performed over a mass range of m/z 400-1400 with Q1 set to low 
resolution and Q3 set to unit resolution. Precursors were collided in Q2 with a 
collision energy ramp of 25 to 65 V across the mass range. Spectra acquisition was 
based on a survey Precursor Ion Scan. A positive ion Enhanced Resolution Scan 
was performed at 250amu/s to determine the charge state of the ion. Enhanced 
Product Ion (EPI) scans (MS2) were performed at 4000 amu/s and collision voltages 
were calculated automatically by rolling collision energy and it performed a maximum 
of one repeat before adding ion to the exclusion list for 60 s. Once this duty cycle 
was completed, the polarity was switched back and the cycle repeated. The entire 
cycle duration, including fill times and processing times was less than 5.3 s. Data 
were acquired and processed using Analyst software (Applied Biosystems) and 
processed by using MASCOT in house software. 
 
3.3 RESULTS AND DISCUSSION 
 
Molecules modified by oxidation, nitration and nitrosilation can act as cellular 
biomarkers. Identification of the specific targets of protein oxidation was generally 
accomplished by the detection and quantification of NO2Tyr using 2-DE and Western 
blot techniques followed by mass spectral identification of candidate proteins (25). 
However, these procedures generally led to the identification of nitrated proteins but 
the fine localization and quantification of the nitration sites in complex protein mixture 
still remain a challenging task. In the precedent chapter, it was showed a strategy 
leading to the selective detection of nitrated tyrosine residues by using dansyl 
chloride labelling coupled to advanced mass spectrometry experiments (21). The 
proposed strategy has showed to be specific, sensitive, simple and fast. Because no 
heavy form of dansyl chloride is commercially available, quantitative analysis of 
complex protein mixtures cannot be addressed directly. However the improvements 
given by selective MS analysis could make possible the “quantitative identification” of 
nitrated proteins. For its structural features it was found iTRAQ as “RIGhT” reagent to 
achieve this result. The idea proposed is outlined in the Scheme 1. According to the 
so-called “gel-free procedures”, the analysis is carried out at peptide levels following 
tryptic digest of the whole protein mixture. This approach was first applied to bovine 
serum albumin as model protein. Two hundred µg of BSA were nitrated using TNM 
as described in materials and methods section. Then the resulting BSA and N-BSA 
mixture was reduced, alkylated and hydrolyzed using trypsin. The peptide mixture 
was then analyzed via MALDI-MS to verify the extent of nitration.  
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Scheme 3.1. Strategy for selective labelling of 3-nitrotyrosine residues. 
 
BSA is a protein of about 66 kDa, showing 20 tyrosine residues along its sequence. 
However mass spectral analyses demonstrated that in vitro nitration was limited to 
only few tyrosine residues, namely the ones exposed in the structure of the protein 
and thus more sensitive to nitration. Nitrated peptides were identified by MALDI 
mapping procedure, by comparing the experimental peptides masses with the 
theoretical values on the basis of amino acid sequences. As already reported a ΔM 
of +45 was attributed to the modified peptide, due to introduction of a nitro-group 
(26). Figure 1 (panel A and B) showed partial MALDI-MS spectrum of the tryptic BSA 
and N-BSA mixture. As an example, the signals occurring at m/z 972.5, 1524.8 
showed molecular masses 45 Da higher than the theoretical ones. These signals 
were attributed to the peptides 137-143, 396-408, having the Tyr residue been 
modified by a nitro group. As a whole, the MALDI-MS analysis showed the 
occurrence of four signals exhibiting a mass increment of 45 Da. These signals were 
attributed to the nitro-peptides 137-143, 396-408, 322-334, 444-457 (at m/z 972.5, 
1524.8, 1612.9, 1770.8, respectively) As further proof, these signals exhibited the 
characteristic pattern of nitrated peptides, due to photodecomposition of nitrated 
tyrosine residues by MALDI source (26).  
In the previous chapter, the selective labelling of 3-nitrotyrosine residues was 
essentially based on a reduction step and conversion to 3-aminotyrosine residues 
followed by specific dansylation at pH 5,0. A similar approach was attempted here. 
However, iTRAQ labelling does not permit to exploit the low pKa value (3) of such 
amine to obtain a selective labelling, as observed for the dansyl-chloride strategy. 
Only a small percentage of primary aromatic amine modification by iTRAQ was 
observed. This behavior may be explained by the faster rate of hydrolysis of both the 
iTRAQ N-hydroxysuccinimide-esther group and the formed aminotyrosine-iTRAQ 
derivative in mild acidic conditions (27). 
Thus, it was necessary to set up a double step procedure. First of all, lysine residues 
and N-terminus primary amine were protected to facilitate specific labelling of the 3-
nitrotyrosine residues. Blocking can be easily performed under mild conditions by a 
variety of reagents that are commercially available. In fact, several strategies to 
introduce NH2- labels have been described (28-29). Generally, it is not possible to 
reliably control the selectivity of the reaction, because the ε-amino group of lysine is 
readily and stably modified by reagents that target the N-terminus (30-31). Blocking 
the N-terminus and the lysine side chain can be done either prior or after the 
enzymatic digestion of the sample. By blocking the lysines after digestion, we 
retained the ability to use trypsin as enzyme for proteolytic cleavage. 
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Preliminary acetylation experiments were performed by using acetic anhydride as 
reagent and peptide mixture obtained from trypsin digestion of myoglobin, as model. 
MALDI-MS analysis performed on the resulting peptide mixture showed that the 
acetylation reaction was not quantitative. Thus, we decided to use acetic acid N-
hydroxy-succinimide esther as reagent since it has been shown to lead to an efficient 
lysine acetylation (32). The yield of the reaction was monitored by MALDI-MS. As an 
example Figure 3.2 reports the partial MALDI-MS spectrum of the acetylated 
myoglobin tryptic mixture. The signal at m/z 1649.2 was attributed to the peptide 
fragment 18-23 carrying an acetyl group, fully modified. No signal related to the 
unmodified peptide was observed thus indicating that the acetylation was 
quantitative.  
 
Figure 3.2. Detail of MALDI-MS spectrum of acetylated myoglobine showing peptide 18-23 with 
acetylated N-terminus; there are no evidence in the spectrum for non acetylated form of the same 
peptide. 
 
Thus, nitrated peptides were subjected to the acetylation using acetic acid N-
hydroxy-succinimide esther as described in material and methods section. All the 
successive analyses revealed that every peptide detected had the N-term amine and 
eventually the ε-amino group of lysine protected. Only after the acetylation step it 
was possible to reduce the nitro-group of 3-nitrotyrosine residues to an amino group, 
susceptible to iTRAQ addition. Conversion of nitropeptides into their amino 
derivatives was accomplished by Na2S2O4 treatment. The peptide mixture was 
desalted by sep-pak C18 cartridge and the extent of reduction was monitored by 
MALDI-MS.  
As for quantitative analysis, labelling reaction was carried out on the newly generated 
amino groups by following the default protocol. iTRAQ technology (trademarked by 
Applied Biosystems), allows quantitative analysis of protein expression through the 
use of isobaric tags, enabling the quantitation of four (22) to eight complex protein 
samples (23) in a single multiplexed analysis.  
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As an example to illustrate the possibility to use iTRAQ labelling strategy for selective 
quantitative analysis of 3-nitrotyrosine residues and at the same time to reduce the 
costs, we decided to carry out our methodology just on a duplex. Thus we analyzed 
only two samples and we choose iTRAQ 114 and iTRAQ 117 as labelling reagents. 
After the labelling, the resulting samples, N-BSA(114) and N-BSA (117), were pooled 
in molar ratio 1:1 and 1:4 respectively. The two mix (1:1 and 1:4) were then 
submitted to LC-MS2 analysis in PIS mode, by using a 4000QTrap coupled with a 
1100 nano HPLC system, thus allowing the simultaneous identification and 
quantification of differentially labelled peptides in a single chromatographic run. Thus, 
we set up an experiment by using a precursor ion scan (PIS) for the iTRAQ reporter 
ions at m/z 117.1. Moreover, in order to demonstrate that the choice of the fragment 
to monitor nitrated peptides in PIS mode is un-relevant, because of the isobaric 
characteristic of the iTRAQ, we decided to analyze the same sample in two separate 
chromatographic runs, the first in PIS of ion 114.1 and the second in PIS of ion 
117.1. 
 
Figure 3.3. Overlapped chromatograms of nitrated BSA recorded by PIS analysis of ions 114 (grey 
line) and 117 (bold line) respectively. The chromatogram of PIS 114 is shifted back of 1 minute to 
have a better comparison of signals. The symbols +, Ο, X , *, are referred to BSA nitrated peptides 
137-143, 396-408, 444-457, 322-334, respectively. The symbols Δ, ∂ are referred to BSA un-specific 
peptides detected in PIS of 114 and PIS of 117 respectively. 
 
As shown in the Figure 3.3, the two chromatographic profiles are quite identical and 
super imposable, differing just in the total ion current intensity that reflects the original 
ratio 1:4 between the two samples. In fact, it should be noted that PIS ion current is 
recorded from the fragment generated in MS2 and no memory is retained about the 
intensity of the parent ion. To gain information about the sequence of the peptide and 
the site of nitration, a second stage of mass analysis is performed in which the 
precursor ion is selected by the first mass analyzer and fragmented. Differentially 
labelled peptides were indistinguishable during a single step of MS analysis due to 
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typical characteristics of iTRAQ reagents. During MS2, labelled peptides produce 
fragmentation spectra that allow the identification of the protein. Moreover, MS2 
produces fragmentation at the sites modified by the iTRAQ reagent yielding the 
reporter ions (m/z 114 and 117) that are visible as separated peaks in the low mass 
region of the MS2 spectrum. The ratios of the areas of these peaks were then used to 
perform a relative quantitative analysis (33-34). Figure 3.4 shows the reconstructed 
ion chromatogram of the 1:1 N-BSA sample analyzed by precursor ion scan of 117 
(A) and a classical full scan MS (B). 
 
 Figure 3.4. Panel A Chromatogram of nitrated BSA recorded in PIS 117. Panel B Chromatogram of 
nitrated BSA recorded in a full scan MS mode. 
 
As clearly shown, the PIS analysis led to reduce the number of un-desired signals, 
improving also the duty cycle of the method and the sensitivity toward nitro-peptides 
enhancing signal/noise ratio. However, others signals appear in the chromatogram 
not related to nitrated peptides This effect might be generated by the presence of 
different fragment ions in the region 113-114 or 116-117, many of which generated 
after the acetylation step (Table 3.1). For this reason we used the 114 and 117 
iTRAQ reagents, in order to have the worst condition of selectivity and demonstrate 
the feasibility of the proposed methodology. An accurate manual analysis of MS2 
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spectra revealed that many false positive were selected for the presence of m/z 114 
fragment whose intensity would be negligible on the quantitative estimation (Figure 
5). To enhance the selectivity of the analysis made by the 4000QTrap, we also tried 
to introduce an MS3 event as done in dansyl-based strategy (21). In particular we 
tried to fragment the MS2 ion at m/z 145 and monitor the loss of CO giving rise to the 
peculiar reporter ions of iTRAQ in MS3 mode. A preliminary experiment revealed that 
MS3 spectra exhibited a very poor intensity caused by the low yield of ion fragment at 
m/z 145 in MS2 mode. Thus, we found that to enhance the selectivity of LC/MS2 
analysis good results were obtained increasing the signal threshold of PIS using the 
great difference in signal intensity between the iTRAQ reporter ions and others 
mentioned previously (Table 3.1).  
 
Figure 3.5. MS2 spectra enlargement of characteristic iTRAQ m/z region of non specifically detected 
BSA peptides. Panel A peptide AEFVEVTK was detected in PIS 114 due the presence of an 
acetylated b1 ion of alanine residue at m/z 114.2. Panel B peptide VLASSARQR was detected in 
PIS114 mode because of the presence of an acetylated immonium ion of valine at m/z 114.0. Panel C 
peptide TVMENFVAFVDK was detected in PIS 117 mode because of the presence of an acetylated 
immonium ion of threonine at m/z 116.3 or its isotope. 
 
In these operative conditions, we inferred that our LC/MS2 method for the 4000QTrap 
analysis resulted to be a good compromise between selectivity and sensitivity that 
are fundamental parameters in nitro-proteome analysis because of the sub-
stoichiometric characteristic of protein nitration. In fact we want to underline that, 
without any chromatographic nitro-peptide enrichment, just using the mass 
spectrometer gas phase fractionation features, we had eliminated about 96% of BSA 
un-desired peptides detected with a classical LC/MS2 approach. Furthermore if 
eventually, in a borderline case, the detection of a false positive may complicate the 
analysis, the sample may be re-analyzed inverting the diagnostic iTRAQ reporter ion 
monitored by PIS analysis. Indeed un-specific ions detected in PIS of 114 were not 
detected in PIS of 117 and vice versa. Identification of nitrated tyrosine residues was 
carried out by taking advantage of the flexibility of the in house MASCOT software. 
The software was properly modified by adding in the “modification file” the value of 
ΔM 159 for iTRAQ labelled ammino-tyrosine residue. For Mascot analysis it was 
necessary to set the software supplying key information, e.g. proteolytic enzyme, 
fixed modifications, variable modifications, sample taxonomy, eventually missed 
cleavage, etc. The data obtained from MS2 analysis in PIS mode where exploited  
AEFVEVTK VLASSARQR TVMENFVAFVDK 
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TABLE 3.1. Un-labelled BSA peptides and their precursor detected in PIS 114 and PIS 117 mode. 
 
both to identify nitration sites by using SwissProt database and to perform 
quantitative analysis.  
Nitration sites Y137, Y406, Y457, Y337 were identified by the detection and by MS2 
spectra interpretation from MH2+ ions at m/z 564.8, 841.0, 963.5, 885.3, respectively. 
As an example the MS2 spectrum of modified peptide 137-143 is shown in Figure 
3.6A. The derivatized product ions were identified from either the corresponding bn or 
yn product ion series. By using the Analyst software tool for calculation of peaks area 
(Applied Biosystems), it was possible to compare the areas signals relative to 
reporter ions at m/z 114 and 117. As an example, for the MS2 spectrum mentioned 
above a ratio of 1.1 + 0.2 was calculated.  
Figure 3.6B showed the MS2 spectrum relative to the peptide 444-457 for the mixture 
1:4 molar ratios between N-BSA labelled with iTRAQ 114 and N-BSA labelled with 
iTRAQ 117. In this case nitration site was detectable from y ions and the area ratios 
for the reporter ions at m/z 117 and 114 resulted to be 4.1 + 0.4, thus providing an 
accurate measurement of the relative abundance of each nitrated peptide. Moreover, 
the presence of an intense iTRAQ-labelled amino tyrosine immonium ion at 292.1 
m/z could be detected in both spectra (Fig. 3.6). This ion might be used as an 
indication for the occurrence of a nitration site in the peptide.  
 
Analysis of complex mixtures  
In a proof of principle, to investigate the feasibility of applying the method to 
proteomic analysis, a model system was constituted by adding 5 ng of protein mix 
containing BSA and N-BSA to 30 mg of an E.coli entire soluble protein extract. 
Aliquots of mix of BSA and N-BSA, as control, and E.coli extract spiked with BSA mix 
were fractionated by SDS-PAGE and submitted to a western blot analysis using anti-
nitrotyrosine antibody as indicated in Figure 3.7. The analysis showed that the 
amount of N-BSA was quite impossible to differentiate from the other bacterial 
proteins. Moreover, in lane D is possible to appreciate that the sample used could be 
considered similar to a “dirty” N-BSA E. coli protein extract, thus being a good 
candidate for the nitro-proteome study. The total protein extract was then submitted 
to the procedure described above. The mixture was hydrolyzed with trypsin and 
lysine residues were protected by acetylation. Nitrotyrosines were then reduced with 
dithionite, and the newly generated amino Tyr-containing peptides were submitted to 
the iTRAQ labelling protocol, using 114 iTRAQ molecule.  
 
Interfering ions Mass Peptides Scan 
(Ac)b1 Ala 114.1 (Ac)ADE(Ac)K(Ac)KFWGK(Ac) PIS 114 
(Ac)b1 Ala 114.1 (Ac)AEFVEVTK(Ac) PIS 114 
(Ac)Immonium 
Val 
114.1 (Ac)VLASSARQR PIS 114 
(Ac)Immonium 
Val 
114.1 (Ac)VH(Ac)KECCHGDLLECADDR PIS 114 
(Ac)Immonium 
Thr 
116.1 (Ac)TCVADESHACCEK(Ac) PIS 117 
(Ac)Immonium 
Thr 
116.1 (Ac)TVMENFVAFVDK(Ac) PIS 117 
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Figure 3.6. Panel A MS2 spectrum of nitrated BSA peptide 137-143 labelled by iTRAQ reagent in 1:1 
ratio. Panel B MS2 spectrum of nitrated BSA peptide 444-457 labelled by iTRAQ reagent in 1:4 ratio. 
Spectra enlargement showed iTRAQ signals allowing quantitative estimation. 
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After the labelling reaction, LC-MS2 
analysis of the mixture was 
performed by using the 4000QTrap, 
as already described. Figure 3.8 
shows a three-dimensional graphic, 
defined as Counter Plot, 
representing LC-MS2 parameters, 
namely elution time, m/z and ion 
counts expressed in greyscale 
intensity. This graphical view, 
obtained by the Analyst software 
tool, showed the duty cycle and 
sensitivity improvement of the 
strategy proposed. A full scan MS 
analysis of N-BSA spiked with an 
entire digest of E.coli protein extract 
is reported Figure 3.8A. As clearly 
shown in figure, this MS analysis is 
not competitive for such complex 
peptide mixture. Indeed, due to the 
large time spent by the spectrometer 
analyzing the most abundant 
peptides, only 3 of 4 nitrated 
peptides present in the mixture were 
detected. The high selectivity of the 
optimized PIS analysis (Fig. 3.8B) 
greatly reduced the number of 
analyzed species, leading to a real 
increase in sensitivity. Protein 
Identification of nitrated proteins was 
carried out using the modified MASCOT software as described above. These 
peptides corresponded to the same peptides previously detected in the analysis of 
homogeneous nitrated BSA. Thus, our results underscored the ability of the 
proposed selective labelling strategy to discriminate nitropeptides from their 
unmodified counterparts in a complex matrix. The proposed strategy was finally 
employed to identify unknown 3-nitrotyrosine residues in a complex sample as the 
entire bovine milk. Bovine milk was in vitro nitrated with TNM and the extent of 
nitration was monitored by SDS-PAGE and western blot analysis as described 
above. Figure 3.9 (lane A) showed that the high difference of milk protein abundance 
in the sample reflected the high dynamic range features of the proteomic analysis. In 
addition the immuno-detection (lane B) showed the low extent of protein nitration 
thus indicating that this model system could be suitable for the proteomic analysis. 
The entire milk protein extract was then dissolved in denaturant buffer, and cysteine 
alkylation and nitro groups reduction were performed “one pot” as described in the 
Materials and Methods section. Two protein samples were then desalted and 
digested with trypsin. The resulting peptide mixtures were acetylated, differentially 
labelled with iTRAQ reagents (114 and 117) and mixed in molar ratios of 1:1 and 1:4. 
The samples were then selectively analyzed by nano-LC/MS2 in PIS mode for the 
reporter ion at m/z 117.  
 
 
Figure 7. SDS-PAGE and western blot analyses of E.coli 
Figure 3.7. SDS-PAGE and western blot analyses 
of E.coli protein digest spiked with nitrated BSA 
(lane B) where N- BSA band was indistinguishable 
by the others. Lane A: Standard mix of BSA and N-
BSA as control. Lanes C and D :western blot 
analysis by using anti-nitrotyrosine antibody of 
control and E. coli samples, respectively. 
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Figure 3.8. Counter plot representation of a whole E.coli protein digest spiked with nitrated BSA 
analyzed, by a classical full scan MS (Panel A) and PIS (Panel B) after iTRAQ selective labelling. 
 
Identification of nitrated milk proteins was carried out 
using the modified MASCOT software as described. 
The results obtained were mediated on triplicate 
analyses and are summarized in the Table 3.2. As 
indicated in the table, besides the high-abundant milk 
proteins (α-casein and β-lactoglobulin), this 
procedure was also able to assess the nitration sites 
occurring in low-abundant proteins, like Vimentin and 
Integrin thus demonstrating the feasibility of this 
strategy for the identification of protein nitration in 
proteomics. Concerning for the quantifications, we 
realized the quantitative estimation of 7/9 nitrated 
peptides. In fact, the spectra of the two lower 
abundant proteins, although let us to unequivocally 
identify the nitration site, were too weak to make an 
accurate quantitative measure all over the signals. 
Figure 3.10 the MS2 spectrum of a nitrated peptide 
within α-casein is shown. It is interesting to note that 
the occurrence of an acetylated threonine residue at 
N-terminal position does not affect the quantitative 
estimation.  
 
 3.4 CONCLUSIONS 
 
The iTRAQ approach has been successfully applied 
to a variety of prokaryotic and eukaryotic samples including Escherichia coli, yeast, 
human saliva, human fibroblasts and mammary epithelial cells to identify and 
Figure 3.9. SDS-PAGE (lane 
A) and western blot analysis 
by using anti-nitrotyrosine 
antibody (lane B) of in vitro 
nitrated milk proteins. 
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Figure 3.10 MS2 spectrum of α-Casein nitrated peptide TVYQHQK detected in an in vitro nitrated milk 
proteins extract. In the spectrum enlargement of iTRAQ mass region, the characteristic signals of the 
reporter ions and a signal at m/z 116.1 of acetylated threonine immonium ion are visible. 
 
quantify the proteins in these samples (35-36). Zhang et al. (37) combined the iTRAQ 
labelling approach with immunoprecipitation to quantify tyrosine phosphorylated 
peptides epithelial cells.  
However, iTRAQ has been also applied to identify and quantify protein level in 
shotgun proteomics approach (38-39). This work represents the first innovative 
application of iTRAQ labelling strategy to the analysis of post-translational 
modification. In particular we addressed the analysis of protein nitration, thus 
providing a powerful analytical method to identify nitrated protein, localize tyrosine 
nitration sites and to quantify the extent of protein nitration in a single experiment.  
The newly developed procedure was successfully tested on complex biological 
systems (manuscript in preparation), to assess its feasibility for proteomic 
investigation of nitroproteins. Here the strategy proposed, taking in account the 
availability of linear ion trap to select specific labelled peptides giving rise to 
diagnostic MS2 product ions, resulted to be of interest in the selective detection of 
protein nitration. Moreover, because of its operational simplicity, avoiding long-lasting 
and time-consuming fractionation procedures, this new strategy seems to be well 
suited for the large-scale quantitative profiling of nitration sites. Because of the cost 
of iTRAQ kits, it is preferable to integrate the previously proposed method to 
selectively identify nitration sites on a screening scale and further select the samples  
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TABLE 3.2. Nitrated milk Proteins detected by the selective iTRAQ labelling strategy coupled with a 
selective PIS-MS analysis 
 
to be of interest for quantitative analysis. The strategy reported here was set up with 
a 4000QTrap mass spectrometer, however this approach may be realized also using 
others mass spectrometer optics, with opportune modifications. For example, 
Niggeweg et al showed the possibility to perform PIS compatible with 
chromatographic separationscoupled to a QTOF (40). Moreover, it would be very 
interesting to evaluate possible improvements, in terms of selectivity and quantitative 
estimation, by measuring with high resolution and accuracy (< 10 ppm) iTRAQ 
reporter ions. This may be accomplished by a Thermo LIT/Orbitrap performing MS2 
experiments in Higher Energy Collision Induced Dissociation (HCD) (24). The optics 
and the electronics of this instrument leads to perform analysis in an operation mode 
called “Parent Ion Mapping” that may be considered as reconstructed PIS. However, 
the feeling is that, because of the higher duty cycle of a triple quadrupole based PIS, 
eventual improvement would have real effectiveness in an off-line LC-MALDI/MS2 
analysis more than in a classical LC-ESI-MS2. The use of iTRAQ reagents for the 
selective detection and quantification of nitration sites in proteins was recognized to 
be a valid Proteomic tool. Indeed, the data showed in this chapter were published on 
a first class Proteomic journal (Chiappetta G, Corbo C, Palmese A, Marino G, 
Amoresano A, Quantitative identification of protein nitration, Proteomics (2008) in 
press) 
 
 
 
 
 
 
 
 
m/z  
OBSERVED 
SCORE SEQUENCE RATIO  
114/117 
PROTEIN  
ACC. NUMB. 
740.2 59 (Ac)VLVDTY*K(Ac)K(Ac) 4.1+0.1    
1.2+0.2 
Beta-Lactoglobulin   
P02754 
796.5 49 (Ac)DMPIQAFLLY*QEPVLGPVR 3.8+0.4    
0.9+0.2 
Beta-Casein   P02666 
573.5 44 (Ac)TVY*QHQK(Ac) 4.3+0.2    
1.2+0.3 
Alpha-s1-Casein   
P02663 
568.8 42 (Ac)Y*LYEIAR 3.9+0.1    
0.8+0.3 
Albumin bovine   
P02769 
426.8 36 (Ac)ADLIAY*LK(Ac)K(Ac) 4.1+0.4    
1.3+0.2 
Cytochrome c   
P62849 
716.3 34 (Ac)STRTVSSSSY*R 4.1+0.4    
1.2+0.4 
Vimentin   P48616 
617.4 30 (Ac)AY*PTPARSK(Ac) 4.2+0.7    
1.4+0.3 
Glycoprotein 
hormones alpha chain   
P01217 
565.9 29 (Ac)HFHLY*GR 5.2+1.6    
1.8+0.9 
Integrin alpha-L   
P61625 
559.8 29 (Ac)LELY*LPK(Ac) 7.1+3.4    
1.8+1.2 
Plasma serineprotease 
inhibitor   Q9N212 
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4. IMPROVED LC-MALDI-MS2  ANALYSIS BY PEPTIDES DANSYLATION 
 
4.1 Introduction 
 
The effects of the peptide dansylation in the MALDI-TOFTOF ion mode are showed. 
As described in chapter 1, MALDI-MS was one of the first tools developed for the 
Proteomic-scale studies to perform the PMF approach thanks to its high resolution 
and accurate mass measurement. Structural information may be also obtained using 
the classical MALDI-TOF instruments by the fragmentation spectra generated by the 
Post Source Decay (PSD) decompositions of the analytes. However, an effective 
MALDI-MS2 high throughput method it is also amenable since the commercialization 
of MALDI-TOFTOF spectrometers. The effects of peptide dansylation on MALDI-MS 
analysis were already presented by Parker et al. (1). However, no considerations on 
the fragmentation characteristics of the dansyl-peptides and the application of this 
technique to the Proteomic wide-scale were done. 
 
4.1.1 MALDI-TOFTOF mass spectrometer 
 
The main features of MALDI-TOF mass spectrometry have been already briefly 
discussed in the paragraph 1.2.1a. The main limitation of this technique relies in the 
lacking of satisfactory fragmentation spectra that can give fundamental peptide 
primary sequence information. The use of a single analyzer MALDI-TOF equipped 
with a reflector device allows the acquisition of peptide product ions spectra 
generated by the metastable fragmentation using the PSD technique (2) whose 
principle are summarized in Figure 4.1.  
 
The ions generated in the source by the pulsed laser irradiation are accelerated in 
the field free region of the TOF. At this stage ions have acquired higher internal 
energy by many processes (laser absorption, collisions, thermal heating, etc.) that 
may cause the uni-molecular metastable fragmentation on time scale shorter than 
the flight time. Because the ion decay occurs between the source and the reflectron, 
after the initial acceleration the precursor and the daughter ions travel the TOF with 
the same velocity but with different kinetic energies, arriving to the deflecting mirror at 
the same time. In this region the trajectory of precursor and product ions are 
differentiated both geometrically by the different curvature angle and timely by the 
different acceleration impressed at the exit of the reflector, thus a fragmentation 
Fig.4.1 Schematic representation of PSD experiment by using a MALDI-TOF instrument 
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spectra may be recorded. However, to record one single complete product ion 
spectra several steps have to be acquired by ramping the reflectron potentials. This 
because the ion reflector is able to analyze ion masses with sufficient resolution only 
within a certain range of kinetic energies. In fact, after the decay the fragment ions 
lose their kinetic energy. Thus in every step, besides the resolved fragment ions 
corrisponding to the appropriate kinetic energy range, the low mass range contains 
also un-resolved fragments, tha should be further focalized. In order to analyze these 
lower mass ions, the potentials of the reflector have to be decreased in steps until all 
product ions have been focalized on the detector with sufficient mass resolution. 
Finally, all the PSD spectrum sections have to be concatenated by the computer and 
mass calibrated. Also if MALDI-PSD technique leads to obtain peptide structural 
information with simple MS equipment, the product ion spectra are characterized by 
poor sensitivity and relatively low mass accuracy and resolution. All these limits were 
definitively overcome by the TOFTOF optic, as showed in figure 4.2, composed by 
two field free regions separated by a collision cell. The principles of the fragmentation 
in TOFTOF instruments are slightly different to that of the classical MALDI-TOF 
devices. 
 
Because of the ions dissociation is induced by the laser excitation, 20-30% higher 
intensity is used in MS2 mode. After the delayed extraction the ions pass through the 
first field free region undergoing the post source decay cited above. At the end of the 
first TOF a Timed Ion Selector (TIS) leads to isolate the precursor and its product 
ions that flight at the same velocity. This is realized by opening and closing a 
deflecting gate, calculating their arrive time. Inside the collision cell the precursor 
may be further fragmented filling the region with neutral gas (CID ON mode). In this 
case richer spectra similar to the beam type instruments are obtained, characterized 
by the presence of both b and y ions, immonium ions and internal fragments. The 
presence of the collision cell is certainly one of the main improvements introduced by 
the TOFTOF optics, increasing the low fragmentation efficiency of the PSD 
technique. However, in many cases the PSD mode gives rise to good spectra leaving 
the collision cell empty by the gas (CID OFF mode). Because the most intense 
Fig.4.2 Schematic representation of the Applied Biosystems 4800 MALDI-TOFTOF mass 
spectrometer 
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fragment peak is 1-2% of the precursor signal (3), the latter is removed by a 
metastable suppressor device in order to overcome the suppression of the daughter 
ion signals, eliminating the eventual metastable ions that would be generated in the 
second TOF. Before their entrance in the second TOF, ions are newly accelerated 
within one single range of kinetic energy. This event leads to finally separate in the 
second TOF the fragment ions that assume different velocities in function of their 
mass with the same kinetic energy. In practice, the second TOF plays the role 
deputed to the reflectron in the classical PSD experiments realized with MALDI-TOF 
instruments, resulting an increased resolution and accuracy of the MS2 spectra. 
Since the ions do not arrive with the same kinetic energy to the reflectron, it has not 
been ramped to focalize the fragments. The MALDI-TOFTOF mass spectrometer is 
equipped with extremely modern materials and electronic components leading to 
enhance the laser pulse rate and power and also the ion transfer efficiency 
consenting to realize hundreds of MS2 spectra per hour in a totally automated mode. 
This feature finally leads to couple off-line a MALDI spectrometer to a 
chromatographic separation by using a automated spotter that deposes drops of 
column eluate and matrix on a MALDI-plate. Thus, the chromatographic peptide 
separation, being fixed on the plate, may be analyzed several times by the MALDI-
TOFTOF mass spectrometer, resulting in a very robust LC-MALDI/MS2 technique. 
 
4.1.2 Enhanced MALDI-MS analysis by peptide modification: state of the art. 
 
It is widely accepted that the MALDI-MS development is one of the events that 
played a key role in the implementation and the appraisal of the proteomics 
approach, finally becoming nowadays a routinely used technique. Despite the 
ionization mechanisms are not yet completely understood, it is retained that the 
ionization efficiency is highly dependent by the peptide structure and the amino acid 
composition. This phenomenon is supported by the evidence that the MS signal 
intensities do not reflect the effective relative concentration of the peptides, In 
particular, the presence of basic sites and hydrophobic groups (4) leads to enhance 
the yields of the ionization process. In addition, it has also been postulated that the 
UV-adsorbing group, as aromatic moiety, are capable to favorite 
desorption/ionization, aiding the laser energy transfer to the analyte (4-5).  
Hence, in order to increase the MALDI-MS analysis, many studies based on the 
chemical peptides modification with “MALDI-active” groups were realized. For 
instance, it was found that lysine C-terminated peptides have a lower ionization 
efficiency than the arginine C-terminated ones (6) because of the weaker gas phase 
basic feature of the ε-amine group (7). Brancia et al. set up the conditions for lysine 
conversion to homoarginine by guanidination with o-methylisourea, leading to 
increased relative intensity of labelled peptides and also a higher recovery of the un-
detected ones (8). It was further demonstrated that the permanent cationic tag, 
sequestrating the “mobile proton”, suppresses the PSD fragmentation (9). On the 
contrary, the introduction of a strongly acid sulfo-group in peptide N-Terminal position 
decreases the MS signal intensity by the addition of a negative charge. However, for 
a singly charged peptide the presence of a “second” mobile proton enhances the 
PSD fragmentation (10). A combination of the two labeling procedures was 
performed to improve the results by using different cumarin aromatic derivatives (5, 
9, 11). Other UV-adsorbing groups were evaluated demonstrating the importance of 
the energy transfer assistance in the MALDI techniques (12-13). The features of 
peptide N-Terminal labeling with the fluorescent dansyl chloride reagent were first 
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evaluated by Park et al. (1). They found that the characteristic protein MALDI-MS 
fingerprint changed by using this reagent because of usually un-detected peptides 
are revealed with higher signal intensities. However, some classical peptides are not 
detected after the dansylation. By this complementary an improved PMF 
identification and protein coverage resulted, undergoing to the database analysis a 
combined peak list generated by the labeled and un-labeled spectra. More recently it 
was also demonstrated that the dansylation improve the MALDI ionization and 
fragmentation in TOFTOF instruments of glycosylated peptides whose analysis is 
many times problematic (14). 
 
4.2 Materials and Methods 
 
Chemicals. Tri(hydroxymethyl)aminomethane (Tris), 5-N.Ndimethylaminophtalene-1-
sulfonyl chloride (dansyl chloride, DNS-Cl), sodium carbonate and iodoacetamide 
(IAM) were purchased from Fluka. Bovine serum albumin (BSA), 
ethylenediaminetetraacetic acid (EDTA), trifluoroacetic acid (TFA), guanidine, trypsin. 
and dithiothreitol (DTT), alpha-cyano-4-hydroxycinnamic acid (HCCA) were 
purchased from Sigma (St. Louis.MO). All the solvents were of the highest purity 
available from Baker. All other reagents and proteins were of the highest purity 
available from Sigma. 
 
Protein digestion. Aliquots of the BSA were dissolved in denaturant buffer 
(guanidine 6M, Tris 300mM, EDTA 10 mM, pH 8.0) to a final concentration of 
0.1µg/µL (2.0 pmol/µL), reduced with DTT (10-fold molar excess on the cysteine 
residues) for 2 h at 37 °C and then alkylated with IAM (5-fold molar excess on the 
thiol residues) for 30 min at room temperature in the dark. Protein samples were 
desalted by the size exclusion cartridge PD-10 (Amersham). The elution was 
performed in Na2CO3 100 mM pH 8.8. Protein elution was monitored at 280 and 350 
nm. The fractions containing the proteins were pooled, concentrated and then 
digested. Trypsin digestion was carried out using an enzyme/substrate ratio of 1:50 
(w/w) either at 37 °C for 18 h or by microwave heating putting the tube in a water-
bath and warming for 1 minute in a domestic microwave oven at 700W. 
 
Bacterial strains growth conditions and protein extract preparation. Escherichia 
coli K12 strain was grown in aerobic conditions at 37°C in LB medium. After 16 h 
bacteria were harvested by centrifugation and re-suspended in Buffer Z (25 mM 
HEPES pH 7.6, 50 mM KCl, 12.5 mM MgCl2, 1.0 mM DTT, 20% glycerol, 0.1% triton) 
containing 1 µM phenyl methyl sulfonyl fluoride. Cells were disrupted by sonication. 
The suspension was centrifuged at 90.000 x g for 30 min at 4°C. After centrifugation 
the protein concentration of the extract was determined with Bradford assay. 
 
Peptide dansylation. To 50 µL of the BSA peptide mixture (2.0 pmol/µL) were 
added 50µL of a solution 5 ng/ µL (18.5 nmol/µL) of DNS-Cl in ACN resulting in a 
approximate reactive excess of 1:10000. The reaction was carried out either for 45 
min at 75 0C or warming the tubes in a water bath and warming for 5 min in a 
domestic microwave oven at 700 W. 
 
MALDI-MS2 analysis. Peptide mixtures in Na2CO3 were diluted 10 folds in TFA 0.1% 
and then 0.5 µL of the resulting solutions were charged on a 4800ABI plate and co-
crystallized with 1µL of a solution 4mg/mL of HCCA in 70%ACN 30%. The spectra 
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were automatically acquired first in MS mode than the 25 most intense peaks with a 
minimum signal/ratio 100 were selected as precursor for the further MS2 analysis. 
The MS spectra were recorded using a fixed laser intensity of 2100, for 1200 shots. 
The fragmentation spectra were acquired using a laser at 3500, for 2400 shots, with 
an acceleration voltage of 2kV, CID OFF and the metastable suppressor ON.  
 
 
LC-MALDI-MS2. NanoLC-MALDI-MS2 experiments were performed on a 4800 
TOFTOF mass spectrometer (Applied Biosystems) coupled to an Ultimate 
3000system (Dionex). Peptide mixtures were loaded onto an Dionex reversed-phase 
pre-column cartridge (C18 PepMap 100, 15 × 1 mm, 5 µm) at 20 µL/min with solvent 
A (0.1% formic acid, 2% ACN in water) for a loading time of 5 min. Peptides were 
then separated on a Dionex reversed-phase column (C18 PepMap 100, 150 mm × 
75 µm. 3.5 µm), at a flow rate of 0.2 µL/min using solvent A, 0.1% formic acid, 10% 
water in ACN as solvent B. The elution was accomplished by a 0-50% linear gradient 
of solvent B in 35 min. The elutes were continuously mixed with a solution of HCCA 5 
mg/mL with a flow of 436nL/min by a T junction. One hundred eighty spots were 
collected deposing the mixture (one each 10 sec) on a 4800ABI plate. The resulting 
plate was analyzed in MS and in MS2 mode by the 4800 TOFTOF mass 
spectrometer. The MS method consists in a previous MS analysis of all the spots 
generating a list of precursor that are successively fragmented in MS2 mode. The MS 
spectra were recorded using a fixed laser intensity of 2100, for 1200 shots. The 7 
more intense peaks with a minimum signal/noise of 100 were selected as precursor 
for the successive MS2 analysis. The fragmentation spectra were acquired using a 
laser at 3500, for 2400 shots with an acceleration voltage of 2kV, CID OFF and the 
metastable suppressor ON.  
 
Protein identification. The MS and MS2 data were used for the database analysis. 
By using the Applied Biosystems GPS tool, peak lists were generated, selecting MS 
signals with a signal/noise ratio 50 for the PMF analysis and signal/noise 30 for the 
MS2 data. The created peak lists were submitted to MASCOT software using as 
research parameters: other mammalia and Escherichia coli as taxonomy respectively 
for the analysis of BSA and the E.coli protein extract. Cysteine carboxamido-
methylation was selected as fixed modification and Lysine N-Terminal dansylation 
and Methionine oxidation were selected as variable modifications. The MS mass 
tolerance was set 75 ppm for the MS and 0.6 Da for the MS2. The instrument window 
was set on “MALDI-TOFTOF”. 
 
4.3 Results and discussion 
 
In order to improve the MALDI-MS2 analysis by peptide dansylation, different reaction 
conditions were evaluated. To this aim Albumin Bovine (BSA) was chosen as 
standard protein. BSA aliquot was reduced, carbamidomethylated and digested by 
trypsin both classically by over night incubation at 37 oC and by microwave (MW) 
warming for 1 min of reaction time. An aliquot of the resulting peptide mixtures 
obtained were reacted with dansyl chloride both at 75 0C for 45 minutes and by MW 
warming for 5 minutes. The four different labeled samples, and the un-labeled 
classical and microwave BSA digests, used as controls, were analyzed in triplicate in 
MS mode by an Applied Biosystems 4800MALDI-TOFTOF by spotting 0.5 µL of the 
peptide solutions on the plate.  
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S/N 20 S/N 50 S/N100  
Match Un-
match 
Match Un-
match 
Match Un-
match 
MS2 
confirmed 
 
Classical digestion 
(mean peptides) 
 
 63.0 
 
57.0 
 
64.5 
 
56.0 
 
44.5 
 
20.3 
 
26 
Microwave 
digestion (mean 
peptides) 
 
65.0 
 
35.0 
 
65.0 
 
27.5 
 
47.0 
 
14.0 
 
34 
Classical 
digestion-classical 
dansylation (mean 
peptides) 
 
52.0 
 
49.3 
 
50.6 
 
48.0 
 
38.0 
 
28.0 
 
24 
Microwave 
digestion -
classical 
dansylation (mean 
peptides) 
 
 
69.0 
 
 
29.0 
 
 
69.0 
 
 
27.3 
 
 
48.5 
 
 
18.3 
 
 
28 
Microwave 
digestion -
microwave 
dansylation (mean 
peptides) 
 
 
70.6 
 
 
29.3 
 
 
69.7 
 
 
30.0 
 
 
48.3 
 
 
12.6 
 
 
31 
However, it must be underlined that the equivalent of dansylated mixture on the plate 
are two fold less abundant than the un-labeled one. This is due to the fact that the 
dansylation conditions generally consist in the 50% dilution of the sample with a 
solution of the reactive in ACN.  Normalizing the final volume by a drying step is not 
advisable since the concentrated salts and un-reacted reagent may interfere with the 
correct crystallizations. As the final goal of this work is to set up a LC-MALDI/MS2 
based strategy the BSA samples were not desalted by ZIP-TIP chromatography, but 
diluted 10 folds in TFA 0.1% before to be spotted. Finally, 100 fmol per spot for the 
BSA sample and 50 fmol for the dansylated BSA were estimated to be analyzed. In 
order to develop a high throughput method it is important to set up an automatic MS2 
routine based on MS data. To set up the MS method, the analysis of a standard 
protein is performed. In practice for each spot the mass spectrometer first records an 
MS spectrum then a prefixed number of ions, which have generated an MS signal 
over a signal-noise ratio threshold, is selected and fragmented. Therefore, to perform 
an automatic MS2 method it is important to define the optimal signal/noise ratio (S/N) 
to discriminate what ions detected in MS have to be further fragmented. This 
parameter is also important for the generation of the peak-lists that are further 
submitted to MASCOT software. In fact, the database searching consists in a hybrid 
search using both the MS and the MS2 data. Thus, for each sample previous 
Table 4.1 shows the number of peptides identified by PMF averaged on three analyses using 
different parameter for the peak list generation 
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analyzed, three peak-lists are generated including ions having MS signals with S/N of 
100, 50 and 20 and submitted to PMF analysis using MASCOT software. 
 Identified peptides Total score Coverage 
 
Classical digestion 
 
16 
 
680 
 
37% 
Microwave 
digestion 
 
23 
 
1193 
 
49% 
MW digestion 
diluted 
 
14 
 
436 
 
28% 
Classical digestion-
classical 
dansylation 
 
8 
 
104 
 
12% 
Microwave 
digestion -classical 
dansylation 
 
15 
 
399 
 
22% 
Microwave 
digestion- 
microwave 
dansylation 
 
16 
 
441 
 
23% 
Combined research 
MW digest +MW 
digest-MW 
dansylation 
 
32 
 
1625 
 
57% 
 
The variable dansyl modification of peptide N-terminal, lysine, tyrosine and histidine 
were considered. However in contrast with Park et al. (1) the aromatic amino acids 
were not found modified. The results resumed in the table 4.1 show that using the 
minimum value 20 S/N there are no relevant increments of the identified BSA 
peptides, however an increased number of un-assigned signals is observed The 
value 50 S/N leads to enhance the matched signals in comparison to the higher 100 
S/N. Also if the number of un-matched peptides is increased, it was chosen the 
threshold of 50 S/N for the subsequent peak-list generation for PMF analysis. The 
ions previously detected as related to BSA are fragmented in CID OFF mode and the 
spectra are manually interpreted. It is observed that maximum 34 peptides detected 
in MS and assigned by PMF to BSA resulted to be confirmed by MS2 data (Tab.4.1)  
This result depends on the poor quality of fragmentation spectra related to the less 
abundant ions species generated in the MALDI source. Thus, although the high 
sensitivity and accuracy of such MS technique allows also to the weaker MS signals 
to be relevant for the PMF identification, the MS2 analysis is restricted to a fewer 
number of peptides characterized by higher MALDI ionization efficiency. Also the 
collisional induced fragmentation (CID ON mode) of the less intense ions was 
explored without any relevant improvement. Since the number of peptides giving 
satisfactory MS2 spectra is on average lower than the number of peptides having S/N 
higher of 100 (Table 4.1), this value is chosen as selection criteria for the MS2 
analysis. Thus using these parameters for the mass spectrometry experiments and 
Table 4.2 shows the results obtained by the automatic MALDI-MSMS analysis of the samples. The 
eported data are the mean values obtained by three separated experiments. 
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the database searching, all the samples are routinely analyzed in MS2 by a MALDI-
TOFTOF without limits in the number of peptides to fragment per spot. As showed in 
table 4.2 the maximum of peptides fragmented and identified per spot is 22. Thus, in 
order to preserve the crystals by an excessive usage, leaving part of the sample 
intact for successive analysis, the MS2 method is modified limiting the number of 
peptide to fragment per spot at 25. By the automated analysis a lower number of 
peptides is identified with respect to the manual mode. This it should be considered 
quite logical as in manual mode each peptide is fragmented with specific and 
optimized parameters. Moreover, the manual interpretation of the spectra may lead 
to the correct assignation of the sequence also when, in some borderline cases, 
MASCOT leads to ambiguous output. From the analysis of data in table 4.2, it 
appears that by classical digestion 16 unique BSA peptides are meanly detected 
leading the 37% of sequence coverage and total score of 680. The peptides recovery 
is improved if it is realized in a microwave field, indeed 23 unique peptides are 
meanly detected with 48% of sequence coverage and 1232 of score. This result 
appears also by PMF analysis where a larger number of hypothetical BSA peptides 
are considered. In fact as showed in Table 4.1, MW digested BSA is always identified 
with a larger number of peptides independently by the S/N used. This trend is also 
observed for dansylated peptides. Indeed, it appears that better results are obtained 
by microwave digestion of the sample, leading also to reduce drastically the time of 
analysis as demonstrated by other works (15-16). However, no significant labeling 
yield improvements are observed carrying out the dansylation reaction in microwave 
field. In fact the MW digested BSA dansylated both by classical warming and by 
microwave activation, 15 and 16 unique peptides are respectively identified in MS2 
with 22% and 23% of sequence coverage and score 399 and 441. Therefore, for 
further experiments only the procedure consisting in the protein digestion and 
peptides dansylation by MW heating will be taken in consideration. In fact, this 
protocol improved the hydrolysis yield and the whole procedure duration is reduced 
to about 1h with respect to 20h of the classical approach.  
 
 
 
Fig. 4.3 MyProms representation of the MS2data for MW digested BSA labelled and un-lavvelled 
with DNS-Cl.  
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In all the reaction conditions, it was observed that the side chain Lysine modification 
is not always quantitative. Therefore in some cases the same peptide is detected 
twice, both in the N-Terminal and in N-terminal/Lysine modified forms. Park et al. (1) 
demonstrated that after the peptide dansylation, the peculiar mass fingerprint of a 
protein changes. In fact, by the analysis of dansylated mixtures peptides not usually 
identified by the classical procedure are detected and vice-versa. For that reason the 
PMF identification is improved if the generated peak lists of the two analyses are 
combined and used for a unique data base searching. This behavior was also 
verified with MS2 data by using the software MyProms (17), a tool that allows to 
store, to compare and to manage MASCOT searches. As shown in figure 4.3 the 
separated database searches for the dansylated and un-labeled peptide mixtures 
lead to identify BSA respectively with a maximum score of 458 and 1211 and 
maximum sequence coverage of 23% and 49%. By the combined peak list of this 
couple of data, the analysis is improved in fact it results a total score of 1625 and 
sequence coverage of 57%. It is interesting to underline that the statistic relevance of 
the incremented number of MS2 data leads to high enhancement of the probabilistic 
score also if it is related to short increase of sequence coverage. In fact, when 
common peptides are found in their modified and un-modified forms, the best score 
is used for the calculations.  
 
Understanding the effects of peptides dansylation. By analyzing data in tables 1 
and 2 it should be noted that after the dansylation fewer peptides are above the 
selection criteria for fragmentation. Ths results in lower scores and coverages. 
However as already reported the un-labeled sample is more concentrated, so an 
aliquot of this sample is diluted in 50% ACN in order to evaluate if the induced 
modification may suppress the MALDI ionization. By the automatic MALDI-TOFTOF 
analysis of the diluted BSA microwave digest, 14 peptides were detected with total 
score of 436 and sequence coverage of 28%. It confirms that the high differences, in 
terms of total number of fragmented peptides, observed after the peptide dansylation 
has to be attributed to the dilution effect and on contrary the dansylation leads to 
detect a larger number of peptides in MS2. Thus, it is possible to use the diluted 
sample as control also to understand other effects of peptide dansylation on MALDI-
MS2 technique. Besides the dilution, the sequence coverage, obtained from the un-
labeled sample analysis, is higher although a lower number of peptides were used. 
To understand this behavior, a larger number of peptides have to be evaluated and 
to this aim all the control peptides identified by a PMF analysis and not identified by 
the automatic MS2 routine were manually fragmented, as previously done for the 
dansylated mixture. The results are summarized in the Table 4.3. It is reinforced the 
evidence that the dansylation changes the ionization profile of MALDI-MS. In fact, 
according to Park at al., some peptides are detected and others not anymore 
detected after the dansylation. Moreover, it is observed that many peptides are not 
automatically fragmented because their relative signal intensity is too low, thus 
resulting in a change of the ionization hierarchy. For example the peptides m/z 
1652.7 (DNS)-SLHTLFGDELCK and m/z 1672.7 (DNS)-RHPEYAVSVLLR were 
efficiently manually detected and sequenced after the dansylation but they were not 
automatically fragmented. If we exclude the common identified peptides contributing 
equally to the sequence coverage, we obtain 23 unique peptides for the control, 21 of 
which having molecular weight within m/z 1795.8 - 3511.7. Instead, for the 
dansylated sample 18 unique peptides are found within m/z 714.4 - 1696.8. This 
trend shows that dansylation improves the recovery of peptides in the low mass 
BSA DANSYLATED PEPTIDES 50 fmol 
BSA PEPTIDES 150 fmol 
CUMULATED PEAK LIST 
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 MASS SEQUENCE SCORE MASS SEQUECE SCORE 
 
 
 
 
COMMON 
PEPTIDES 
712.3 
927.4 
1001.5 
1419.7 
1439.7 
1639.8 
1479.8 
1567.7 
1724.8 
2004.8 
SEIAHR 
YLYEIAR 
ALKAWSVAR 
SLHTLFGDELCK 
RHPEYAVSVLLR 
KVPQVSTPTLVEVSR 
LGEYGFQNALIVR 
DAFLGSFLYEYSR 
MPCTEDYLSLILNR 
VASLRETYGDMADCCEK 
 
32.3 
35 
78.3 
42 
54.6 
41.6 
40 
51.6 
26.5 
945.3 
1160.5 
1467.6 
1652.6 
1672.7 
1712.8 
1800.7 
1957.8 
2105.9 
2237.9 
*SEIAHR 
*YLYEIAR 
*AL*KAWSVAR 
*SLHTLFGDELCK 
*RHPEYAVSVLLR 
*LGEYGFQNALIVR 
* DAFLGSFLYEYSR 
*MPCTEDYLSLILNR 
**KVPQVSTPTLVEVSR 
*VASLRETYGDMADCCEK 
 
26.5 
35 
 
 
86 
88.5 
87.5 
89.6 
52 
 
 
 
 
 
 
 
 
 
UNIQUE 
PEPTIDES 
 
1193.6 
1305.7 
1795.7 
1880.9 
1907.9 
1927.7 
2045.0 
2113.9 
2148.0 
2247.9 
2277.1 
2405.2 
2487.1 
2492.2 
2541.2 
2612.2 
2872.3 
3000.4 
3038.3 
3038.3 
3279.5 
3308.5 
3511.7 
 
DTHKSEIAHR 
HLVDEPQNLIK 
DDPHACYSTVFDKLK 
RPCFSALTPDETYVPK 
LFTFHADICTLPDTEK 
CCAADDKEACFAVEGPK 
RHPYFYAPELLYYANK 
VHKECCHGDLLECADDR 
LKPDPNTLCDEFKADEKK 
ECCHGDLLECADDRADLAK 
LFTFHADICTLPDTEKQIK 
LFTFHADICTLPDTEKQIKK 
YNGVFQECCQAEDKGACLLPK 
GLVLIAFSQYLQQCPFDEHVK 
QEPERNECFLSHKDDSPDLPK 
VHKECCHGDLLECADDRADLAK 
CCTKPESERMPCTEDYLSLILNR 
CCTESLVNRRPCFSALTPDETYVPK 
EYEATLEECCAKDDPHACYSTVFDK 
EYEATLEECCAKDDPHACYSTVFDKLK 
EYEATLEECCAKDDPHACYSTVFDKLK 
TVMENFVAFVDKCCAADDKEACFAVEGPK 
SHCIAEVEKDAIPENLPPLTADFAEDKDVCK 
 
33 
61.5 
 
27 
56 
 
 
60 
 
 
51.5 
 
 
 
55.2 
19.3 
 
13 
 
 
 
 
 
 
714.3 
778.3 
805.3 
842.3 
882.3 
891.3 
939.3 
922.3 
1022.4 
1051.4 
1139.5 
1247.6 
1301.4 
1371.4 
1524.6 
1608.7 
1632.7 
1676.6 
1696.8 
 
*FGER 
*VASLR 
*QRLR 
*AFDEK 
*IETMR 
*QEPER 
*CASIQK 
*AWSVAR 
*LVTDLTK 
*ATEEQLK 
*IETMREK 
*QTALVELLK 
*QNCDQFEK 
*CCTESLVNR 
*ECCDKPLLEK 
**KQTALVELLK 
*CCT*KPESER 
*YICDNQDTISSK 
*TCVADESHAGCEK 
 
 
24.5 
 
 
18.3 
 
 
20 
 
 
24 
 
28.5 
18 
 
 
39 
41 
70 
Table 4.3 shows the results of the automatic and manual MS2 analysis of the MW digested/dansylated sample and for the diluted MW digested sample (control). 
For the manually fragmented peptides were not reported the MASCOT score because they are strongly dependent by the ad hoc parameters used to obtain good 
spectra. When the same peptide is detected in different dansylated form it is reported that ones with a better score or spectrum. Amino acids labeled with a star 
are dansylated 
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 range and decreases the ionization of the heavier, thus confirming the 
complementary characteristic of the double analysis This result leads to understand 
the higher sequence coverage of the control sample also with less detected peptides. 
Park et al. (1) suggested that the dansylation of the strong basic lysine ε-amine in 
some cases might suppress the peptide ionization. However, this conclusion was 
achieved by using MS data only by comparing a few numbers of peptides with 
multiple modification sites. By using a larger number of MS2 data the nature of the 
Fig.4.4. MS2 spectra of the BSA peptide DAFLGSFLYEYSR in the native (panel A) and tagged 
(panel B) forms 
B 
A 
A 
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observed effects may be better clarified. Among 23 peptides disappeared after the 
dansylation and 21 of them contained a C-Terminal Lysine. In fact the conversion of 
the ε-amine (pKa 10.5) to sulfonamide decrease drastically its affinity toward the 
protonation. In addition the basic group introduced by the dansyl moiety is an 
aromatic tertiary amine (pKa 4.0) (4) that does not give the same contribution to the 
ionization as the C-Terminal lysine does (5-6). However, the detection of arginine C- 
terminal peptides with internal labeled lysine residues confirms that the basic 
properties of the C-terminal are very important for an efficient MALDI ionization. This 
behaviour can be observed for the peptides m/z 1467.6 (DNS)-AL(DNS)-KAWSVAR 
and m/z 1632.7 (DNS)-CCT(DANS)-KPESER (Tab.4.3). On the contrary, the 
decreased peptide N-Terminal basicity (pKa 8-9) is less relevant than the presence 
of a di-methylamino-naphtalene group in the same position.  
In conclusion the peptide dansylation has two opposite effects in the MS mode.  
A positive increased energy transfer due to the UV- absorbing naphtalene group that 
in the case of the BSA leads to identify 18 peptides not detected by the classical 
approach. This effect appears to be not linked to the peptide sequence. A negative 
suppressing effect when the C-Terminal basicity is loss by the modification. 
Obviously, these effects may be modulated by the peptide sequence and dansyl-
lysine is detected when other basic sites are present in the sequence. This is the 
case for the peptide (DNS)-VASLRETYGDMADCCE(DNS)-K (not reported in the 
Tab. 4.3) whose N-Terminal and lysine were found both labelled. As concerning the 
MALDI-MS2 features of dansyl-peptides it is interesting to underline that they are in 
most cases identified with higher score than the corresponding un-labeled one in the 
control (Tab. 4.3). This MASCOT score evaluation is made only considering the 
common 7 peptides that were automatically fragmented, under the same operative 
conditions. The reasons of this result are verified analyzing the respective 
fragmentation spectra of the peptides detected both in the control and the dansylated 
peptide mixtures. It appears that the fragmentation pattern of dansylated peptides 
exhibit in PSD mode enhanced b-type ions that may lead to a better sequence 
determination (Fig.4.4). The nature of fragmentation improvement has to be 
attributed to the fluorescent moiety in N-terminal position. These results are in perfect 
agreement with previous works where a fluorescent modification of N-Terminal amino 
acid induced a better generation of b series ions (5, 11-13). To better understand this 
effect, the values of the relative intensity of the b ions and their complementary y ions 
are evaluated for the automatically fragmented peptides. By the comparison of these 
values it is possible to monitor the trend of a singly-charged ion to preferentially give 
rise to b or y fragment ions. The values obtained are graphically represented in figure 
4.5 where the relative intensities are reported as function of the relative ions. The 
curves obtained, blue for the b series and red for the y series, give a snapshot of how 
the peptide sequence is covered by MS2 experiments performed with a MALDI-
TOFTOF. It appears, by the larger extent of the red curve, that the generation of y 
ions it is generally a preferential event. This is in agreement with the evidence that for 
a mono-charged tryptic peptide the probability that the charge is retained at the C-
Terminal position is higher (20). Moreover, it is observed that the y-type ions 
intensities are higher for the first members of the series, then they decrease for the 
higher mass range. This heterogeneus intensity distribution effect may be attributed 
to the hybrid charge-directed/charge-remote fragmentation of tryptic peptides (cfr. 
par. 1.2.1)(19). In fact, following the mobile-proton model, the charge is transferred in 
the gas-phase by the basic sites to the vicinal amide-bond leading to its 
destabilization and further fragmentation. This event is statistically retired along the 
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YLYEIAR 
ALKAWSVAR 
 
LGEYGFQNALIVR 
DAFLGSFLYEYSR 
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Fig.4.5 graphic representation of ion intensities in function of the different bn and yn fragments. The 
resulting red curve is related to the y-type ions and the blue curve is related to the b-type ions 
 
peptide chain, generating a population of isomer ions. However the charge 
localization of the arginine or lysine basic-group reduces the proton mobility to the 
amino acid near the C-Terminal position, with consequent destabilization of the 
amide bond in the N-Terminal region. The peptide DAFLGSFLYEYSR (fig 4.4 and 
4.5) has a strong y12 for the presence of the aspartic acid in N-Terminal position that 
favorizes the vicinal amide bond protonation, providing a supplementary mobile 
proton. However, the enhanced y-type ion generation is thought to be caused by a 
MPCTEDYLSLILNR 
 
KVPQVSTPTLVEVSR 
 
VASLRETYGDMADCCEK 
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charge remote mechanism (21). Also the peptide KVPQVSTPTLVEVSR has high 
mass range y series ions characterized by strong intensities. This is probably due to 
the presence of an N-Terminal lysine residue that may enhance the charge-
directed/charge-remote fragmentation of the N-Terminal peptide region. 
This conclusion is enforced considering the bi-dansylated form of this peptide that 
was automatically fragmented leading to perform a comparison with the un-
dansylated and mono-dansylated forms (see figure 4.4). The side-chain dansylation 
of the N-Terminal lysine decreases the intensity of the y-type ions mainly in the range 
y8 to y14, confirming that the localization of a proton in N-Term position plays an 
important role in the charge directed- fragmentation. Obviously, the loss of the N-
Terminl lysine charge localization affects mainly the b-type ions whose intensity 
results drastically decreased. The double dansylation of the peptide ALKAWSVAR 
has not the same drastic effect probably due to the internal position of the lysine and 
also the shorter length of the peptide. However, also in this case the y ions decrease 
in proximity of the dansylated lysine. The absence of the mono-dansylated form does 
not lead to make wider observation as previously done. As showed in figure 4.4, the 
N-Terminal amine dansylation does not influence the normal intensity distribution of y 
series. In fact, the red curves related to the dansylated and control peptides, remains 
unchanged, showing the typical decreasing intensity at the higher members of the 
series. Moreover, the blue curve, related to the b-type ions, appears greater for the 
labelled peptides than the un-modified one, confirming the starting observation that 
the N-Terminal amine dansylation increases the b ions generation. In addition, by the 
graphical representations of figure 4.4, others conclusion may be done. The b series 
of the un-modified peptides has the intensity distribution not complementary to the y 
series curve, but the higher values are mainly concentrated in the middle of the 
series. This may be due to the absence of the charge localization in the N-Terminal 
position making the b ion generation highly dependent on the charge directed 
fragmentation. Thus, the b-type ion generation is more probable at the central 
peptide-bond cleavages, where the amide protonation is still possible and the C-
Terminal basicity has less sequestering power caused by the distance. Therefore, 
the N-Terminal region of a peptide remains not well covered by the MS2 analysis. N-
Terminal dansylation, beside increasing the b-type ion intensity, appears to change 
the b series intensity distribution, shifting the higher values to the N-Terminal region 
and thus leading to a better sequence coverage by the MS2 data. This effect may be 
rationalized considering a double effect that the dansyl-moiety may give to the 
peptide fragmentation. In fact the UV-adsorbing dansyl naphtalene group may 
transfer the energy adsorbed by the laser radiation to the vicinal peptide bonds 
promoting the local destabilzation without the introduction of a new mobile proton. In 
addition the dansyl moiety stabilize also the charge retention both introducing a 
second amine group and by the aromatic delocalization. The results obtained in this 
work perfectly agree to Renner and Spiteller (1985), where dansylated peptides were 
analyzed by Fast Atom Bombardment (FAB) MS (22)  
 
Complex protein mixture analysis. In order to validate the results obtained on the 
standard protein and to evaluate the feasibility of peptide dansylation on large scale 
proteomic approach, a soluble protein extract of E.coli is reduced and alkylated in 
denaturant conditions. Then the protein mixture is desalted by size chromatography 
eluting in Na2CO3 (see Materials and Methods paragraph). Finally, E.coli proteins are 
digested by trypsin in MW field. The resulting peptide mixture is divided in two 
aliquots, one of which is directly analyzed by LC-MALDI/MS2. The second aliquot is 
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dansylated in MW field as described above (cfr. par.4.2), then dried to eliminate the 
ACN, re-suspended in 1% of formic acid and finally analyzed by LC-MALDI/MS2. It is 
expected 400 fmol of both  un-dansylated and dansylated peptide mixtures are 
injected. The MS2 data are used for the database research both by separate and 
combined peak lists. The results obtained are resumed in the Table 4.4. It appears 
that the improvements in the sequence coverage, score and complementary peptide 
recovery, evidenced by Park et al.(1) by PMF and then confirmed for the MALDI-MS2 
technique in the first part of this work, are kept un-varied also at Proteomic-scale. In 
fact, of the 22 identified proteins 6 were found only by dansylated peptides and 8 only 
by control ones. The others 8 proteins identified both by labelled and un-labelled 
peptides show an increased MASCOT score and higher sequence coverage. Again,  
peptides found both in the un-labelled and labelled forms have higher score in their 
dansylated form. As an example, the peptide ELANVQDLTVR of the RNA 
polymerase subunit alpha (RPOA) was identified with 80 as Score value in the 
dansylated form and 37 when is un-modified. 
 
Protein Mascot score 
Score before 
dansylation 
Numb. 
Peptides 
Dansylated 
peptides 
Coverage 
(%) 
Coverage 
before 
dansylation 
RPOA 433.4 280.0 9 4 28.3 17.3 
RBSB 288.2 156.0 5 2 17.6 12.8 
DNAK 188.4 87.0 5 3 9.2 3.8 
EFTS 185.0 68.0 5 3 15.2 4.3 
TIG 182.0 182 3 0 10.0 10.0 
EFTU 169.4 105.2 6 2 18.8 9.9 
RS1 111.9 87.0 3 1 7.5 5.6 
RL10 108.4 54.3 2 1 9.7 9.7 
CH60 103.6 47.7 2 0 6.4 6.4 
RL18 91.2 0 3 3 19.7 0 
RL9 68.6 31.7 2 1 12.8 7.6 
ENO 56.0 0 2 2 2.8 0 
SLYD 54.7 54.7 1 0 4.6 4.6 
DBHA 50.3 50.3 2 0 32.2 32.2 
RL2 46.2 0 1 1 3.3 0 
CSPC 43.0 43.0 1 0 24.6 24.6 
YJGF 41.0 0 2 2 17.2 0 
CH10 33.8 33.8 1 0 14.4 14.4 
TNAA 32.6 0 1 1 1.7 0 
RL25 32.3 32.3 1 0 8.5 8.5 
HNS 30.4 0 1 1 5.8 0 
DINJI 30.1 30.1 1 0 8.1 8.1 
Table 4.4 E.coli proteins identified by LC-MALDI/MS2 by the dansyl based method  
 
4.4 Conclusion 
 
The strategy described in this chapter aims to improve the identification power of the 
LC-MALDI/MS2 by using the peptide dansylation. Peptide MALDI-MS features of this 
modification were first evidenced by Park et al (1). In fact, they found a 
complementarity between the protein peptide fingerprint of the labelled and un-
labelled trypsin digests, which was used to enhance the sequence coverage and the 
MASCOT score. In the proposed work this behavior was confirmed and applied to gel 
free high-throughput and automated nanoLC-MALDI/MS2 technique. Moreover, the 
global strategy has been also improved introducing the microwave-based chemistry 
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for the protein digestion and the peptide modification, resulting in a more efficient and 
very fast procedure (1h). The reaction conditions and the MS methods were first set 
up using BSA as standard protein. This experiments lead to understand that the 
complementarity of the detection concerns the peptide size and the presence of C-
terminal lysine. In fact, large part of newly detected dansyl peptides is in the lower 
m/z region. This feature leads to cover short regions of the protein sequence, that are  
normally un-detected, that however, may be post-translational modified and escape 
mass spectral analysis in the classical approach. The observation of Park et al. that 
the side chain dansylation of C-Terminal lysine may, in some cases, decrease the 
peptide ionization was confirmed by using a larger number of MS2 data. However, 
this feature does not invalidate the power of the strategy that is based on the use of 
MS data of modified and un-modified peptide mixtures. The large number of 
evaluated peptides led also to understand the effect of peptide dansylation on the 
peptide fragmentation in a MALDI-TOFTOF instrument. It was observed that in CID 
experiments, the introduction of a UV-adsorbing moiety in N-Terminal position 
favorizes the peptide bond cleavage in this region that is normally not probable for a 
singly-charged peptide. This feature was probably due to the naphtalene group that 
increases the energy transfer from the MALDI laser to the peptide. The redistribution 
of the energy along the vibrational-rotational degrees of freedom of the amino acid 
chain has a local effect, causing the de-stabilization of the peptide bond near the 
modification site. Finally it results that the “early” b series yielding is enhanced also 
by the N-Terminal charge retention allowed by the dansyl moiety stabilization of the 
charge. This fragmentation feature leads to better complementarities between y and 
b series, having positive effects both on the MASCOT score, for the automatic 
assignation of the spectra, and also for the manual interpretation for the analysis of 
PTMs. The Lysine modification may also decreases the fragmentation yielding. 
Moreover, a control of the reaction toward a selective N-Terminal modification is still 
a challenging task. As perspective works, the lysine conversion to homo-arginine 
followed by N-Terminal dansylation will be also evaluated considering its impact both 
on the MS signal and on the MS2 fragmentation. However the mass spectral data 
obtained demonstrated that the procedure set up in this work is robust for the large-
scale proteomic analysis. This was confirmed by the application of the strategy to the 
analysis a whole E.coli protein extract, which showed relevant improvement in the 
protein identification, in terms of peptide recovery and MASCOT score. 
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5. A NEW METHOD TO SELECTIVELY EVALUATE PROTEIN THIOLS 
OXIDATION STATE. 
 
5.1 Introduction 
 
Proteomics allows the study of post-translational modification state of a proteome. 
However, classical procedures fail to detect the oxidative products of cysteines. In 
the last 5 years alternative chemical labeling methods were developed to further 
investigate this field. 
This project aims to set up a new strategy based on dansyl aziridine fluorescent 
reagent to monitor and characterize thiol oxidative modifications in one unique 
workflow from the tissue or cell to the MS identification.  
Preliminary results showed that the fluorescent characteristic of dansylated proteins 
allowed a selective UV staining of 2DE gels. Only the species that have changed 
their cysteines oxidation state were differentially revealed.  
Protein dansylation improves MALDI ionization yield increasing the energy transfer 
thanking to the 5-(dimethylamino)naphthalene moiety. Moreover, Precursor Ion Scan 
analysis, by using the peculiar MS2 dansyl-peptides fragments, enhances the 
achievable dynamic range. In addition, because dansyl derivatives are cell 
membrane permeable, proteins can be directly labeled inside the cytoplasm giving a 
better picture of the oxidative cell state in vivo. Finally, dansyl features consent to set 
up the conditions for tissue histochemical staining before molecular analyses, 
associating proteomics data with morphological information. 
 
 
5.1.1 Proteomic analysis of oxidation related cysteine: state of the art 
 
Oxidative stress is directly related to many human diseases (19). The reaction 
products of oxidants with biomolecules are actually considered the best biomarker to 
depict a particular cellular redox state. It was demonstrated that several amino acids 
are modified post-translationally under oxidative stress conditions (20). However, 
cysteine residues are perhaps the most sensitive to the oxidation and may result in 
many modification levels that depend on the oxidant nature and concentration. 
Proteomic approach is actually the most powerful tool to depict the post-translational 
modification (PTMs) state of a proteome. However, many classical procedures are 
lacking in the detection of cysteine oxidative products. These findings result from the 
chemical lability of many thiol modifications as the S-nitrosilation, the susceptibility to 
the oxidants and reductants used in many buffers, the absence of specific antibodies 
useful to screen or enrich complex protein mixtures (1). In the last years many 
alternative chemical labeling based methods were developed in order to make 
possible this kind of analysis. These strategies are based on the trapping of a defined 
thiol oxidation state using the differential alkylation. The general approach consists in 
an alkylation step to block -SH- groups, followed by a selective reaction to convert 
the oxidized thiols in their reduced form that is successively alkylated by using a 
second reagent, thus allowing to detect the modified protein (2). In order to obtain a 
“snapshot” of thiol oxidation state in vivo, it is necessary to prevent un-specific air-
mediated oxidations. This may be accomplished blocking the free thiols when the 
proteins are still in the cell using membrane permeable reagents (3). This suggestive 
operating fashion allows to alkylate protein in their native conformation and chemical 
environment, thus giving structure-function information. Indeed, thiol reactivity is 
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based on the chemistry of the anionic state (4), the predominant species of the 
dissociation equilibrium at physiological pH. In proteins the reactivity of this residue is 
regulated by protonation/de-protonation events, changing the local cysteine pKa by 
the influence of the conformation dependent micro-environment (5-7). Thus, the in 
vivo labeling may also give information about thiol reactivity and exposure. An 
alternative strategy consists in the cell harvesting in tri-chloro acetic acid (TCA). By 
using this reagent it is also possible to avoid thiol oxidation by protonation and to 
precipitate the protein extract. Then, protein extract is re-suspended in a solution of 
the alkylant in strong denaturant buffer (8). This strategy consents to have the same 
accessibility and reactivity toward all free thiol enhancing their recovery even losing 
the structural information. The further alkylation steps are pursued after a selective 
reduction (9-10). Thiol group may be also regenerated by the reaction of S-
nitrosilated proteins with ascorbate (11). The commercial availability of a large 
number of thiol alkylating agents has favored the development of many labeling 
strategies. The most common ones are based on the thiol labeling with a fluorophore 
moiety in order to selectively detect oxidized protein separated by bidimensional 
electrophoresis (2DE) (12-14). However, in some cases the use of a bulk fluorescent 
tag, that un-favor peptides mass spectrometry (MS) detection, may lead to identify 
the oxidized protein but not to find the site of modification. An interesting strategy 
uses the classical 14C enriched iodoacetamide for the differential alkylation (8). 
Radioactive labeled protein may be selectively visualized after 2DE fractionation. In 
addition IAM is MS compatible and since alkylation step is based on two chemical 
identical molecules, the 2DE co-migration of differentially alkylated proteins is 
improved. Other methods use a biotin or also ICAT chemistry in order to enrich the 
labeled peptides or proteins making also possible the gel-free analysis and 
quantitative estimations (15-16). It must be considered that, also in this case the 
presence of a bulky moiety may un-favor the peptides ionization and the eventual tag 
cleavage reactions, associated to various chromatography purification/enrichment 
steps, may be time consuming and cause of material loss. An interesting solution to 
these problems seems to be the HIS-TAG strategy that uses an iodoacetamide 
derived synthetic peptide (17). In this case the tag does not interfere with ionization 
propriety and it leads also to the immuno-detection because specifically recognised 
by an anti-body. N-Dansyl-S-nitrosohomicysteine was used as fluorescent probe to 
detect S-nitrosilation in vivo (18). In this case the cellular membrane permeability of 
dansyl derivatives leads to label proteins in the cytoplasm making a picture of the 
redox state of cysteines. However, no MS analysis or proteins identification were 
done. 
  
5.2 Material and methods 
 
Chemicals. Bovine serum albumin (BSA), ammonium bicarbonate (AMBIC), 
guanidine, dithiothreitol (DTT), trypsin, iodoacetamide (IAM) were purchased from 
Fluka. Dansyl aziridine was purchased from Invitrogen. 
Tris(hydroxymethyl)aminomethane, Magnesium Chloride, trifluoroacetic acid (TFA), 
trichloro acetic acid (TCA), Urea, Thiourea, 3[(3 Cholamidopropyl)dimethyl 
ammonio)-1-propanesulfonateas] (CHAPS) well as the MALDI matrix α-ciano-4-
idrossicinnamic acid were purchased from Sigma. Non Detergen Sulfo-Betain 
(NSDB) was purchased by Merck, Agarose, Temed, Acrylamide were purchased by 
BioRad Acetonitrile (ACN) are HPLC grade type from Baker. Gel filtration columns 
PD-10, are from Amersham. 
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BSA dansylation. An aliquot of 200 µg BSA was dissolved in 198 µl of denaturing 
buffer (7M Urea, 2% CHAPS, 40mM Tris, pH 8.0) and it was added 2 µl (1% v:v) of 5 
µg/µl solution of DAZ in ACN in a molar ratio 1:10 BSA : DAZ. The reaction was 
carried out under agitation for 4h at 37°C und agitation using a Bio Rad thermo block.  
 
Reduction and carboxamidomethylation of BSA. BSA-DAZ was diluted in 
denaturation buffer (guanidine 6 M, Tris 0.2 M, EDTA 10 mM, pH 8.0). Reduction 
was carried out by using a 10:1 DTT: cysteine, DAZ molar ratio. After incubation at 
37°C for 2 h, iodoacetamide was added to perform carboamidomethylation using an 
excess of alkylating agent of 5:1 respect to the moles of thiol groups. The mixture 
was then incubated in the dark at room temperature for 30 min. The alkylation 
reaction was stopped by addition of formic acid, in order to achieve an acidic pH. The 
mixture was then desalted by size exclusion chromatography on a SEPHADEX G-
25M column; the elution was carried out with AMBIC 50 mM and the fractions 
analyzed through UV spectrometry at 220 and 280 nm wavelength. Positive fractions 
were collected and dried. 
 
BSA digestion. Protein digestion was carried out in AMBIC 50mM pH 8.0 buffer 
using trypsin or chimotrypsin at a 50:1 protein : enzyme mass ratio. The sample was 
incubated at 37°C for 16 h. Then the sample was dried.  
 
Microwave (MW) assisted BSA digestion. MW digestion was carried out in the 
same buffer and trypsin concentration showed above. However, the reaction was 
driven for 2 min in a domestic Microwave (Whirpool) oven at 900W putting the tubes 
in a water bath. 
 
Bacterial strains, growth conditions and protein extract preparation. Escherichia 
coli K12 strain was grown in aerobic conditions at 37°C in SOC medium. After 16 h, 
bacteria were centrifuged (5 min, 4000g, 4oC) and washed three times with 500µl of 
100mM Sodium Bicarbonate 12.5 mM MgCl2 pH 7.4 buffer.  
 
E.coli protein denaturating labeling. E.coli cells were harvested in TCA by three 
sonication steps of 30 sec. The solution was centrifuged and the protein pellet was 
re-suspended in 50µl of denaturing buffer with 10% (v:v) of 5 µg/µl solution of DAZ in 
ACN. The mixture was reacted at 37°C for 1h. To stop the reaction 50 µl of TCA was 
added, dry protein pellet was re-suspended in 150 µl of TUC buffer (2M thiourea, 7M 
urea, CHAPS 2%, DTT 1%, Tris 40mM, NSDB 1M) 
 
In vivo DAZ labeling. E.coli cells (0,6 O.D.600) suspended in 500µl 100mM Sodium 
Bicarbonate 12.5 mM MgCl2 buffer pH 7,4 was incubate with 10% (v:v) of 5 µg/µl 
solution of DAZ  in ACN at 37°C under gentle stirring. Then the cells were washed 
three times to eliminate the reactive and centrifuged at 4000g for 5min. The 
supernatant were wasted and the dry cell pellet was harvested in TUC buffer and 
incubated with rotator over night at 4 oC. 
 
2DE. The E.coli protein extracts (100µg) were purified for the 2DE by the 2-D Clean-
Up Kit (Amersham). The pellets were dissolved in the TUC buffer (Thiourea 2M, Urea 
7M, CHAPS 2%, Tris 40 mM pH 8.8, NSDB 1M, DTT 1%) and then they were 
ultracentrifuced ad 70000g. The supernatant was loaded on 7 cm IPG 4-7 strips 
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(Amersham) as reported by the manufacturer. The iso-electrofocusing was realized 
using an Amersham IPG-Phore and the migration was carried out for 20h. After the 
first dimension the strips were re-hydrated in 3mL of Rehydratation buffer (Urea 6M, 
40 mM Tris pH8.8, glycerol 30%, SDS 2%) with DTT 10 mg/ml for 15 min and then in 
3mL of Rehydratation buffer with IAM 25mg/ml for 15 min. The strips were then 
deposed on a 12,5% acrylamide gel, fixing with Agarose 1%. Two SDS-PAGE were 
run at the same time at 50 mA constant for 1h. The gels were washed with MilliQ 
water (3x15min) then the fluorescence image was taken. Finally the gels were 
stained by the Imperial Code Coomassie (Pierce) for the time necessary to the spots 
detection. 
 
In situ protein digestion. Protein spots that undergo to the MS analysis were 
excised than washed three times drying and hydrating the gel respectively with ACN 
and 50mM AMBIC. Protein were reduced by a solution of DTT 10 mM for 30 min at 
560C and then alkylated by a solution of IAM 55mM for 30 min at room temperature 
in the dark. Then, gel spots were washed by the reagents and a cold solution 1ng/µL 
of trypsin in 10mM AMBIC, was added. The tubes were incubated 2h at 4 0C then 
they were centrifuged and the supernatant were substituted with a fresh solution of 
10mM AMBIC and incubated o.n. at 37 0C. After the digestion the tubes were 
centrifuged and the supernatant collected in other news tubes. After a further peptide 
extraction using ACN the solutions were dried by Speed-Vac and re-suspended in 10 
µL of Formic acid 1%. 
 
LC ESI/MS2. The samples were loaded onto an Dionex reversed-phase precolumn 
cartridge (C18 PepMap 100. 15 × 1 mm. 5 µm) at 20 µL/min with solvent A (0.1% 
formic acid. loading time 5 min). Peptides were then separated on a Dionex 
reversed-phase column (C18 PepMap 100. 150 mm × 75 µm. 3.5 µm). at a flow rate 
of 0.2 µL/min using 0.1% formic acid. 2% ACN in water as solvent A, 0.1% and 
formic acid. 10% water in ACN as solvent B. The elution was accomplished by a 0-
50% linear gradient of solvent B in 35 min. Mass spectra were recorded with a LTQ-
FTICR (Thermo-Finnigan) mass spectrometer. Data were acquired in automatic high 
dynamic mode consisting of alternate acquisitions in FTMS full scan survey mode 
(m/z range 500-2000), 3 FTMS SIM scan mode for exact mass and charge state 
determination of peptide and 3 LIT MS/MS mode for the petide sequencing  
 
MALDI-MS2 analysis. Peptide mixtures were diluted 10 folds in TFA 0.1% and then 
0.5 µL of the resulting solutions were charged on a 4800ABI plate and co-crystallized 
with 1µL of a solution 4mg/mL of HCCA. The spectra were automatically acquired 
first in MS mode than the 25 most intense peaks with a minimum signal/ratio 100 
were selcted as precursor for the further MS2 analysis. The MS spectra were 
recorded using a fixed laser intensity of 2100. for 1200 shots. The fragmentation 
spectra were acquired using a laser at 3500. for 2400 shots. with an acceleration 
voltage of 2kV. CID OFF and the metastable suppressor ON.  
 
Protein identification. The MS and MS2 data were used for the database analysis. 
using MASCOT software with the following parameters: Other Mammalia and 
Escherichia coli as taxonomy respectively for the analysis of BSA and the E.coli 
protein extract. Cysteine carboxamido-methylation, Cysteine dansylation, Cysteine 
oxidation, Methionine oxidation were selected as variable modifications. The MS 
mass tolerance was 75 ppm for the MS and 0.6 Da for the MS2 for the MALDI-
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TOFTOF data. While for the LTQ-FTICR data 5ppm for the MS and 0,3 Da for the 
MS2 were used 
 
5.3 Result and discussion 
 
The biological relevance of determining protein redox behavior drives to a continuous 
request of new strategies and methodologies aimed to detect oxidation products and 
to evaluate their variations in function of different cellular events. As fully treated in 
the part 5.1.1, the main problem of the cysteine thiol PTMs detection is related to the 
chemical lability of the modifications. For this reason the best approach for this kind 
of study is the differential alkylation leading to “freeze” the thiol oxidation state and 
recognize the 
modifications. Thus, many 
useful methods were 
published using different 
alkylating agents allowing 
to improve the MS 
analysis (17), to make 
possible the selective 2DE 
staining (8, 12-14) and to 
perform the alkylation 
inside the cells in vivo (3,18). However, many of these methods improve part of the 
Proteomics analysis, disadvantaging the rest of procedures. Thus, currently it is not 
still available a unique reagent allowing the analysis of cysteines PTMs from the 
tissue or cell to the MS identification. Here, the latest developments for the realization 
of a new Dansyl based method that should consents for the first time the unique 
analysis of stress oxidative Cys modifications are proposed.  
 
Thiol alkylation by Dansyl Aziridine. DAZ is a fluorescent reagent to selectively 
label cysteine thiols showing little or no reactivity toward other weaker nucleophiles 
such as amines and alcohols (21). However in order to confirm by advanced MS 
approach the selectivity of the reaction and to test the feasibility of a differential 
alkylation, a standard free thiol containing protein was alkylated by using DAZ. Then 
the sample was reacted with IAM under reductive conditions and the sites of 
modification were identified by MALDI-MS2 analysis. BSA was chosen as standard 
because it is characterized by the presence of 35 Cys, involved in 17 disulfide bonds 
and one free thiol. A solution 1mg/ml of BSA was reacted with DAZ in denaturing 
conditions as reported in Material and Methods section. The protein disulfide bridges 
were reduced by DTT leading to eliminate eventual DAZ excesses. Then the formed 
sulfhydryl groups were alkylated by iodoacetamide. In order to obtain higher 
sequence coverage, three aliquots of the solution were digested respectively by 
trypsin with classical heating, by trypsin in microwave field and by chimotrypsin. The 
peptides mixtures were analyzed by a MALDI-TOFTOF mass spectrometer obtaining 
S
N
OO
N
NH
S-
O
+
S OO
NH
N
NH
S
O
Scheme 5.1.Thiol alkylation by Dansyl aziridine 
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accurate mass measurements and primary sequence data. The identifications were 
carried out using the flexibility of in house optimized MASCOT software to that was 
added in the “modification file” the value of 276 Da for the DAZ modification. In figure 
5.1 are shown the results obtained by using the software MyProms (22). As showed 
in figure higher coverage and score resulted by MW assisted hydrolysis. By using the 
MS2 data from the different hydrolyses, it was possible to cover 77% of the entire 
sequence and 100% of the cysteine residues. Moreover, the reaction conditions set 
up allowed the differential alkylation using DAZ. In fact, the reduced Cys58 was 
detected completely dansylated as indicated by the signal at m/z 2711.3 in the MS 
spectrum of the MW trypsin digest. This ion was further fragmented and the 
sequence reconstructed, confirming the detection of the peptide 45-65 (Fig. 5.1). 
Moreover, the dansylation of Cys58 was verified by the presence of the “y7” and 
“y8”fragment ions whose mass difference is 379 Da, corresponding to cysteine 
dansylation. 
 
Fig. 5.1 MyProms graphic representation of the protein coverage obtained with three different 
digestions. 
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Fig 5.2 Ms and MS2 spectra of the peptide containing the BSA free thiol selectively alkylated by DAZ 
 
All the others cysteines involved in disulfide bridges were found exclusively alkylated 
by IAM. Moreover, no other signals related to un-specific dansylated amino acid were 
found in the spectra (Fig.5.2). 
 
Detection of reduced cysteines in proteins fractionated by SDS PAGE. As 
demonstrated in previous works, the use of Dansyl derivatives allows to perform 
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improved gel free strategies for PTMs identification (23-25). From the results showed 
 
Fig.5.3 SDS-PAGE lanes loaded with different amounts of DAZ labelled BSA. The autoradiography 
image shows the higher sensitivity of the fluorescence detection of free thiols  
 
above seems that the dansyl chemistry may be useful also to study the oxidative 
status of protein thiols. Moreover, dansyl derivative features improve widely the 
proteomics analysis, in fact labeled proteins, fractionated by SDS-PAGE, may be 
visualized by taking advantage of its peculiar fluorescence (26). On this basis the 
conditions to selectively detect free thiol in proteins fractionated by electrophoresis 
were evaluated.  
 
Fig.5.4 In order to show the capacity to appreciate little difference in free thiol concentration, on a 
SDS-PAGE were loaded different amounts of BSA-DAZ pooled with un-labelled BSA to reach 1µg of 
total protein. In order to perform a better software quantification of gel bands intensity the images were 
converted in negative. 
 
The BSA free thiol was labeled with DAZ as previously described. The modified 
protein (BSA-DAZ) was fractionated by SDS PAGE. Respectively 0.5 µg, 100 ng, 10 
ng and 1 ng of protein were charged in separated lanes. After the electrophoretic run 
the gel was exposed to an UV lamp and a picture was recorded. As showed in figure 
5.3 fluorescent bands relative to the labeled BSA 
were visualized up to 1 ng. Then the gel was 
stained by a classical Coomassie dye however the 
bands containing 10 ng and 1 ng of protein were not 
visualized. Thus, by DAZ-labeling method it is 
possible to selectively detect free thiols containing 
proteins with improved sensitivity. In order to 
evaluate the capability to recognize the variation of 
thiol oxidation state and to perform semi-
quantitative estimation based on the fluorescence 
intensity, others experiments were performed. In 
particular, to four aliquots containing respectively 
100ng, 80ng, 60 ng and 20 ng of BSA-DAZ, an 
amount of BSA was added in each sample in order 
to obtain 1µg protein concentration. Thus, such 
samples were loaded in separate gel lanes and 
fractionated by SDS-PAGE. The resulting gel was 
first visualized by fluorescence then it was stained 
by Coomassie (Fig.5.4). As shown in figure, it is 
possible to appreciate the different quantities of 
labelled protein by the gel autoradiography. In 
contrast labelled and un-labelled protein are un-distinguishable by Coomassie 
Fig.5.5 The graphic shows the 
linearity between the 
fluorescence/Coomassie values 
and the theoretical protein 
concentration 
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staining and the total amount of protein in all the samples is equal. Using the 
software “Image J” a measurement in an arbitrary scale (o.d.) of both fluorescence 
and Coomassie band intensities was carried out. In order to normalize the data for 
each sample the ratio between the value relative to the fluorescence and that relative 
to the Comassie was calculated. The ratios obtained were graphically represented 
versus the theoretical amounts of labeled protein. It results a curve that confirms the 
linear relation between variation of the fluorescence intensity and the concentration 
(Fig.5.5). Then, the feasibility of the method to detect unknown oxidative modification 
of thiols was evaluated. A solution of 1mg/ml of BSA was reacted for 10 min at 37 oC 
with 1mM of H2O2, A similar solution of protein undergoes to the same procedure 
without the oxidant as control. Further the two samples were labeled with DAZ and 
an 
aliquot of eache one was fractionated by SDS-PAGE in two different lanes. The gel 
was first visualized using fluorescence detection then by tCoomassie staining and the 
images were recorded (fig 5.6).  
In lane B the oxidized BSA was loaded. The corresponding fluorescent band resulted 
to be less intense respect to the control one in lane A. However, the Coomassie 
staining was able to detect the same protein quantity in both the sample meaning 
that the decreased fluorescence depends by the partial modification of the free thiol 
that is not available for the nucleophilic attack toward the aziridine. By the semi-
quantitative estimation, based on the ratio of the fluorescence/Coomassie intensities, 
it appears that about the 40% of the protein was modified. The gel band were 
excised and the protein digested with trypsin. The peptide mixtures were analyzed by 
MALDI-TOFTOF and the modification site was found related to the BSA free Cys that 
Fig.5.6 By the use of DAZ it is possible to detect change in thiol oxidation state in protein 
fractionated by gel electrophoresis. MS2 analysis lead to determine the modification site and the 
oxidation state of the cysteine thiol 
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was oxidized from sulfidric to sulfonic acid. This finding was demonstrated by the 
presence in the MS2 spectrum (fig.5.6) of the signals related to the fragment ions “y7” 
and “y8”, exhibiting a mass difference of 151 Da compatible with the modification 
cited above. By these results it appears that by using DAZ as alkylating agent it is 
possible to detect selectively oxidative variations of cysteine, in protein fractionated 
by electrophoresis. 
To confirm these data, the strategy was applied to a more 
complex protein mixture. E.coli protein extract was chosen as 
model. Reduced thiols were trapped by the method optimized 
by Leichert et al. (8), harvesting the cells in TCA. Then the first 
sample consisted of an E.coli protein extract labeled with DAZ 
in un-reductant denaturing conditions. The second sample was 
characterized by 100µg of reduced and carboxamidomethylated 
E.coli protein extract, spiked with 0,5µg of BSA. This mixture 
was then reacted with DAZ in un-reductant denaturing 
conditions. The two samples were fractionated by SDS-PAGE 
in two distinct lanes. By an UV lamp, the resulting gel was 
visualized and its image is reported in figure 5.7. In the lane A 
the first sample was charged, E.coli proteins alkylated with DAZ 
in non-reductant condition were visualized with intense 
fluorescence. The results obtained showed that the dansyl-
based method is also suitable for the detection of protein 
containing reduced cysteines in complex mixtures. Moreover, 
the high percentage of free thiol in growing E.coli is coherent 
with previous data obtained by other works (8). In the lane B, 
where the second sample was loaded, only the band related to 
labelled BSA was detected while the rest of E.coli proteins 
alkylated by IAM were not fluorescent thus showing the high 
selectivity of DAZ alkylation at proteomic scale. 
 
 In vivo alkylation of protein free thiols. Dansyl Aziridine 
reagent was largely used in studies related to the understanding 
of thiol catalytic role or to reveal protein conformational change (27-28). Moreover, 
the cell membrane permeability of dansyl derivative was observed (18). The reduced 
cysteine has many physiological functions as transduction signaling or catalytic 
effects that are regulated or also altered in vivo modulating both the redox state and 
the exposure of this residue. Therefore, it may be interesting evaluate the global thiol 
availability using DAZ to detect reduced cysteine inside the cell. In fact in this 
conditions the true physiological state of the protein complex networks and proteins 
conformation are kept, so the DAZ features may be used both to distinguish buried 
form exposed thiol and oxidized from reduced one. Moreover, it should be also 
interesting to evaluate the possibility to monitor the disulfide bonds formation in newly 
synthetized proteins. 
In order to set up the in vivo alkylation conditions, 0,6 O.D.(600) of E.coli cells were 
suspended in the isotonic buffer (see Material and Methods). To keep the cell stable 
the alkylation was performed adding 1% (v:v) of DAZ in ACN solution and incubating 
at 37 oC. A time course experiment was performed; thus aliquots were taken at 
different time of reaction, cells was harvested and the protein extracts were analyzed 
by SDS-PAGE visualizing the fluorescence and then the gel was Coomassie stained. 
A B 
Fig.5.7. Selectivity 
trials using E.coli 
protein extracts 
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As it results in figure 5.8 already after 30 min. of reaction the proteins resulted 
alkylated.  
 
However, after the over night incubation an intense fluorescence appears that is not 
explained by an increment of total protein concentration (fig 5.8). This could possible 
due to the access to buried thiols at longer time of reaction. Thus, it is possible 
modulate the labeling selectivity by choosing the time of incubation. Therefore, to 
have a more selective method for the further experiment DAZ incubation of the cell 
was driven for 30 min. The tolerance of the cells to DAZ was evaluated both by the 
blue trypan test and by fluorescence microscopy and flux cytometry analyses finding 
no toxicity. 
To show the feasibility of the strategy two samples were prepared. The first consisted 
of E.coli growing cells as control and the second was represented by E.coli cells 
exposed for 10 minutes to an isotonic solution containing 1 mM H2O2. Cells were 
then labeled with DAZ as described above and the protein extracts were fractionated 
by 2DE, visualizing the resulting image first by fluorescence, then by Coomassie 
staining. The gel images were processed and superposed using the software “Delta 
2D“ developed by Decodon. Briefly, the software discharge for each image all the 
color information, keeping just the green channel for the Coomassie staining image 
and the red channel for that relative to the fluorescence. Thus, when the images are 
superposed the spots appear yellow whose tonality allows the software to make 
quantitative estimation, calculating the ratio from the intensity of the two different 
detections. However, also if the fluorescence intensity is given only by the reduced 
proteins and the Coomassie intensity is related to the total proteins amount, the ratio 
between the two measures may not be converted in an absolute percentage of 
reduced/oxidized forms, because the two detections has different sensitivity. 
However, in this mode it is possible to normalize the measure and to compare 
different analysis.  
Fig.5.8 Time course for the in vivo alkylation conditions setting up 
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LC-MS2 using an FT-ICR mass spectrometer. In order to show the application of this 
strategy to the comparison of two different cellular states, E.coli cells were exposed.  
 
Fig.5.9 2DE of in vivo DAZ-alkylated free thiol protein in tw  different oxidative cell states. 
A 
 
B 
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Figure 5.9 showed the image resulting by the superposition of the Coomassie and 
the fluorescence 2DE visualization, related to in vivo alkylated E.coli proteins. In the 
control sample (figure 5.9A), many spots appear as combination of red and green 
component confirming that during the normal growth the greater part of proteins are 
in their reduced form (8). Figure 5.9B reports the image related to the oxidized cells. 
It is evident that large part of the spots is green thus suggesting that the fluorescence 
is strongly decreased due to cysteines oxidation. In addition, changes in the protein 
expression are observed. This event could be rationalized by considering the cells 
response to the oxidative stress. In particular the attention was focused on 12 spots 
that were quantified by “Delta 2D”, then they were excised, digested by trypsin and 
analyzed by LC-MS2. The semi-quantitative approach allows the estimation of the 
oxidation levels for the proteins identified from the examined spots (Tab. 5.1). This is 
realized calculating for each spot the ratio between fluorescent and Coomassie 
intensities obtaining a “Q“value. By the comparison of the Q values obtained from the 
control (Qcon) and oxidized (Qox) samples the extent of cysteine modifications may 
be extimated.  
 
Spot 
number 
Protein name Sigle-Acc. Number Qcon  Qox 
1 Autonomus glycyl radical factor GRCA-A8A391 1.2 0.6 
2 Alkyl hydroperoxidase reductase sub.C AHPC-P0AE08 1.2 0.5 
3 Inorganic pyrophosfatase IPYR-P0A7A9 1.2 0.8 
4 Phosphoribosyl-aminoimidazole-succino carboxi 
amide syntetase 
PUR7-A7ZPS1 3.1 1.0 
5 2-deoxy-D-gluconate-3-dehydrogenase KDUD-P37769 1.2 0.5 
6 Ribose-5-phosphate isomerase A RPIA-P0A7Z0 1.3 0.9 
7 KHG/KDPG aldolase ALKH-P0A955 1.7 0.3 
8 Adenylate kinase KAD-P699441 1.0 0.6 
9 6-phosphofructokinase isozyme 1 K6PF1-P0A796 1.5 0.8 
10 Elongation factor Ts EFTS-P0A6P1 1.5 0.3 
11 Triosophosphate isomerase TPIS-P0A858 1.7 0.9 
12 30S ribosomal protein S2 RS2-P0A7V0 2.1 0.9 
Table 5.1 
 
It is very interesting underline than many identified proteins are known to be 
regulated by their thiol oxidation state. For example AhpC has been demonstrated to 
be a peroxiredoxine that plays the role of H2O2 scavenger by the oxidation of 
cysteines 46 and 165 (29). IPYR was found S-Glutathionylated in human peripheral 
blood mononuclear cells and its activity is regulated by glutathione in Streptococcus 
faecalis and it is S-cysteinylated in Bacillus Subtilis (30-32). PUR7 and K6PF1 were 
found sensitive to the thiol oxidation also in Bacillus Subtilis after treatment with 
diamide (12). Ribose-5-phosphate isomerase was already suggested to be redox-
regulated in photosynthetic organisms. This hypothesis was reinforced by the 
evedence that was found S-Thiolated in Chlamydomonas reinhardtii (33). The 
Elongation factor Ts activity is regulated by the correct oxidation of the Cys22 (34) 
and its oligomer Elongation factor Tu was already demonstrated thiol-sensitive to the 
H2O2 stress in E. coli (15). The TPIS cysteines oxidation was demonstrated play 
important roles in different organisms. In the chicken the Cys126 oxidation leads to 
discriminate three isoforms and the accumulation of the higer oxidized one is 
accumulated during aging (35). The oxidation of the same residue in Rabbit and 
yeast causes the inactivation of the protein (36). 
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The MS analysis let us to identify the proteins that undergo to the change of thiol 
oxidation state, but also to localize the site of modification. However, the experiment 
here reported has just the aim to show the ability to in vivo detect thiol modifications 
by using the fluorescence features of a dansyl derivative by 2DE. Even if image 
analysis coupled to the MS analysis leads to recognize the oxidized protein, almost in 
all the cases it is not simple to attribute what and how many a cysteine residue has 
contributed to the observed decreased fluorescence. This because in vivo protein 
thiols are mainly in a percentage of reduced/oxidized forms also in stress oxidative 
conditions. Thus from this scenario, it is generated a pool of peptides whose 
cysteines are modified in different extents by each reactive used. Therefore, it results 
that, except the case of quantitative modification, it is not possible to know what 
cysteine has changed its oxidation state if isotopically enriched reagents are not 
used, as done by Leichert et al. with their Oxycat strategy (15). For the identified 
protein no spectra of cysteine higher oxide were found, that is in contrast to the 
results obtained with the standard protein where a sulfonation was detected. This 
result is in agreement with other data, where it is affirmed that the irreversible 
sulfonic acid formation is strongly avoided in vivo by the ROS scavenger (37).   
 
5.4 Conclusion 
 
This chapter showed the preliminary results for the optimization of a unique strategy 
aimed to study the stress oxidative related cysteine PTMs, using Dansyl derivatives. 
From the preliminary results obtained it appears that the fluorescent thiol reactive 
Dansyl Aziridine (DAZ) may be used for the specific alkylation of thiols without 
secondary reactions involving other amino acid. Dansylated proteins fractionated by 
electrophoresis may be visualized selectively by fluorescence with sensitivity 
comparable to the silver staining. By using this kind of gel visualization it is possible 
to detect change in the oxidation state of thiols. DAZ may be used to differentially 
label thiols both in protein extracts in denaturing buffer and in vivo by using dansyl 
derivatives cell permeability. By using specific image software, it was demonstrated 
possible to generate redox maps of 2DE fractionated proteins using the double 
visualization fluorescence/Coomassie, making also possible semi-quantitative 
estimation between different cellular states. Mass spectrometry also benefits of the 
dansyl labeling. In fact dansylation of no-basic amino acid improve the MALDI 
ionization as demonstrated in the chapter 4. Moreover the “Bidimensional Tandem 
MS” analysis in PIS/MS3 mode may enhance the sensitivity toward labelled peptides. 
However the procedures optimized is still to be improved. Optimization of 2DE 
fractionation is necessary, in addition reproducibility between in vivo and in vitro 
alkylations have not been explored yet. Moreover, the differential alkylation using 
different thiol reactive dansyl derivatives as Dansyl iodoacetamide has to be verified.  
 
5.4.1 Perspectives 
 
The methods already set up may be part of a wider strategy aimed to monitor 
cysteines redox changes starting from tissues or cell populations using the Dansyl 
derivatives features in each analytical step. The study may start from the cells that 
may be labelled in vivo as showed above. Different oxidative stressed cell 
populations may be fractionated by flow cytometry (38) discriminating the different 
fluorescence intensity. In fact oxidized cells labelled with DAZ are less fluorescent by 
the un-reactivity of oxidized cysteines. By this analysis it will be possible both to 
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make a snapshot of different cell populations and to separate them for the further 
differential analysis. The study may also start by tissues in fact different methods 
were proposed in the past for the hystochemical detection using dansyl derivatives 
(39-42). The modern technique as the laser capture (43) or micro-dissection may be 
applied to recover the interesting tissue slices for the further analysis. This kind of the 
analysis leads to enrich with morphological information the Proteomic data. Cells or 
tissues may be then homogenized and the extracted proteins may undergo to more 
specific PTMs detection by differential alkylation followed by 2DE fractionation and 
selective visualization as showed above. The use of Dansyl derivatives allows also to 
overcome 2DE classical limits by the possibility to perform parallel or alternative gel 
free approach by RIGhT strategy. Also the quantitative aspects may be explored. In 
fact fluorescence intensity may be used for semi-quantitative estimation in several 
analytical steps. In future the synthesis of isotopically enriched dansyl derivatives 
may also allow the MS quantitation approach, leading to set up the first strategy 
capable to localize un-ambiguously the modified cysteines in protein fractionated by 
2DE.  
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Bidimensional Tandem Mass Spectrometry for
Selective Identification of Nitration Sites in
Proteins
Angela Amoresano,*,†,‡ Giovanni Chiappetta,† Piero Pucci,† Marco D’Ischia,† and Gennaro Marino†,‡
Department of Organic Chemistry and Biochemistry and School of Biotechnological Sciences, Federico II University of
Naples, 80126 Napoli, Italy
Nitration of protein tyrosine residues is very often re-
garded as a molecular signal of peroxynitrite formation
during development, oxidative stress, and aging. However,
protein nitration might also have biological functions
comparable to protein phosphorylation, mainly in redox
signaling and in signal transduction. The major challenge
in the proteomic analysis of nitroproteins is the need to
discriminate modified proteins, usually occurring at sub-
stoichiometric levels from the large amount of nonmodi-
fied proteins. Moreover, precise localization of the nitra-
tion site is often required to fully describe the biological
process. Existing methodologies essentially rely on im-
munochemical techniques either using 2D-PAGE frac-
tionation in combination with western blot analyses or
exploiting immunoaffinity procedures to selectively cap-
ture nitrated proteins. Here we report a totally new
approach involving dansyl chloride labeling of the nitration
sites that rely on the enormous potential of MSn analysis.
The tryptic digest from the entire protein mixture is
directly analyzed by MS on a linear ion trap mass
spectrometer. Discrimination between nitro- and unmodi-
fied peptide is based on two selectivity criteria obtained
by combining a precursor ion scan and an MS3 analysis.
This new procedure was successfully applied to the
identification of 3-nitrotyrosine residues in complex pro-
tein mixtures.
Nitration of protein tyrosine residues leading to o-nitrotyrosine
is a most intriguing post-translational modification commonly
regarded as a “footprint” of peroxynitrite formation during
development, oxidative/nitrosative stress, and aging. Tyrosine
nitration can compromise protein structure and function,1,2 partially
due to the shift of the phenolic pKa value into the physiological
range, i.e., 7.1,3 entailing that a significant fraction of o-nitrotyrosine
may exist in vivo in its deprotonated state, displaying a net negative
charge. The functional consequences of protein nitration may be
manifold, but the impact is mainly on the structural and confor-
mational properties and catalytic activity. Protein nitration may
also have biological functions comparable with those of protein
phosphorylation, being involved in redox signaling. On the other
hand, modification of the phenolic ring might impair tyrosine
phosphorylation, thus inhibiting covalent modulation, signal trans-
duction, or both.
Nitration is a relatively stable modification that can be suitably
analyzed by different specific techniques. Methods for separation,
detection, and quantitation of o-nitrotyrosine in biological samples
include immunochemical techniques using anti-o-nitrotyrosine
antibodies, HPLC in combination with various detection systems,
and GC/MS.4 The chromatographic methods usually analyze
o-nitrotyrosine released by acid or enzymatic hydrolysis of protein
extracts.5 A combination of MS techniques had been used to
identify the specific tyrosine residues nitrated in vitro in model
proteins6-8 and in proteins purified from tissues.9 More recently,
a higher throughput characterization of protein targets for tyrosine
nitration in cells and several tissues, including aged tissues, has
been attempted using proteomic methodologies.10,11 These ap-
proaches essentially consist of protein fractionation by two-
dimensional polyacrylamide gel electrophoresis (2D PAGE),
partial transfer onto poly(vinylidene difluoride) membranes and
western blot analysis using anti-nitrotyrosine antibody to identify
the modified proteins. Alignment of the western blots with the
2D PAGE gels enables identification of immunopositive protein
spots. These are then excised, trypsin digested, and identified by
either peptide mass fingerprinting procedures using MALDI mass
spectrometry or capillary LC-MS/MS analyses.12 Usually, how-
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ever, the direct mass spectrometric identification of nitrated
peptides is difficult and merely relies on the correct alignment of
western blot analyses and 2D gels. Moreover, a prerequisite for
successful identification is the presence of a single protein per
gel spot. If the gel spot contains multiple proteins or protein
isoforms,13 unambiguous identification of the nitrated protein can
only be obtained by tandem MS sequencing of the o-nitrotyrosine-
containing peptide.
Recently we developed a novel approach to selectively label
phospho-Ser/-Thr residues in proteins using dansyl modification
coupled with tandem mass spectrometry experiments in precursor
ion /MS3 scan mode, taking advantage of a hybrid mass spec-
trometer.14 This concept led to the development of a general
method, reporter ion generation tag (RIGhT), of potential interest
for large-scale proteomic identification of a broad range of PTMs.
In this paper, we report the extension of this innovative strategy
to the selective isolation and identification of o-nitrotyrosine-
containing proteins. The methodology was first tested on in vitro
nitrated BSA as a model protein and then applied to more complex
matrices.
EXPERIMENTAL SECTION
Chemicals. Tri(hydroxymethyl)aminomethane (Tris), 5-N,N-
dimethylaminophtalene-1-sulfonyl chloride (dansyl chloride, DNS-
Cl), ammonium hydrogen carbonate (AMBIC), and iodoaceta-
mide, were purchased from Fluka, Tetranitromethane (TNM),
b;ovine serum albumin (BSA), ethylenediaminetetraacetic acid
(EDTA), sodium dithionite (Na2S2O4), urea, sodium acetate,
trypsin, and dithiothreitol (DTT) were from Sigma (St. Louis, MO),
Acetonitrile (ACN) was purchased from Baker (Phillipsburg, NJ).
SDS-PAGE and western blot chemicals were purchased from Bio-
Rad. Nitrotyrosine antibody was from Alexis. Trifluoroacetic acid
HPLC grade was from Carlo Erba. All solvents were of the highest
purity available from Baker. All other reagents and proteins were
of the highest purity available from Sigma.
In Vitro Nitration of BSA. A BSA solution (10 mg/mL) in
200 mM Tris buffer (pH 8,0) was nitrated by addition of 350 mM
TNM in acetonitrile using a Tyr/TNM ratio of 1/1 (mol/mol).
The reaction mixture was stirred at room temperature for 30 min
as previously described.15 Nitrated BSA (N-BSA) was rapidly
desalted by size exclusion chromatography on a Sephadex G-25M
column (Amersham). Protein elution was monitored at 280 and
350 nm. The fraction containing the protein was manually
collected, lyophilized, and stored at -20 °C.
Tryptic Digestion. Aliquots of the BSA and N-BSA mixture
were dissolved in denaturant buffer (urea 6 M, Tris, EDTA pH
8.0), reduced with DTT (10-fold molar excess on the cysteine
residues) for 2 h at 37 °C and then alkylated with iodoacetammide
(5-fold molar excess on the thiol residues) for 30 min at room
temperature in the dark. Protein samples were desalted by
reversed-phase (RP)-HPLC on a reversed-phase C4 column (100
× 4.6 mm, 5 µm; Phenomenex). Fractions were lyophilized and
then dissolved in 50 mM AMBIC buffer (pH 8,0). Trypsin
digestion was carried out using an enzyme/substrate ratio of 1/50
(w/w) at 37 °C for 18 h.
Reduction of Nitrotyrosine to Aminotyrosine. Reduction
of o-nitrotyrosine to o-aminotyrosine was carried out on aliquots
of the modified peptide mixtures by using Na2S2O4 as previously
reported.16 Before MALDI-TOF analysis, cleaning of the samples
was performed using reversed-phase Zip-Tips C18 from Millipore
(Billerica, MA).
Synthesis of o-Aminodansyltyrosine. The mixture of re-
duced BSA tryptic peptides was desalted by RP-HPLC on a
reversed-phase C18 column (100 × 4.6 mm, 5 µm; Phenomenex).
Peptide fractions were lyophilized and then dissolved in 100 mM
sodium acetate pH 5.0 buffer, 0.9% sodium chloride. Samples were
treated with a 18.5 ng /µL solution of DNS-Cl in ACN (1000-fold
molar excess), and the buffered solutions were allowed to react
at 65 °C for 16 h as previously reported.17
Labeling of Bovine Milk Protein Extract. A sample of
commercially available bovine milk was reacted with a 100 mM
solution of TNM for 30 min at room temperature. Modified milk
proteins were purified by precipitation with the Amersham Clean
Up kit and dissolved in denaturant buffer. Reduction of both the
SH and nitro groups of the protein mixture was carried out in
“one pot” using 20 mM DTT, 40 mM iodoacetamide, and a 200
mM solution of Na2S2O4 in the dark for 30 min.
The protein mixture was purified by size exclusion chroma-
tography on a Sephadex G-25 M column equilibrated and eluted
with 50 mM AMBIC. Protein fractions were concentrated and then
digested with trypsin as already described. The resulting peptide
mixture was reacted with DNS-Cl as described above.
Mass Spectrometry. MALDI-MS experiments were per-
formed on a Voyager DE-STR MALDI-TOF mass spectrometer
(Applied Biosystems, Framingham, MA) equipped with a nitrogen
laser (337 nm). Typically, 1 µL of the total mixture was mixed
(1/1, v/v) with a 10 mg/mL solution of R-cyano-4-hydroxycinnamic
acid in acetonitrile/50 mM citrate buffer (2/3, v/v).
NanoLC-MS2 and MS3 experiments were performed on a 4000
QTrap mass spectrometer (Applied Biosystems) coupled to an
1100 nanoHPLC system (Agilent Technologies). Peptide mixtures
were loaded onto an Agilent reversed-phase precolumn cartridge
(Zorbax 300 SB-C18, 5× 0.3 mm, 5 µm) at 10 µL/min with solvent
A (0.1% formic acid, loading time 7 min). Peptides were then
separated on a Agilent reversed-phase column (Zorbax 300 SB-
C18, 150 mm × 75 µm, 3.5 µm), at a flow rate of 0.2 µL/min using
0.1% formic acid, 2% ACN in water as solvent A 0.1% and formic
acid, 2% water in ACN as solvent B. The elution was accomplished
by a 5-65% linear gradient of solvent B in 60 min. A micro-ion-
spray source was used at 2.5 kV with liquid coupling, with a
declustering potential of 50 V, using an uncoated silica tip (o.d.
150 µm, i.d. 20 µm, tip diameter 10 µm) from New Objectives
(Ringoes, NJ). Spectra acquisition was based on a survey precur-
sor ion scan for m/z 170. The Q1 quadrupole was scanned from
m/z 500 to 1000 in 2 s with resolution “low”, and the precursor
ions were fragmented in q2 using a linear gradient of collision
potential from 30 to 70 V. Finally, Q3 was set to transmit only
ions at m/z 170 with resolution “unit”.
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This scan mode was followed by an enhanced resolution
experiment for the ions of interest and then by MS3 and MS2
acquisitions of the two most abundant ions. MS2 spectra were
acquired using the best collision energy calculated on the basis
of m/z values and charge state (rolling collision energy). MS3
spectra were performed on the fragment ion at m/z 234 and
acquired using Q0 trapping, with a trapping time of 150 ms and
an activation time of 100 ms, scanning from m/z 160 to 210. The
entire cycle duration is 5.3 s.
RESULTS
BSA (1 mg) was nitrated with TNM, and the excess reagent
was rapidly removed by size exclusion chromatography as
described in the Experimental Section. TNM-induced modifica-
tions were determined by MALDI mapping analyses. Aliquots of
the BSA and N-BSA mixtures were reduced with DTT and
alkylated with iodoacetamide. Proteins were then digested with
trypsin, and the resulting peptide mixtures were directly analyzed
by MALDI mass spectrometry. Spectral analyses led to ∼85% of
BSA sequence coverage, and more important, ∼95% of tyrosine
residues could be verified. Two mass signals recorded at m/z 972.5
and 1524.8, respectively, did not correspond to any peptide within
the BSA sequence. These values occurred 45 Da higher than the
signals corresponding to the peptides 137-143 and 396-409,
respectively, suggesting that they originated from the nitrated
derivatives of these fragments. This hypothesis was corroborated
by satellite peaks at -16 and -32 Da, revealing the typical
photodecomposition pattern of nitrated peptides previously de-
scribed to occur during the MALDI analysis of nitropeptides1
(Figure 1A). This finding indicated that Tyr137 and Tyr399 were
partially converted into the corresponding 3-NT residues following
TNM treatment. These data were in perfect agreement with
previous results on in vitro BSA nitration.18,19However, signals
occurring at m/z 927.5 and 1479.7 were attributed to the theoreti-
cal fragments, m/z 137-143 and 396-409, respectively, were
detected thus indicating that the nitration reaction was not
quantitative.
Synthesis of o-Aminodansyltyrosine. Conversion of ni-
tropeptides into their o-dansylamino derivatives was accomplished
as indicated in Scheme 1. First, nitro groups were reduced by
(18) Pettersson, A. S.; Steen, H.; Kalume, D. E.; Caidahl, K.; Roepstorff, P.
J. Mass Spectrom. 2001, 36, 616-625.
(19) Cappelletti, G.; Maggioni, M. G.; Tedeschi, G.; Maci, R. Exp. Cell Res. 2003,
288, 9-20.
Figure 1. MALDI-MS analysis of peptide mixture from BSA. Panel A: Partial MALDI-MS spectrum of nitrated peptides. Panel B: Partial
MALDI-MS spectrum of o-aminotyrosine-containing peptides. Panel C: Partial MALDI-MS spectrum of dansylated o-aminotyrosine-containing
peptides.
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Na2S2O4 treatment,16 the peptide mixture was desalted by HPLC,
and the extent of reduction was monitored by MALDI-MS. Mass
spectral analysis showed the disappearance of the classical
o-nitrotyrosine photodecomposition pattern, indicating nearly
quantitative reduction, and its replacement by two new signals at
m/z 942.4 and 1494.8, attributed to peptides m/z 137-143 and
396-409, respectively, containing an amino-Tyr residue
(Figure 1B).
Aminotyrosine residues were chemoselectively labeled with
DNS-Cl following the reported procedure.16 The reaction was
carried out at pH 5.0 exploiting the different pKa value of the
o-aminotyrosine (4.7),15 which is partly deprotonated and is
therefore amenable to reaction with DNS-Cl at variance with
aliphatic (10.4-11.1) and N-terminal amino groups (6.8-8.0),
which are largely protonated.
The extent of reaction was monitored by MALDI-MS analysis
showing the presence of two new signals at m/z 1175.6 and 1727.8
occurring 233 Da higher than the o-aminotyrosine-containing
peptides (Figure 1C). These signals corresponded to the expected
dansyl derivatives of the o-aminotyrosine peptides. The occurrence
of signals at m/z 942.0 and 1494.7 corresponding to the unmodified
o-aminotyrosine peptides indicated that the extent of dansyl
reaction was ∼60%. No modification at the N-terminus or Lys
residues was detected.
LC-MS/MS Analysis of o-Aminodansyl-Tyr Peptides. The
exact location of the original nitro groups was assessed by LC-
MS/MS analysis of the peptide mixture using a linear ion trap
4000 Q-Trap instrument and an experimental procedure that
combines precursor ion scan with MS3 scan mode as already
described.14 In the precursor ion scan mode, only the precursor
ions producing the m/z 170 fragment were detected. The selected
precursor ions were then subjected to a combined MS2 and MS3
experiment to specifically detect only those ions originating the
dansyl-specific m/z 234f 170 transition in MS3 mode as indicated
in Scheme 2.
Figure 2 shows the LC-MS/MS traces corresponding to the
various experiments. The chromatographic profiles reported in
Figure 2B and C for the m/z 170 precursor ion scan and for the
transition m/z 234/170 in MS3 mode, respectively, showed a lower
number of signals compared to the LC-MS/MS full scan profile
(Figure 2A). Moreover, a significant increase in the signal/noise
ratio could be achieved as the higher selectivity MS criteria were
applied (Figure 2B and C). However, the precursor ion TIC
exhibited a large number of ions that very unlikely could be only
related to o-aminodansyl-Tyr peptides (Figure 2B). The MS3 TIC
(Figure 2C) showed the presence of only three peaks related to
doubly charged ions at m/z 588.2, 792.9, and 986.8. The corre-
sponding MS2 fragmentation spectra led to the determination of
the entire sequence of these species, identifying the fragments
m/z 137-143, 396-409, and 445-458, respectively, all of which
contain o-aminodansyl-Tyr residues. Moreover, modified Tyr
residues could easily be detected at the level of Tyr137, Tyr399,
and Tyr451, allowing for the exact identification of the original
nitration sites.
As an example, Figure 3A shows the MS/MS spectrum of the
peptide m/z 396-409 carrying a dansyl moiety. The modified ion
is stable during collision-induced dissociation, providing easily
interpretable daughter ion spectra. Both the y and b fragment
ions still retained the modifying group linked to the amino Tyr
residue, thus denoting original nitration. As indicated in the
spectrum, the mass difference between the b4 and b3 fragment
ions is 411 Da corresponding to the o-dansylaminotyrosine residue.
It should be noted that the LC-MS/MS analysis revealed the
occurrence of a further nitration site within the peptide m/z 448-
458 at level of Tyr451, which escaped previous MALDI analysis.
Moreover, the daughter ion spectra of o-dansylamino-Tyr-contain-
ing peptides showed some peculiar features. Besides the signals
at m/z 170 and 234, typical of dansyl derivatives, a further signal
at m/z 384 was always observed and assigned to the immonium
ion of o-dansylamino-Tyr.19 This stable fragment could then be
used either as an alternative diagnostic fragment in the precursor
ion scan or simply to confirm the presence of an o-dansylamino-
Tyr residue in the peptide sequence. Finally, a fragment ion related
to the loss of the dansyl moiety as neutral group was always
observed in the daughter ion spectra when the o-nitrotyrosine
residue is located at N-terminal position (Figure 3B). In fact, the
fragment ion at m/z 942.5 in Figure 3B belongs to the y series
and occurs 233 Da lower than the molecular mass of the
dansylated peptide m/z 137-143 , showing the neutral loss of the
dansylated moiety.
Location of BSA o-Aminotyrosine-Containing Peptides in
Complex Protein Mixtures. The feasibility of the developed
procedure to identify o-nitrotyrosine peptides in proteomics
analysis was probed by mixing 100 µg of the mixture of BSA and
nitrated BSA with 10 mg of the entire cellular extract from
Escherichia coli. An aliquot of the modified proteome was fraction-
ated by SDS-PAGE to demonstrate that BSA was indistinguishable
from and in similar amount to other E. coli proteins (data not
shown).
The total protein extract was then submitted to the procedure
described above. Nitrotyrosines were reduced with dithionite, and
the modified protein mixture was digested with trypsin. The newly
generated amino Tyr-containing peptides were labeled with dansyl
chloride at pH 5.0, and an aliquot of peptide digest containing
∼100 fmol of nitropeptide mixture was submitted to the bidimen-
Scheme 1. Syntesis of o-Dansylaminotyrosine
Scheme 2. ESI-MS/MS Fragmentation Pathway
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sional tandem mass spectrometry procedure described above.
Figure 4 shows the reconstructed ion chromatogram for the
precursor ion scan (A) and the selective dansyl transition in MS3
mode (B). As clearly indicated in the figure, the precursor ion
scan mode still showed the occurrence of a large number of
signals, most of which not related to 3-NT-containing peptides.
In fact, the corresponding MS2 spectra do not show the occurrence
of fragment ion at m/z 234. The further selection based on the
MS3 scan removed a large number of false positives leading to a
simple ion chromatogram essentially dominated by three intense
signals. Identification of nitrated tyrosine residues was carried out
by taking advantage of the flexibility of the MASCOT software, a
database search utility available on the net. First, a variable
modification of 411.0 Da corresponding to o-aminodansyltyrosine
residues was introduced into the Modification File within the
MASCOT software. Second, the peak list used for database search
only consisted in the MS2 spectra of the peptide species that had
generated a signal both in the precursor ion TIC and in the MS3
ion scan. The MS2 fragmentation spectra of the three signals
observed in the MS3 scan reported in Figure 4B revealed the
occurrence of three 3-NT-containing peptides originated from the
BSA sequence. In particular, these peptides corresponded to the
same peptides previously detected in the analysis of homogeneous
nitrated BSA. Moreover, this procedure led to the identification
of additional endogenous nitration sites in E. coli proteins that
had been nitrated in vivo. Table 1 reports the nitropeptides found
in the BSA-complex mixture and the MASCOT scores with the
corresponding identifications of E. coli proteins.
Labeling and Analysis of a Nitrated Protein Extract of
Bovine Milk. The proposed strategy was finally employed to
identify o-nitrotyrosine residues in a more complex sample, the
entire bovine milk. Bovine milk was in vitro nitrated with TNM,
and an aliquot of milk proteins were fractionated by SDS-PAGE
and submitted to a western blot analysis using o-nitrotyrosine
antibody to confirm the extent of nitration. The presence of
nitrated proteins was essentially detected in the regions between
20 and 35 and 45-60 kDa as indicated in Figure 5.
The entire milk protein extract was dissolved in denaturant
buffer, and then cysteine alkylation and nitro groups reduction
were performed in “one pot” as described above. The protein
sample was then desalted and digested with trypsin. The resulting
peptide mixture was selectively labeled with dansyl chloride and
directly submitted to LC-MS/MS analyze using the double
selectivity criteria.
Figure 2. LC-MS/MS traces of bidimensional mass spectrometry experiment performed on the tripsin digest from BSA. Panel A: LC-MS/
MS full scan profile. Panel B: Chromatographic profile of the m/z 170 precursor ion scan. Panel C: Chromatogram related to the total ion
current for the transition m/z 234/170 in MS3 mode.
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Figure 3. Panel A: MS/MS spectrum of the peptide m/z 396-409 within BSA sequence carrying a dansyl moiety. Panel B: MS/MS spectrum
of the peptide m/z 137-143 within BSA sequence carrying an o-nitrotyrosine residue at the N-terminal position.
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Identification of nitrated milk proteins was carried out using
the modified MASCOT software as described above. As an
example, Figure 6 (panels A-C) reports the MS, MS/MS, and
MS3 spectra for the peptide fragment m/z 108-117 of !-lactoglo-
bulin. The results of the identification procedure are reported in
Table 2 together with the modified Tyr residues and MASCOT
scores. Besides the high-abundant milk proteins (!-casein and
!-lactoglobulin), this procedure was also able to assess the
nitration sites occurring in low-abundant proteins, such as vimentin
and claudin 2.
DISCUSSION
The major problem in the proteomic analysis of nitroproteins
is the need to discriminate modified proteins, usually in very low
concentrations, from the large amount of nonmodified proteins.
Moreover, biological relevant PTMs often occur at substoichio-
metric level making even more difficult the identification of the
o-nitrotyrosine-containing proteins in the presence of a larger
percentage of the corresponding nonnitrated form. Finally, precise
localization of the nitration site is often required to fully describe
the biological process.
Existing methodologies essentially rely on immunochemical
techniques, whereby nitrated proteins can be detected by align-
ment of the western blots with the 2D PAGE gels of the entire
Figure 4. Reconstructed ion chromatogram for the precursor ion scan (panel A) and the selective dansyl transition in MS3 mode (panel B) of
bidimensional mass spectrometry experinent performed on the entire E. coli. cellular extract spiked with a mixture of BSA and nitrated BSA.
Table 1. Nitrated Proteins Identified by RIGhT
Approach in E. coli
protein sequence
MASCOT
scores
hypothetical fimbrial
chaperone
yraI precursor
TRIKMF-NO2Y139-
RPAQHLK
21
hypothetical protei
yciQ
NQQIKHGF-NO2Y10-R 20
homeobox outer
membrane usher
protein yehB
IAAP-NO2Y134-R 23
Figure 5. Fractionation of in vitro nitrated bovine milk proteins by
SDS-PAGE analysis (lane 2) and western blot analysis using o-
nitrotyrosine antibody to confirm the extent of nitration (Lane 1). The
presence of nitrated proteins was detected in the regions between
20 and 25, 75-80, and 100-120 kDa.
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cellular proteome.20 Alternatively, specific capture of o-nitro-
tyrosine-containing proteins by immunoaffinity procedures can
also be employed.21 However, neither of these approaches
completely fulfills the analytical requirements for nitro proteome
analysis. The main problems of the 2D PAGE procedure are
related to the low abundance of the o-nitrotyrosine-containing
proteins, the low steady-state levels of o-nitrotyrosine in modified
proteins, and the poor recovery of nitropeptides from the gel.
Specific nitro-Tyr immunoaffinity purification can preferentially
enrich and isolate nitroproteins, thus overcoming some of the
above-mentioned drawbacks. However, the peptide mixture from
the tryptic digest of the whole enriched nitroprotein bulk is still
too complicated to be analyzed in a simple one-step process and
2D-HPLC, typically consisting of ion exchange and reversed-phase
separations, in conjunction with tandem mass spectrometric
methods had to be used.22
The strategy described in this paper is based on a totally
different approach involving dansyl chloride labeling and relies
on the enormous potential of MSn analysis. According to the so-
called “gel-free procedures”, the analysis is carried out at level of
peptides following tryptic digest of the whole protein mixture.
However, discrimination between nitropeptides and nonmodified
(20) Ye, Y. Z.; Strong, M.; Huang, Z. Q.; Beckman, J. S. Methods Enzymol. 1996,
269, 201-209.
(21) Zheng, L; Settle, M.; Brubaker, G.; Schmitt, D.; Hazen, S. L.; Smith, J. D.;
Kinter, M. J. Biol. Chem. 2005, 280, 38-47.
(22) Fujii, K.; Nakano, T.; Hike, H.; Usui, F.; Bando, Y.; Tojo, H.; Nishimura, T.
J Chromatogr., A 2004, 1057, 107-113.
Table 2. Nitrated Proteins Identified by RIGhT
Approach in Milk
protein sequence
MASCOT
scores
!-casein AVP-NO2Y195-PQR 40
!-lactoglobulin VLVLDTD-NO2Y115-KK 36
V-NO2Y115-EELK 20
vimentin QQ-NO2Y275-ESVAAK 25
claudin 2 AKSEFNS-NO2Y224-SLTGYV 23
homeobox protein
hox-D12
F-NO2Y101-TPDVAAGPEERGR 21
Figure 6. MS spectrum (panel A), MS/MS spectrum (panel B) and MS3 spectrum (panel C) for the peptide fragment m/z 108-117 of
!-lactoglobulin.
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peptides is achieved by taking advantage of the instrumental
features of a hybrid (triple quadrupole/linear ion trap) mass
spectrometer. Peptide analysis is carried out by LC-MS/MS, and
the peptide ions of interest are discriminated by two selectivity
criteria based on two subsequent tandem MS experiments, a
precursor ion scan followed by an MS3 scan mode. This procedure
can then be considered as a sort of “instrumentally driven”
bidimensional selection.
This instrumental selectivity approach needs an appropriate
derivatizing agent producing stable and diagnostic fragment ions
to be used in the MS/MS scan modes and capable of improving
ionization of modified peptides. A valuable agent that can purpose-
fully serve in this function is dansyl chloride, recently introduced
by us to selectively label phospho-Ser/Thr residues. Following
MS/MS fragmentation, in fact, dansyl-derivatized peptides produce
a stable fragment ion at m/z 170 very useful for a precursor ion
search scan. Moreover, in the MS3 mode, these species undergo
a specific and diagnostic transition from m/z 234 to 170, providing
an effective second selectivity criterion.14
The proposed strategy consists in two simple chemical
manipulation steps, namely, reduction of o-nitrotyrosine residues
to the corresponding amino-Tyr derivatives and chemoselective
labeling with DNS-Cl at pH 5.0, exploiting the lower basicity of
aromatic amines compared to the aliphatic ones.
Analysis of chemically nitrated BSA following tryptic digestion
confirmed the ability of the bidimensional selection to simplify
the peptide ion chromatogram, leading to selective identification
of o-nitrotyrosine-containing peptides. This experiment underlined
the usefulness of the two selectivity criteria in that the precursor
ion scan still showed the presence of non-nitrated peptide ions
that were completely ruled out in the MS3 scan mode. Moreover,
since this combined MS approach provides only the daughter ion
spectra of the nitrated peptides, this procedure always leads to
the unambiguous localization of the nitrated Tyr residues.
The newly developed procedure was tested on complex
systems, including the entire E. coli proteome and the whole milk
proteins, to assess its feasibility for proteomic investigation of
nitroproteins. In both cases, the results underscored the ability
of the instrumental bidimensional selection to discriminate ni-
tropeptides from their unmodified counterparts in a complex
matrix. The three nitrated peptides in BSA could selectively be
identified even in a mixture with the tryptic digest of the entire
E. coli proteome, producing the same results obtained on pure
BSA. Investigation of nitrated milk proteins led to the identification
of several different proteins including integrin, a strongly associ-
ated membrane protein. Because of its operational simplicity,
avoiding long-lasting and time-consuming fractionation proce-
dures, this new strategy seems to be well suited for large-scale
proteomic profiling of nitration sites. Moreover, the general
rationale of the method can in principle be extended to the
detection of other PTMs.
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Abstract Human body fluids have been rediscovered in
the post-genomic era as a great source of biological markers
and perhaps as source of potential biomarkers of disease.
Recently, it has been found that not only proteins but also
peptides and their modifications can be indicators of early
pathogenic processes. This paper reports the identification
of free phosphopeptides in human fluids using an improved
IMAC strategy coupled to iterative mass spectrometry-
based scanning techniques (neutral loss, precursor ion,
multiple reaction monitoring). Many peptides were detected
in the enriched extract samples when submitted to the MS-
integrated strategy, whereas they were not detected in the
initial extract samples. The combination of the IMAC-
modified protocol with selective “precursor ion” and
constant “neutral loss” triple quadrupole scan modes
confers a high sensitivity on the analysis, allowing rapid
phosphopeptide identification and characterization, even at
low concentrations. To the best of our knowledge this work
represents the first report exclusively focused on the detec-
tion of free phosphorylated peptides in biological fluids.
Keywords Free peptide . Phosphorylation . Linear ion trap .
Precursor ion . Neutral loss
Introduction
The analysis of peptides in biological fluids holds the
promise of providing diagnostic and prognostic information
for cancer and other diseases. “Peptidomics” is the field that
deals with the comprehensive qualitative and quantitative
analysis of peptides in biological samples [1]. These pep-
tides are either intact small molecules, such as hormomes,
cytokines, growth factors or peptides that are released from
larger protein precursors during protein processing, repre-
senting degradation products of proteolytic activity.
Thus, in biological fluids, peptides represent protein
synthesis, processing, and degradation. Since the amount
and repertoire of peptides in the circulating body fluids
dynamically change according to the physiological or
pathological state of an individual, it is possible that
comprehensive peptide analysis (i.e., the exploitation of
the “peptidome”) may lead to the discovery of novel
biomarkers or to new diagnostic approaches [2].
Recently, many groups have reported the identification
of biomarkers or biomarker patterns which allow the
identification and detection of cancer patients with the
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development of new proteomics-based tools to analyze
tissue and blood samples from cancer patients [3]. Among
others, surface-enhanced laser desorption ionization/time-
of-flight mass spectrometry (SELDI/TOF-MS) has been
used to identify differential peptide and protein expressions
in various biological fluids, such as serum, plasma, urine
and pancreatic juice [4].
The extraordinary power of mass spectrometry to
identify and quantify peptides and their modifications in
complex biological mixtures offers opportunities to develop
novel technologies for the diagnosis of cancer and other
diseases [5]. However, the analysis of free peptides is still
challenging because knowledge of the C-terminal amino
acid is insufficient.
A number of strategies devoted to the separation of
phosphorylated proteins and peptides from the nonphos-
phorylated counterparts have been exploited [6–7]. A
widely used enrichment technique for phosphorylated
peptides is the use of metal ions for the binding of the
negatively charged phosphopeptides, i.e., immobilized
metal affinity chromatography (IMAC). This enrichment
strategy has also been extensively adapted for the enrich-
ment of phosphorylated peptides prior to mass spectromet-
ric analysis [8–9].
The aim of this work was to identify the free phospho-
peptides in human serum, saliva and urine using the IMAC
strategy coupled to different tandem mass spectrometry
experiments (neutral loss, precursor ion, multiple reaction
monitoring) and a bidimensional LC–MS/MS approach.
Several papers have been published on the analysis of
naturally occurring free peptides, expecially in saliva [23–
25] or phosphoproteins; however, to the best of our
knowledge this work represents the first report that is
exclusively focused on the detection of free phosphorylated
peptides in biological fluids.
Materials and methods
FeCl3 and alfa-cyano-4-hydroxycinnamic acid were pur-
chased from Sigma (St. Louis, MO, USA). Chelating
Sepharose (IDA) was from Amersham Bioscience (Piscat-
away, NJ, USA). Acetonitrile HPLC ultra gradient was from
Romil (Cambridge, UK). All of the solvents used were of
the highest purity available from Baker (Phillipsburg, NJ,
USA). All other reagents and proteins were of the highest
purity available from Sigma.
Eight pathological sera samples were obtained from
Servizio Analisi del Secondo Policlinico di Napoli with
informed consent. Consent for our studies was obtained
from the Hospital Ethical Committee. Salivary and urine
samples were taken from five healthy voluntaries with
informed consent.
IMAC chromatography
A ratio of 10:1 of peptide mixture (vol/vol) to resin was
used to ensure specific binding of the phosphospecies. The
IDA resin was charged with FeCl3 and stored using the
procedure recommended by GE Healthcare. The charged
resin was equilibrated with binding solution (15% acetic
acid and 60% acetonitrile, pH 2.5). The dried peptide
mixture was suspended in binding solution and incubated
with the charged resin for three hours at room temperature.
The washes were performed using washing solution (60
acetonitrile, 5% acetic acid) and a final wash was done with
Milli-Q water. The elution was performed using 2% NH3 in
water (pH 12.0).
Acetonitrile precipitation
Acetonitrile, rather then a different organic solvent [10],
was used to precipitate the large proteins out of solution.
These conditions dissociated smaller proteins from their
carrier molecules, allowing the detection of a larger number
of peptides [11].
Two volumes of acetonitrile HPLC ultra gradient Romil
were added to one volume of fresh biological fluids,
followed by gentle mixing for 30 min at room temperature.
The samples were spun for 15 min at 12,000 rpm, the
highly abundant precipitated proteins were removed, and
the supernatant was concentrated in a SpeedVac system and
lyophilized. Supernatant still containing low molecular
weight proteins was submitted to the Bradford protein
assay (reagent from Bio-Rad, Hercules, CA, USA) accord-
ing to manufacturer’s instructions. The final concentration
was estimated as 1 pg/μl. This value was used for further
analyses.
MALDI mass spectrometry
MALDI-TOF mass spectra were recorded using a Voyager
DE-PRO mass spectrometer (Applied Biosystems, Fra-
mingham, MA, USA) operating in reflector mode. A
mixture of the peptide solution and alpha-cyano-hydrox-
ycinnamic acid (10 mg/mL in 70% ACN and 10 mM citric
acid in water) was applied to the metallic sample plate and
dried at room temperature. The mixture of phosphopeptides
was mixed with 2,5-dihydroxybenzoic acid (25 mg/mL in
50% ACN and 2% phosphoric acid in water) and applied
onto the sample plate. Mass calibration was performed using
a mixture of peptides from Applied Biosystems, including
des-Arg1-bradykinin, angiotensin I, Glu1-fibrinopeptide B,
ACTH (1–17), ACTH (18–39) and insulin (bovine) as
external standards. Raw data were analyzed using Data
Explorer software (4.0 version, Applied Biosystems) and
reported as monoisotopic masses.
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2DC-MS/MS conditions
Samples were analyzed by two-dimensional microchroma-
tography coupled to ion trap mass spectrometry (2DC-
MSMS), using a ProteomeX system (Thermo Electron
Corporation, San José, CA, USA). In particular, 10 μl of
loaded sample (about 8 μg) were first separated by ion
exchange chromatography (Biobasic-SCX column, 0.32
i.d.×100 mm, 5 μm, ThermoHypersil, Belloeonte, PA, USA)
by applying a four step ammonium chloride concentration
gradient (0, 50, 200, 600 mM). Each salt step eluate was
directly loaded onto a reversed-phase column (Biobasic-18,
0.180 i.d.×100 mm, 5 μm, ThermoHypersil) and separated
with an acetonitrile gradient (eluent A, 0.1% formic acid in
water; eluent B, 0.1% formic acid in acetonitrile); the
gradient profile was 5% eluent B for 3 min followed by 5–
50% eluent B within 40 min. Flow-rates for each column
(SCX and C18) were 50 μl/min split with 1 μl/min.
The peptides eluted from the C18 column were directly
analyzed with a linear ion trap LTQ mass spectrometer
equipped with a nanospray (Thermo Electron Corporation,
Waltham, MA, USA). The main MS conditions were the
following: the heated capillary was held at 185 °C, ion
spray at 1.52 kV and capillary voltage at 13 V. Spectra were
acquired in positive mode (in the range 400–2000 m/z)
using data-dependent scan and dynamic exclusion modes
for MS3 analysis (collision energy 35%), and MS3 spectra
were collected when an 80-amu neutral loss was detected.
Mass spectrometry data handling
The experimental mass spectra (full MS and MSMS) were
correlated with peptide sequences by comparing them with
the theoretical mass spectra deduced from the human protein
database downloaded from the NCBI website (http://www.
ncbi.nlm.nih.gov), using Bioworks 3.2 (Thermo Electron
Corporation), based on the SEQUEST algorithm1 (Univer-
sity of Washington, licensed to Thermo Finnigan, San José,
CA, USA). The following parameter filters were used:
peptide mass accuracy, 0.5 amu; Xcorr score, greater than
1.5, 2.0 and 2.5 for singly, doubly and triply charged peptide
ions, respectively; Sp, 500; P(pro) statistic ≤1×10−4.
nanoLC mass spectrometry
The solution containing the mixture of peptides was
analyzed by LC-MS analysis using a 4000 Q-Trap (Applied
Biosystems) coupled to an 1100 nano HPLC system
(Agilent Technologies, Santa Clara, CA, USA). The
mixture was loaded onto an Agilent reverse-phase precol-
umn cartridge (Zorbax 300 SB-C18, 5×0.3 mm, 5 μm) at
10 μl/min (A solvent 0.1% formic acid, loading time
5 min). Peptides were separated on a Agilent reverse-phase
column (Zorbax 300 SB-C18, 150 mm×75 μm, 3.5 μm) at
a flow rate of 0.3 μl/min with a 0–65% linear gradient in
60 min (A solvent 0.1% formic acid, 2% ACN in MQ
water; B solvent 0.1% formic acid, 2% MQ water in ACN).
The nanospray source was used at 2.5 kV with liquid
coupling, with a declustering potential of 20 V, and an
uncoated silica tip from NewObjective (O.D. 150 μm, I.D.
20 μm, T.D. 10 μm; Woburn, MA, USA). Data were
acquired in information-dependent acquisition (IDA) mode,
in which a full-scan mass spectrum was followed by MS/
MS of the five most abundant ions (2 s each). In particular,
spectral acquisition during MS/MS analysis was based on
an enhanced MS scan (EMS) survey from 400 m/z to
1400 m/z at 4000 amu/s. This scan mode was followed by
an enhanced resolution experiment (ER) for the five most
intense ions, and then MS2 spectra (EPI) were acquired
using the best collision energy calculated on the basis of m/z
values and charge state (rolling collision energy) from
100 m/z to 1400 m/z at 4000 amu/s. Data were acquired and
processed using Analyst software (Applied Biosystems).
Precursor ion scan
Spectral acquisition was based on a precursor ion scan
survey. It was performed over the mass range of m/z 400–
1400 at 333 amu/s (with Q1 set to low resolution and Q3
set to unit resolution) with a nanospray voltage of −2350 V
applied to a Picotip from NewObjective (O.D. 150 μm, I.D.
50 μm, T.D. 15 μm). Precursors were collided in Q2 with a
collision energy ramp of −25 to −65 V across the mass
range. When a precursor of −79 was detected above a pre-
set threshold value (2500 cps), the polarity was automati-
cally switched to +2500 V (after a 700-ms dwell period at
0 V) with the same gas settings, and a positive ion
enhanced resolution scan was performed at 250 amu/s to
determine the charge state of the ion. The Information-
dependent acquisition (IDA) software automatically adjusts
the mass for the polarity switch from negative ion to posi-
tive ion, and assigns a more accurate monoisotopic mass.
Enhanced product ion (EPI) scans (MS/MS) were
performed at 4000 amu/s, and collision voltages were
calculated automatically by rolling collision energy,
performing a maximum of one repeat before adding the
ion to the exclusion list for 60 s. Once this duty cycle was
completed, the polarity was switched back to negative (after
a 700-ms dwell period at 0 V) and the cycle was repeated.
The duration of the entire cycle, including fill times and
processing times, was less than 5.3 s.
Neutral loss
Spectral acquisition was based on a neutral loss scan
survey. It was performed over a mass range of m/z 400–
Identification of free phosphopeptides in different biological fluids by a mass spectrometry approach 149
1400 at 333 amu/s (with Q1 set to low resolution and Q3
set to unit resolution) with a nanospray voltage of 2500 V
applied to a Picotip from NewObjective (O.D. 150 μm, I.D.
50 μm, T.D. 15 μm). Ions were passed into Q2 where they
were fragmented with a collision energy ramp of 20–50 V
across the mass range. Q3 was scanned over a similar mass
range, offset by the 49 Da. Therefore, the two most intense
peaks that lost 49 Da were automatically selected for ER
and EPI scans under the conditions described above.
MASCOT analysis
Spectral data were analyzed using Analyst software
(version 1.4.1), and MS/MS centroid peak lists were
generated using the MASCOT.dll script (version 1.6b9).
The threshold of the MS/MS centroid peaks was at 0.1% of
the base peak. MS/MS spectra with less than ten peaks
were rejected. MS/MS spectra were searched against the
Swiss Prot database (2006.10.17 version) using the licensed
version of MASCOT (version 2.1, Matrix Science, Boston,
MA, USA) after converting the acquired MS/MS spectra
into the generic Mascot file format. The MASCOT search
parameters were: taxonomy, human (for biological fluids);
enzyme, none; missed cleavages, up to three; fixed
modifications, none; variable modifications: oxidation, M;
pyroGlu, N-term Q; phosphorylation of S, T; MS/MS
tolerance, 0.4 Da; peptide tolerance, 0.6 Da; top 20 protein
entries. Spectra of poor quality with a MASCOT score of
<25 were rejected. The score used to evaluate the quality of
matches for MS/MS data was >30. However, spectral data
were manually validated and contained sufficient informa-
tion to assign not only the sequence but also the site of
phosphorylation. This conservative criterion resulted in the
omission of many peptides identified as being phosphory-
lated, but for which spectral quality was insufficient to
allow further characterization.
Results and discussion
This study focused on the identification of free phospho-
peptides occurring in different biological samples like
serum, saliva and urine using a modified IMAC strategy
coupled to iterative mass spectrometry-based scanning
techniques (neutral loss, precursor ion).
Biological fluids have been shown to contain peptides
resulting from the degradation of proteins and other tissues,
and the change in composition of these peptides and their
PTMs can be indicative of changes in the physiology of the
Table 1 Proteins identified by the MS/MS analysis of precipitated peptides from biological fluids
Origin Identified protein Number of
peptides
Observed
coverage
Saliva (P02814) Submaxillary gland androgen-regulated protein 3 homolog B precursor (proline-rich
protein)
19 72%
Saliva (P02812) Basic salivary proline-rich protein 2 (salivary proline-rich protein) (Con1 glycoprotein) 30 54%
Saliva (P04281) Basic proline-rich peptide IB-1 14 77%
Saliva (P02811) Basic proline-rich peptide P-E (IB-9) 17 98%
Saliva (P02810) Salivary acidic proline-rich phosphoprotein 1/2 precursor (PRP-1/PRP-2) (parotid
proline-r)
19 56%
Saliva (P10163) Basic salivary proline-rich protein 4 allele S precursor (salivary proline-rich protein Po) 16 50%
Saliva (P02808) Statherin precursor 3 38%
Saliva (Q13942) Collagen alpha-2(XI) chain precursor 13 13%
Saliva (Q9UMD9) Collagen alpha-1(XVII) chain (bullous pemphigoid antigen 2) (180 kDa bullous
pemphigoid antigen 2)
2 0.7%
Saliva (Q04118) Basic salivary proline-rich protein 3 precursor (parotid salivary glycoprotein G1) 4 25%
Urine (P07911) Uromodulin precursor 7 2%
Serum (P02671) Fibrinogen alpha chain precursor 15 20%
Serum (P01024) Complement C3 precursor 3 1.5%
Serum (P22670) MHC class II enhancer factor C 3 2%
Fig. 1A–B MALDI-MS analysis of enriched α-casein by Fe3+-IDA
agarose (panel A); MALDI-MS of enriched α-casein by Fe3+-NTA
agarose (panel B). Unspecific nonphosphorylated peptides are
indicated
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organism. Because such peptides could be bound to highly
abundant proteins (i.e., albumin, amylase and uromodulin),
their depletion from biological fluids under native conditions
may possibly result in the loss of the potential biomarkers.
Protein precipitation and direct MS analyses of free
phosphopeptides
The samples from different donors were pooled into three
different classes (namely saliva, urine and serum sam-
ples), and the best sample preparation conditions were
employed (see the “Materials and methods” section). The
supernatants containing free peptide mixtures were sub-
mitted to direct MALDI-MS and LC-MS/MS analysis.
MALDI-MS analysis was carried out in order to determine
the complexity of the samples and the mass range of the
peptides in them (see the “Electronic supplementary
material,” Fig. S1).
The MALDI mapping procedure was not able to identify
any protein using bioinformatic tools (MASCOT fingerprint,
Protein Prospector, Profound) due to the fact that these
fingerprint programs need knowledge of the enzyme.
Mapping phosphorylation sites within phosphoproteins by
MALDI-MS is currently the method of choice for identifying
phosphorylation sites because of its high sensitivity and
accuracy [12]. However, MALDI-MS analysis of phospho-
peptides is challenging due to the low ionization efficiency
and suppression effects in the positive MS mode. Further-
more, MALDI mapping analysis of phosphopeptides and the
identification of phosphorylation sites are difficult tasks to
perform without a priori knowledge of the protein sequence,
which enables the large-scale application of phosphoproteo-
mic analysis to be avoided. In addition, the presence of
several possible phosphorylation sites complicates the
correct assignment of phosphorylated residues.
Thus, the same mixture was submitted to LC-MS/MS
analysis. The fragmentation of tryptic peptides was opti-
mized thanks to the presence of a basic aminoacid at the C-
terminal residue. Unfortunately, many free peptides did not
present a lysine or an arginine at the C-terminal residue. In
our study, in fact, many peptides were found to have
different cleavage sites, and this was reflected in the quality
of the fragmentation spectra. Therefore, we optimized the
MS/MS parameters and tandem mass spectrometry allowed
us to establish the sequence of peptides and the identities of
the proteins in the mixture, as reported in Table 1, using the
MASCOT MS/MS Ion Search program. The homology
degree, derived by BLAST alignment, is reported in Table B
Fig. 2 Partial MALDI-MS spectrum of enriched methylated α-casein.
The attributions of different phosphopeptides and satellite peaks are
reported
Fig. 3 Total ion current chromatogram of the precursor ion scan analyses performed on the serum phosphopeptide mixture
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in the “Electronic supplementary material.” All fragmenta-
tion spectra were identified by MASCOT searches, taking
into account the possible presence of phospho-Ser and Thr
among variable modifications. Unfortunately, direct MS
analyses were unable to detect any free phosphopeptides in
the serum, saliva or urine. Thus, a preliminary enrichment
step was needed. For this reason, a combination of a
precipitation protocol for highly abundant proteins and the
IMAC strategy was chosen.
IMAC enrichment step on different fluids
Reducing the complexity of peptide mixtures by enriching
and separating the phosphopeptides by liquid chromatogra-
phy is the common method used in phosphoproteomics [13].
A modified IMAC protocol was applied to enrich the
phosphopeptide mixture in order to identify the phosphor-
ylated peptides inside the biological fluids.
The conditions set up for model phosphopeptide analysis
were employed for the enriched free phosphopeptides in the
biological fluids. The nature of the chelator, the stationary
phase and the buffer systems are factors that are potentially
important for improving selectivity. The effectiveness of the
isolation procedure was tested by using 100 fmol of α-
casein peptide mixture. Enzymatic digestion was carried
out with trypsin in 50 mM ammonium bicarbonate pH 8.5
at 37 °C for 18 h using an E/S ratio of 1/50 (w/w) under
standard conditions, using both NTA and IDA agarose
resin. The eluted phosphopeptides were analyzed by
MALDI-MS to compare the two enrichment protocols. As
Fig. 4A–B Comparison between a precursor ion scan and a neutral
loss scan of the same peptide. A Precursor ion spectral survey performed
in negative ion mode for a free phosphopeptide in the serum eluting at
35 min. The resulting ER scan performed in the positive ion mode and
the corresponding EPI scan performed on the triply charged precursor
ion at m/z 515.86 are shown. B Neutral loss (of 49 Da) survey of the
same peptide, but doubly charged, eluting at the same retention time.
The resulting ER scan performed in the positive ion mode and the
corresponding EPI scan performed on the precursor at m/z 773.31 are
reported
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clearly indicated in Fig. 1, the enrichment procedure
performed using Fe3+−IDA-agarose (panel A) showed
greater selectivity and recovery for binding phosphopep-
tides rather than nonphosphorylated peptides compared to
Fe3+-NTA agarose (panel B). Therefore we decided to use
Fe3+-IDA agarose resin in all subsequent IMAC experi-
ments [13]. It should be noted that, under these conditions,
the pentaphosphorylated peptide occurring within the α-
casein sequence was not detected.
Acidic peptides affect the specificity of the IMAC peptide
purification. Methyl-esterification of peptide side chains was
suggested by Ficarro et al. [14] to minimize the effect of
nonspecific binding. However, when we performed this
reaction, MALDI-MS analysis showed that the peptide
chemical modification reaction was not quantitative, as
indicated by the occurrence of satellite peaks at 14 Da that
were higher than the theoretical ones (Fig. 2). This effect
diluted the sample into populations of modified and unmod-
ified peptides, effectively reducing the amount of any given
peptide and increasing the overall sample complexity. For this
reason, methylation was omitted in the present study.
Therefore, we decided to modify the current IMAC
protocol. To minimize nonspecific binding in the IMAC
step, the pH of the sample was carefully adjusted to 2.0,
which resulted in the protonation of the majority of the
glutamic and aspartic acid residues. In addition, a high-
organic (60% acetonitrile, 15% acetic acid, pH 2.0) buffer
was used to minimize hydrophobic unspecific interactions
with the matrix and to solubilize the peptides before loading
them onto the IMAC resin. These two steps represent major
and important modifications that we have made to the
classical IMAC procedure [14].
Fig. 4 (continued)
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The elution was performed by changing the pH. A
solution of volatile ammonia (pH 12.0) was chosen as the
eluting buffer, thus avoiding the presence of salts and other
contaminants.
The feasibility of the developed strategy for detecting
phosphopeptides in a highly complex mixture was probed
by adding an aliquot of α-casein to a peptide mixture from
Escherichia coli protein extract. MALDI mass spectral
analysis led to complete coverage of S1 α-casein phospho-
peptides and partial coverage of S2 phosphopeptides
(Table SA and Fig. S10 in the “Electronic supplementary
material”). Only a few signals attributed to nonphosphory-
lated peptides were detected, thus demonstrating the
success of the enrichment strategy.
MALDI-MS analysis performed on serum and saliva after
the IMAC enrichment step clearly indicated the presence of a
different number of signals compared to the same analysis
performed on the sample before IMAC enrichment (Fig. S2
of the “Electronic supplementary material”). MALDI-MS
analysis of enriched urine phosphopeptides did not give
such good results (data not shown).
Selective tandem mass spectrometry experiments
Coupling liquid chromatography to hybrid mass spectrom-
etry (LC-MS/MS) can overcome the phosphorylation
problems described above, leading to both the identification
of phosphoproteins and the determination of the exact
locations of phosphorylation sites.
In this work the detection of phosphorylated peptides
was improved by selectively monitoring the phosphopep-
tides in the mass spectrometer and taking advantage of the
scanning capabilities of a new generation of instruments
based on linear ion traps. Our analyses were carried out on
Fig. 5 MS/MS spectrum showing the properly annotated sequence of the doubly charged peptide (MH2
2+ 773.31)
Table 2 Free phosphopeptides identified in serum
Sequence peptide Protein Modification Observed m/z Charge (z) Score
DpSGEGDFLAEGGGV P02671 Fibrinogen α-chain pS 695.21 2+ 85
ADpSGEGDFLAEGGGV P02671 Fibrinogen α-chain pS 730.74 2+ 70
ADpSGEGDFLAEGGGVR P02671 Fibrinogen α-chain pS 808.85 2+ 121
DpSGEGDFLAEGGGVR P02671 Fibrinogen α-chain pS 773.31 2+ 101
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Fig. 6A–B MS/MS spectrum showing the properly annotated sequence of a doubly charged monophosphorylated (A) and a diphosphorylated
peptide (B)
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a 4000 Q-Trap. Specific mass spectrometry scanning
modes, such as neutral loss and precursor ion scanning,
have been implemented to improve the detection of the
phosphorylation sites in highly complex peptide mixtures
[15, 16]. Furthermore, the performance of the system based
on a nanospray ESI source combined with capillary
chromatography was characterized by higher sensitivity
and resolution, even leading to the detection of phospho-
peptides present at substoichiometric amounts.
Therefore, peptide mixtures from different biological
human fluids were submitted to the selective analysis of
phosphopeptides by tandem MS/MS. The MS analysis was
reiterated twice. In precursor ion experiments a higher
number of phosphopeptides than those detected by using
neutral loss analysis were identified despite the inferior
quality of the MS/MS spectra. This is probably due to the
poorer stability of the spray on switching the polarity, the
total length of the acquisition cycle, and the different charge
states of the parent ion between precursor ion and neutral
loss analysis. In this case, the neutral loss scan was
performed at 49 Da, corresponding to the loss of neutral
phosphoric acid from doubly charged peptides, whereas the
precursor ion scan was performed on doubly and triply
charged peptides. However, a smaller number of species
were detected by neutral loss scan compared to precursor
ion scan analysis, probably due to the presence of non-
phosphorylated peptides that interact nonspecifically with
IMAC resin and give rise to a loss of 49 Da during neutral
loss analysis. These considerations can be applied to all of
the samples analyzed.
Urine tandem MS analyses
It is worth underlining that only a few free peptides and no
free phosphopeptides were identified in urine samples, in
contrast to the free peptides detected in saliva and serum
(seven peptides), as reported in Table 1. This finding may
be due to the fact that the porous wall of the glomerular
capillaries in the kidney generally only allows proteins with
a molecular weight of <65 kDa to pass into the tubular
system, whereas larger proteins stay in the blood stream.
The tubular cells subsequently reabsorb the smaller pro-
teins, and only low concentrations of proteins are normally
present in the urine [17].
Serum tandem MS analyses
Figure 3 shows the total ion current chromatogram of the
precursor ion scan analyses performed on the serum
phosphopeptide mixture. The resulting precursor ion spec-
tral survey performed in negative ion mode for a free
phosphopeptide in the serum corresponding to differently
Fig. 7 MS/MS spectrum of a doubly charged phosphopeptide at m/z 731.27
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processed fibrinogen α-chain peptide is reported in Fig. 4
(panel A). The resulting ER scan performed in the positive
ion mode and the corresponding EPI scan performed on
the triply charged precursor ion at m/z 515.86 are shown.
The resulting neutral loss (of 49 Da) survey performed at
the same retention time for the same peptide, but doubly
charged, is shown in Fig. 4 (panel B). The resulting ER
scan performed in the positive ion mode and the cor-
responding EPI scan performed on the precursor at m/z
773.31 are also reported. The specificity of the precursor
ion and neutral loss scans is highlighted by the good quality
of the survey MS spectrum.
A comparison between the MS/MS spectra shows that
the EPI spectrum arising from the doubly charged peptide is
richer in signals and is higher quality with respect to the
same fragment spectrum than the triply charged peptide.
The properly annotated sequence of the doubly charged
peptide (MH2
2+ 773.31) is shown in Fig. 5.
Similar results were obtained when serum-enriched
peptide mixtures were submitted to two-dimensional micro-
chromatography coupled to mass spectrometry. Each 2DC-
MS/MS analysis of the digested samples produced seven
reversed-phase chromatograms, which corresponded to four
SCX column salt steps of increasing ammonium concen-
tration (0, 50, 200, and 600 mM). The peptides eluted from
the columns were immediately directed into the mass
spectrometer where they were ionized, mass-selected, and
fragmented. This procedure allowed for the identification of
several peptides that were then associated with different
forms of fibrinogen alpha-chain by the SEQUEST software
[18]. All serum results are summarized in Table 2, and they
essentially show the detection of different isoforms of a
phosphorylated fibrinogen fragment. Our data agree per-
fectly with the data of Marshall and coworkers. In 2003,
Marshall et al. claimed that peptides from the sera of
normal individuals and patients who suffered from myo-
cardial infarction produce MALDI-TOF patterns that allow
the accurate diagnosis of myocardial infarction [19]. In
some patients who had occluded coronary arteries, phos-
phorylated fibrinogen alpha levels were increased com-
pared with patients who had patent coronary arteries. These
results provide some support for the idea that increased
synthesis of circulating fibrinogen may result in a procoa-
gulant tendency. Thus, phosphorylated fibrinogen alpha
content may serve as a risk index for thrombosis [20].
Saliva tandem MS analyses
When the experiments were carried out using an enriched
saliva sample, many free phosphopeptides belonging to
salivary proteins were observed in neutral loss and
precursor ion scan analyses.
As an example, the fragment identified at m/z 538.24
corresponding to statherin precursor is shown in Fig. 6A. In
addition to a dominant H3PO4 (m/z 98/2) loss ion at m/z
489.4 that was characteristic of a doubly charged mono-
phosphorylated peptide, a continuous series of ions ranging
from y1 to y6 was observed. Moreover, a series of b ions,
namely, b3-H3PO4, b4-H3PO4 and y7-H3PO4, which
resulted from the fragmentation of the β-eliminated
489.4 m/z ion, were detected. In this case, the loss of
phosphoric acid was complete and assigning the correct
phosphorylation site was a hard task.
Moreover, the MS analysis led to the detection of
another free phosphopeptide in saliva identified as
DpSpSEEKFLR within the statherin sequence, the spec-
trum of which shown in Fig. 6B. As indicated, the spectrum
exhibited two diagnostic ions for a doubly charged
diphosphopeptide: a dominant H3PO4 (m/z 98/2) loss ion
at m/z 586.8 and a second H3PO4 (m/z 98/2) loss at m/z
537.8. A continuous series of ions ranging from y7 to y10
consistent with a phosphoserine residue at positions 2 and 3
was observed. It is clear that the interpretation of this
spectrum is complicated by the presence of fragmentation
Table 3 Free phosphopeptides identified in saliva. Known phosphorylation sites are indicated with (p)
Sequence Protein Modification Observed
m/z
Charge
(z)
Score
GGDpSEQFIDEER P02810 Salivary acidic proline-rich phosphoprotein 1/2
precursor (PRP-1/PRP-2)
1P 731.27 2+ 72
GGDpSEQFIDEERQ P02810 Salivary acidic proline-rich phosphoprotein 1/2
precursor (PRP-1/PRP-2)
1P 795.28 2+ 44
PGKPQGPPPQGGSKpSRpSARS P02812 Basic salivary proline-rich protein 2 2P 712.64 3+ 41
SpSEEKFLR P02808 Statherin precursor 1P 538.24 2+ 65
pSpSEEKFLR P02808 Statherin precursor 2P 578.22 2+ 50
DSpSEEKFLR P02808 Statherin precursor 1P 595.74 2+ 49
DpSpSEEKFLR P02808 Statherin precursor 2P 635.70 2+ 44
pSHEKRHHGYR P15515 Histatin-1 precursor 1P 693.82 2+ 80
New phosphorylation sites detected by MS analysis are underlined
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series from MH2
2+, MH2
2+-H3PO4 and MH2
2+- 2H3PO4;
often unexplained by conventional b- and y-type ions.
Figure 7 shows the MS/MS spectrum of a doubly charged
saliva phosphopeptide at m/z 731.27 within a salivary
acidic proline-rich phosphoprotein precursor whose partial
sequence was GGDpSQFIDEER (identified by MASCOT
analysis), showing a complete loss of phosphoric acid and
the presence of a unique serine residue within the sequence.
A total of ten free phosphopeptides and 14 phosphor-
ylation sites within the eight protein sequences were
identified (Table 3). In particular, free phosphopeptides
from salivary proline-rich phosphoprotein precursor
(PRPP), salivary acidic proline-rich protein precursor,
statherin precursor, centaurin gamma 3, cytokeratin 13,
cyclin G-associated kinase, mucin 7 precursor, and Sal-
like protein 2 were detected. Whole fragmentation spectra
are reported in the “Electronic supplementary material”
(Figs. S3–S9). It is well known that human saliva contains
a large number of proteins that have important physiolog-
ical functions (see [23] and references therein). There is a
growing interest in these proteins due their potential
usefulness in proteomic analysis aimed at the diagnosis
of many different diseases. Knowledge of the phospho-
peptides can provide important information about bio-
chemical processes, revealing potential targets for disease
therapies.
Saliva is usually supersaturated with the basic calcium
phosphate salts that form dental enamel, a property that
provides protection for the teeth. An undesirable side effect
of this is that unwanted precipitation of solid calcium
phosphate may occur in the salivary glands, the fluid of the
mouth, or on dental enamel. However, this is avoided by
the presence of proteins such as statherin [21, 23], a
phosphoprotein that prevents calcium phosphate precipita-
tion and the growth of hydroxyapatite crystals. The latter
activity is shared by acidic proline-rich proteins (APRPs)
[22, 23]. Statherin and APRPs lose these activities upon
dephosphorylation [12, 23]. Moreover, the ability of APRPs
to bind calcium and thereby aid in maintaining the
concentration of ionic calcium in saliva also depends on
the phosphorylation of the proteins (see [23 and references
therein). In addition, the dephosphorylation of APRPs
decreases their binding to hydroxyapatite, thus preventing
them from taking part in the formation of dental pellicle,
the thin layer of adsorbed proteins found on teeth which
may provide protection against demineralization.
Conclusions
In conclusion, the combination of the improved IMAC
protocol with selective “precursor ion” and constant
“neutral loss” triple quadrupole scan modes confers high
sensitivity, allowing rapid peptide identification and char-
acterization at low concentrations.
The unique capabilities of the Q-q-Q linear ion trap in
selective ion scans are due to the decoupling and spatial
separation of the ion isolation, fragmentation, and mass
analysis steps of the instrument.
The results obtained in this work and summarized in the
tables demonstrate that the modified immobilized metal
affinity chromatography and selective tandem mass spec-
trometry of prefractionated biological fluids allows the
selective identification of free phosphopeptides. This
method should be widely applicable to searches for
biomarkers in clinical diagnosis and therapy. It should be
noted that no functional role of the detected species can be
discerned from the present work. Other (different) analyses
are needed to highlight the biological functions of the
detected free phosphopeptides.
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Quantitative identification of protein nitration sites
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Several labelling strategies have been developed targeting specific amino acid residues and/or
PTMs. Methods specifically tailored for the qualitative and sometimes quantitative determina-
tion of PTMs have emerged. Many research groups have focused their attention towards o-
nitrotyrosine residues, developing various methodologies for their identification, while direct
quantification has remained elusive. So far the iTRAQ chemistry has been limited to primary
amines. Here, we report a new strategy based on the use of iTRAQ reagents coupled to MS
analysis for the selective labelling of o-nitrotyrosine residues. This method was proved to lead to
the simultaneous localisation and quantification of nitration sites both in model proteins and in
biological systems.
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1 Introduction
A number of tagging (or labelling) strategies have been
developed to target specific amino acid residues and/or
PTMs. These methods enable the enrichment of subfrac-
tions via affinity cleanup [1–3]. A proposed approach consists
in targeting the specific amino acid by an affinity chroma-
tography step (e.g. biotin–avidin chromatography). This pro-
cedure was used for the isolation of post-translationally
modified peptides [4–7]. The presence of phosphorylation,
glycosylation, glycation, nitration and specific types of oxida-
tion are examples of PTMs that can be targeted [8, 9].
Stable isotope methods have been introduced into MS-
based proteomics to allow relative changes in protein
expression to be determined [10]. The principle of these
methods is the incorporation of a stable isotope derivative in
one of the states to be compared. Stable isotope incorpora-
tion shifts the mass of the peptides by a predictable amount.
The ratio of analyte between two or more states can then be
determined accurately by the measured peak ratio between
the heavy and light derivatised samples One of the first
approaches based on the isotope stable affinity tagging and
MS is the ICAT strategy [11] specifically addressed towards
Cys residues. Another elegant approach use cell-culture
enrichment with a stable isotope-labelled amino acid, for in
vivo incorporation of a mass difference to support relative
quantitation [12].
A novel methodology for quantitative analysis by MS
makes use of iTRAQ (acronym for isobaric tag for relative
and absolute quantification) technology, a newly developed
method by Applied Biosystems for relative and absolute
quantification of proteins. This novel reagent has been
applied for the first time by Pappin and coworkers for the
multiplexed protein quantitation in yeast [13]. iTRAQ
reagents are specifically reactive towards primary amino
groups (namely N-terminal of proteins and peptides and
epsilon-amino groups of lysine) and marketed in four differ-
ent forms called iTRAQ 114.1, 115.1, 116.1 and 117.1,
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depending on the m/z value of the reporter group. The
reagents are differentially isotopically labelled such that all
derivatised peptides are isobaric (isobaric tag with a mass of
145.1 Da). In fact, the overall mass of reporter and balance
components of the molecule are kept constant using differ-
ential isotopic enrichment with 13C, 15N and 18O atoms. The
iTRAQ reagents allow the simultaneously multiplexed anal-
ysis of four samples. Each of these samples is labelled with
one of the iTRAQ reagents; all peptides with the same
sequence, but carrying different versions of the tag will be
chromatographically indistinguishable and identical in
mass, therefore, also identical in single MS mode. Upon
fragmentation, the reporter group is detached, creating sig-
nals in the ‘quite’ low mass range region (114–117 Da) of the
MS/MS spectrum. The balance group is lost as a neutral, so
that the remaining peptide backbone remains unmodified
and can generate backbone fragments that are identical in
m/z for all samples, resulting in improved S/N ratios be-
cause all differentially coded samples contribute to MS/MS
spectrum. Thus, low mass reporter ion signals allow quanti-
tation, while peptide fragment ion signals allow protein
identification. Very recently, an octu-plex iTRAQ kit has been
proposed thus allowing the simultaneous analysis of eight
different samples [14]. Moreover, iTRAQ labelling coupled
with pulsed Q dissociation technique has been recently pro-
posed for protein quantitation [15].
Among PTMs, protein nitration can occur in cells during
oxidative stress and over-production of nitric oxide [16, 17].
Tyrosine nitration is becoming increasingly recognised as a
prevalent, functionally significant post-translational protein
modification [18]. This modification is, in fact, implicated in
the control of fundamental cellular processes including cell
cycle, cell adhesion and cell survival, as well as cell prolifera-
tion and differentiation.
Addition of NO2 group to the ortho-position of tyrosine
decreases the pKa of its hydroxyl group of about three units.
This bulky substituent can induce changes in protein con-
formation, resulting in the generation of antigen epitopes,
altered enzyme catalytic activity, modulation of metabolic
pathways and inhibition of tyrosine phosphorylation by pro-
tein kinases [19–21]. For these reasons and for its chemical
stability NO2Tyr is considered the most important biomarker
for identification and quantitation of cellular processes,
associated to reactive nitrogen species (RNS) occurrence,
that lead to PTM of proteins.
Many research groups have focused their attention to-
wards 3-nitrotyrosine residues, developing various meth-
odologies for revelation and quantification of NO2Tyr resi-
dues [22–25].
So far the iTRAQ chemistry has been limited to primary
amines even instrumental for the identification of PTMs. As
an example Pflieger and coworkers showed a protocol for
phosphorylation quantification [26] based on the combina-
tion of iTRAQ isobaric labelling of peptide and phosphatase
treatment for the identification of phosphorylated protein in
complex mixtures.
We are planning to extend the chemistry of the reagent to
address quantification of function of other than primary
amines by taking advantage of the experience recently made
with dansyl chemistry. In fact, our group has already report-
ed a new approach involving dansyl chloride labelling of
nitration sites that rely on the enormous potential of MSn
analysis [27]. A similar approach has been reported by
Smith’s laboratory for the selective enrichment and identifi-
cation of nitrotyrosine-containing peptides based on deriva-
tisation with N-succynimidyl S-acetylthioacetate and LC-MS/
MS analysis of newly generated amino-tyrosines deriving
from sodium dithionite-assisted reduction of nitro groups [8]
Here, we report a new strategy based on the use of
iTRAQ reagents coupled to MS analysis for the selective
labelling of o-nitrotyrosine residues. This method was proved
to lead to the simultaneous localisation and quantification of
nitration sites both in model proteins and in biological sys-
tems.
2 Materials and methods
2.1 Chemicals
BSA, tetranitromethane (TNM), ammonium bicarbonate
(AMBIC), guanidine, DTT, trypsin, iodoacetamide (IAM)
and triethyl ammonium carbonate (TEAB) were purchased
from Fluka. Tris, sodium dithionite as well as the MALDI
matrix CHCA were purchased from Sigma. iTRAQ reagents
were furnished by Applied Biosystems. Methanol, TFA and
ACN are HPLC grade type from Carlo Erba, whereas the
other solvents are from Baker. Gel filtration columns PD-10
are from Pharmacia, the HPLC ones from Phenomenex,
whereas the prepacked columns Sep-pak C-18 are from
Waters.
2.2 BSA nitration
An aliquot of 200 mg BSA was dissolved in Tris 200 mM
pH 8.0 buffer and was added to a 830 nmol/mL solution of
TNM in ACN in a molar ratio 1:10 BSA/TNM. The reaction
was carried out under agitation for 30 min at room tempera-
ture. The mix of BSA and nitrated BSA (N-BSA) was then
desalted by SEC on a SEPHADEX G-25M column; the elu-
tion was carried out with Tris 300 mM and the fractions an-
alysed through UV spectrometry at 220 and 280 nm wave-
length. Positive fractions were collected and dried.
2.3 Reduction and carbamidomethylation of BSA
BSA and N-BSA mixture were dissolved in denaturation
buffer (guanidine 6 M, Tris 0.3 M, EDTA 10 mM, pH 8.0).
Reduction was carried out by using a 10:1 DTT/cysteine
molar ratio. After incubation at 377C for 2 h, iodoacetamide
was added to perform carbamidomethylation using an excess
of alkylating agent of 5:1 respect to the moles of thiolic
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groups. The mixture was then incubated in the dark at room
temperature for 30 min. The alkylation reaction was stopped
by addition of formic acid, in order to achieve an acidic pH.
The product was purified by SEC. The elution was performed
with TEAB 50 mM pH 8.0.
2.4 BSA digestion
Protein digestion was carried out in TEAB 50 mM pH 8.0
buffer using trypsin at a 50:1 protein/trypsin mass ratio. The
sample was incubated at 377C for 16 h. Then the sample was
dried.
2.5 Acetylation of peptide mixture
Peptide mixture was dissolved in 30% TEAB 500 mM
pH 8.0, 70% ACN. Acetylation was performed by using
acetic acid N-hydroxy succinimide esther in molar ratio 500:1
reagent/peptides. The reaction was carried out for 1 h at
room temperature.
2.6 Nitro groups reduction
Reduction of nitro groups to amino groups was performed
by adding. Na2S2O4 at 100:1 Na2S2O4/NO2Tyr molar ratio.
The reaction was carried out at room temperature for 10 min
under stable stir. The product was purified by SEP-PAK RP-
LC with C18 column. Peptides were eluted using 80% ACN,
20% formic acid 0.1%. Fractions were collected and lyophi-
lised.
2.7 Bacterial strains, growth conditions and protein
extract preparation
Escherichia coli K12 strain was grown in aerobic conditions at
377C in LB medium. After 16 h, bacteria were harvested by
centrifugation and resuspended in Buffer Z (25 mM HEPES
pH 7.6, 50 mM KCl, 12.5 mM MgCl2, 1 mM DTT, 20%
glycerol, 0.1% triton) containing 1 mM PMSF. Cells were
disrupted by sonication. The suspension was centrifuged at
90 0006g for 30 min at 47C. After centrifugation the protein
concentration of the extract was determined with Bradford
assay.
2.8 iTRAQ selective labelling
Sample was dissolved in TEAB 500 mM pH 8.0 and then was
divided in two shares and each of these was differentially
labelled with alternatively iTRAQ reagent 114 and iTRAQ
reagent 117, following iTRAQ protocol furnished by Applied
Biosystem.
2.9 Labelling of bovine milk protein extract
A sample of commercially available bovine milk was reacted
with a 10 mM solution of TNM for 30 min under agitation at
room temperature. Modified milk proteins were purified by
precipitation with the Amersham Clean Up kit and dissolved
in denaturant buffer. Reduction was carried out by using a
10:1 DTT/cysteine molar ratio. After incubation at 377C for
2 h, iodoacetamide was added to perform carbamidomethy-
lation using an excess of alkylating agent of 5:1 respect to the
moles of thiol groups. Themixture was then incubated in the
dark at room temperature for 30 min. The alkylation reaction
was stopped by addition of formic acid, in order to achieve an
acidic pH. The protein mixture was purified by SEC on a
Sephadex G-25 M column equilibrated and eluted with
50 mM TEAB. Protein fractions were concentrated and then
digested with trypsin as already described. The resulting
peptide mixture was acetylated and the nitro groups were
reduced using a 200 mM solution of Na2S2O4 for 30 min.
The protein mixture was then reacted with ITRAQ as
described above.
2.10 NanoLC-MS
Peptide mixture, obtained as previously described, was ana-
lysed by LC-MS/MS analysis using a 4000Q-Trap (Applied
Biosystems) equipped with a linear ion trap coupled to an
1100 nano HPLC system (Agilent Technologies). The mix-
ture was loaded on an Agilent reverse-phase pre-column
cartridge (Zorbax 300 SB-C18, 560.3 mm2, 5 mm) at 10 mL/
min (solvent A 0.1% formic acid, loading time 7 min). Pep-
tides were separated on an Agilent reverse-phase column
(Zorbax 300 SB-C18, 150 mm675 mm, 3.5 mm), at a flow
rate of 0.2 mL/min with a 5–65% linear gradient in 60 min
(solvent A 0.1% formic acid, 2% ACN in water; solvent B
0.1% formic acid, 2% water in ACN). Nanospray source was
used at 2.3 kV with liquid coupling, with a declustering
potential of 20 V, using an uncoated silica tip from New-
Objectives (od 150 mm, id 20 mm, TD 10 mm). Spectra acqui-
sition was based on a survey Precursor Ion Scanning for the
ion m/z 114 and 117. It was performed over a mass range of
m/z 400–1400 with Q1 set to low resolution and Q3 set to
unit resolution. Precursors were collided in Q2 with a colli-
sion energy ramp of 25–65 V across the mass range. Spectra
acquisition was based on a survey precursor ion scan (PIS). A
positive ion Enhanced Resolution Scan was performed at
250 amu/s to determine the charge state of the ion.
Enhanced product ion (EPI) scans (MS/MS) were performed
at 4000 amu/s and collision voltages were calculated auto-
matically by rolling collision energy and it performed a max-
imum of one repeat before adding ion to the exclusion list for
60 s. Once this duty cycle was completed, the polarity was
switched back and the cycle repeated. The entire cycle dura-
tion, including fill times and processing times was less than
5.3 s. Data were acquired and processed using Analyst soft-
ware (Applied Biosystems) and processed by using MASCOT
in-house software.
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3 Results and discussion
It is well known that some PTMs due to oxidative stress
events are linked with the pathogenesis of different diseases,
therefore, it is very important to find biological markers able
to furnish us information about localisation and physiologi-
cal effects of oxidative stress. Molecules modified by oxida-
tion, nitration and nitrosilation can act as cellular bio-
markers. Identification of the specific targets of protein oxi-
dation was generally accomplished by the detection and
quantification on o-nitrotyrosine using of 2-DE and Western
blot techniques followed by mass spectral identification of
protein candidates [28]. However, these procedures generally
led to the identification of nitrated proteins but the fine
localisation of the nitration sites in complex protein mixture
still remain a challenging task. In this respect, our group has
suggested a strategy leading to the selective detection of
nitrated tyrosine residues by using dansyl chloride labelling
coupled to advanced MS experiments [27]. The tryptic digest
from the entire protein mixture is directly analysed by MS on
a hybrid triple quadrupole/linear ion trap mass spectrome-
ter. Discrimination between nitro- and unmodified peptide is
based on two selectivity criteria obtained by combining a PIS
and an MS3 analysis. The proposed strategy has resulted to
be specific, sensitive, simple and fast. However, because no
heavy form of dansyl chloride is commercially available,
quantitative analysis of complex protein mixture cannot be
addressed. Now taking advantage of the experience made
with the above strategy, we used selective labelling of o-
nitrotyrosine residues exploiting the potential of iTRAQ
reagents to perform quantitative analysis of this PTM in
proteins. The idea proposed is outlined in the Scheme 1.
According to the so-called ‘gel-free procedures’, the anal-
ysis is carried out at level of peptides following tryptic digest
of the whole protein mixture. This approach was first applied
to BSA as model protein. 200 mg of BSA were nitrated using
TNM as described in Section 2. Then, the resulting BSA and
N-BSA mixture was reduced, alkylated and hydrolysed using
trypsin. The peptide mixture was then analysed via MALDI-
MS to verify the extent of nitration.
BSA is a protein of about 66 kDa, showing 20 tyrosine
residues along its sequence. However, mass spectral analyses
demonstrated that in vitro nitration was limited to only few
tyrosine residues, namely the ones exposed in the structure
of the protein and thus more sensible to nitration. Nitrated
peptides were identified by MALDI mapping procedure, by
comparing the experimental peptides masses with the theo-
retical values on the basis of amino acid sequence. As already
reported, a DM of 145 was attributed to the modified pep-
tide, due to introduction of a nitro-group [29]. Figure 1
(panels A and B) showed partial MALDI-MS spectrum of the
tryptic BSA and N-BSA mixture. As an example, the signals
occurring at m/z 972.5, 1524.8 showed molecular masses
45 Da higher than the theoretical ones. These signals were
attributed to the peptides 137–143, 396–408, having the Tyr
residue been modified by a nitro group. As a whole, the
MALDI-MS analysis showed the occurrence of four signals
exhibiting a mass increment of 45 Da. These signals were
attributed to the nitropeptides 137–143, 396–408, 322–334,
444–457 (at m/z 972.5, 1524.8, 1612.9, 1770.8, respectively)
As further proof, these signals exhibited the characteristic
pattern of nitrated peptides, due to photodecomposition of
nitrated tyrosine residues by MALDI source [29]. Moreover,
mass spectral analysis led to a semiquantitative measure of
the degree of the in vitro protein nitration. In fact, by com-
paring the intensity of signals attributed to nitrated peptides
with respect to the unmodified one it was possible to esti-
mate that almost 30% of BSA resulted to be nitrated.
In our previous work [27], the selective labelling of o-
nitrotyrosine residues was essentially based on a reduction
step and conversion to o-aminotyrosine residues followed by
specific dansylation at pH 4.7. A similar approach was
attempted here. However, iTRAQ labelling does not permit
to exploit the low pKa value [30] of such amine to obtain a
selective labelling, as observed for the dansyl-chloride label-
ling. Only a small percentage of primary aromatic amine
modification by iTRAQwas observed. This behaviour may be
explained by the faster rate of hydrolysis of both the ITRAQ
n-hydroxysuccnimide ester group and the formed amino-
tyrosine-iTRAQ derivative in mild acidic conditions [31].
Thus, it was necessary to set up a double step procedure.
First of all, lysine residues and N-terminus primary amine
were protected to facilitate specific labelling of the o-nitroty-
rosine residues. Blocking can be easily performed under
mild conditions by a variety of reagents that are commer-
cially available. In fact, several strategies to introduce NH2-
labels have been described [32, 33]. Generally, it is not possi-
ble to reliably control the selectivity of the reaction, because
the e-amino group of lysine is readily and stably modified by
reagents that target the N-terminus [34, 35]. Blocking the
Scheme 1. Strategy for selective
labelling of o-nitrotyrosine resi-
dues.
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Figure 1. MALDI-MS spectra enlargement of
nitrated BSA. (A) Detail of MALDI-MS spectrum
relative to nitrated peptide 137–143. (B) Detail of
MALDI-MS spectrum relative to nitrated peptide
396–408. MALDI-MS spectrum shows that the
degree of protein nitration is almost 30%.
N-terminus and the lysine side chain can be done either
prior to or after enzymatic digestion of the sample. By block-
ing the lysines after digestion, we retained the ability to use
trypsin as enzyme for proteolytic cleavage.
Preliminary acetylation experiments were performed by
using acetic anhydride as reagent and peptide mixture
obtained from trypsin digestion of myoglobin, as model.
MALDI-MS analysis performed on the resulting peptide mix-
ture showed that the acetylation reactionwas not quantitative.
Thus, we decided to use acetic acid N-hydroxy succinimide
esther as reagent since it has been shown to lead to an efficient
lysine acetylation [36]. The yield of the reactionwasmonitored
by MALDI-MS. As an example, Fig. 2 reports the partial
MALDI-MS spectrum of the acetylated myoglobin tryptic
mixture. The signal at m/z 1649.2 was attributed to the pep-
tide fragment 18–23 carrying an acetyl group, fully modified.
No signal related to the unmodified peptidewas observed thus
indicating that the acetylation was quantitative.
Thus, nitrated peptides were subjected to acetylation
using acetic acid N-hydroxy succinimide esther as described
in Section 2. All successive analysis revealed that every pep-
tide detected had the N-term amine and eventually the e-
amino group of lysine protected. Only after the acetylation
step it was possible to reduce the nitro-group of o-nitroty-
rosine residues to an amino group, susceptible to iTRAQ
addition. Conversion of nitropeptides into their amino deri-
vatives was accomplished by Na2S2O4 treatment [30]. The
peptide mixture was desalted by sep-pak C18 cartridge and
the extent of reduction was monitored by MALDI-MS.
As for quantitative analysis, labelling reaction was car-
ried out on the newly generated amino groups by following
the default protocol. iTRAQ technology (trademarked by
Applied Biosystems), allows quantitative analysis of protein
expression through the use of isobaric tags, enabling the
quantitation of four [13] to eight complex protein samples
[37] in a single multiplexed analysis. Isobaric tagging meth-
ods are emerging as an important tool to study protein
expression dynamics.
As an example to illustrate the possibility to use iTRAQ
labelling strategy for selective quantitative analysis of o-
nitrotyrosine residues and at the same time to reduce the
costs, we decided to carry out our methodology just on a
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tide 18–23 with acetylated N-terminal;
there are no evidence in the spectrum
for non acetylated form of the same
peptide.
duplex. Thus, we analysed only two samples and we choose
iTRAQ 114 and iTRAQ 117 as labelling reagents. After the
labelling, the resulting samples (containing about 30% of N-
BSA), N-BSA(114) and N-BSA(117), were pooled in molar
ratio 1:1 and 1:4, respectively. The two mix (1:1 and 1:4) were
then submitted to LC-MS/MS analysis in PIS mode, by using
4000Q-Trap coupled to a 1100 nano HPLC system, thus
allowing the simultaneous quantification of differentially
labelled peptides in a single chromatographic run. Thus, we
setup an experiment by using a PIS for the iTRAQ reporter
ions at m/z 117.1.
Moreover, in order to demonstrate that the choice of the
fragment to monitor nitrated peptides in PIS mode is irrele-
vant, because of the isobaric characteristic of the iTRAQ, we
decided to analyse the same sample in two separate chro-
matographic runs, the first in PIS of ion 114.1 and the sec-
ond in PIS of ion 117.1. As shown in the Fig. 3, the two
chromatographic profiles are quite identical and super
imposable, differing just in the TIC intensity that reflects the
original ratio 1:4 between the two samples. In fact, it should
be noted that PIS ion current is recorded from the fragment
generated in MS/MS and no memory is retained about the
intensity of the parent ion.
To gain information about the sequence of the peptide
and the site of nitration, a second stage of mass analysis is
performed in which the precursor ion is selected by the first
mass analyser and fragmented. Differentially labelled pep-
tides were indistinguishable during a single step of MS
analysis due to typical characteristics of iTRAQ reagents.
During MS/MS, labelled peptides produce fragmentation
spectra that allow the identification of the protein. Moreover,
MS/MS produces fragmentation at the sites modified by the
iTRAQ reagent yielding reporter ions (m/z 114 and 117) that
are visible as separated peaks in the low mass region of the
MS/MS spectrum. The ratios of related areas of these peaks
were then used to perform a relative quantitative analysis [38-
39].
Figure 4 showed the reconstructed ion chromatogram of
the 1:1 N-BSA sample analysed by PIS of 117 (A) and a clas-
sical full scan MS (B). As clearly shown, the PIS analysis led
to reduce the number of undesired signals, improving also
the duty cycle of the method and the sensitivity towards
nitro-peptides enhancing S/N ratio. However, others signals
appear in the chromatogram not related to nitrated peptides.
This effect might be generated by the presence of different
fragment ions in the region 113-114 or 116-117, many of
which generated after acetylation step (Table 1). Thus we
used 114 and 117 iTRAQ reagents, in order to have the worst
condition of selectivity and demonstrate the feasibility of our
methodology.
An accurate manual analysis of MS/MS spectra, revealed
that many positive false were selected for the presence of m/
z 114 fragment whose intensity would be negligible on
quantitative estimation (Fig. 5). To enhance the selectivity of
the analysis made by 4000QTrap, we also tried to introduce
an MS3 event as done in a previous work [27]. In particular,
Table 1. Unlabelled BSA peptides and their precursor detected in
PIS 114 and PIS 117 mode
Interfering ions Mass Peptides Scan
(Ac)b1 Ala 114.1 (Ac)ADE(Ac)K(Ac)KFWGK(Ac) PIS 114
(Ac)b1 Ala 114.1 (Ac)AEFVEVTK(Ac) PIS 114
(Ac)Immonium Val 114.1 (Ac)VLASSARQR PIS 114
(Ac)Immonium Val 114.1 (Ac)VH(Ac)KECCHGDLLECADDR PIS 114
(Ac)Immonium Thr 116.1 (Ac)TCVADESHACCEK(Ac) PIS 117
(Ac)Immonium Thr 116.1 (Ac)TVMENFVAFVDK(Ac) PIS 117
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Figure 3. Overlapped chroma-
tograms of nitrated BSA recor-
ded by PIS analysis of ions 114
(grey line) and 117 (bold line),
respectively. The chromatogram
of PIS 114 is shifted back of
1 min to have a better compar-
ison of signals. The symbols 1,
s, X, *, are referred to BSA-
nitrated peptides 137–143, 396–
408, 444–457, 322–334, respec-
tively. The symbols D, q are
referred to BSA unspecific pep-
tides detected in PIS of 114 and
PIS of 117, respectively.
Figure 4. (A) Chromatogram of nitrated BSA recorded in PIS 117.
(B) Chromatogram of nitrated BSA recorded in a full scan MS
mode.
we tried to fragment in MS/MS the ion at m/z 145 and
monitor the loss of CO giving rise to the peculiar reporter
ions of iTRAQ in MS3 mode. A Preliminary experiment
revealed that MS3 spectra exhibited a very poor intensity
caused by the low yield of ion fragment at m/z 145 in MS2
mode. Thus, we found that to enhance the selectivity of LC-
MS/MS analysis good results were obtained increasing the
signal threshold of PIS using the great difference in signal
intensity between the iTRAQ reporter ions and others men-
tioned previously (Table 1).
However, we inferred that our LC-MS/MS method for
4000QTrap analysis resulted to be a good compromise be-
tween selectivity and sensibility that are fundamental pa-
rameters in nitro-proteome analysis because of the sub-stoi-
chiometric characteristic of protein nitration. In fact, we
want to underline that, without any chromatographic nitro-
peptide enrichment, just using the mass spectrometer gas
phase fractionation features, we had eliminated about 96%
of BSA undesired peptides detected with a classical LC-MS/
MS approach. Furthermore if eventually, in a borderline case,
the detection of a false positive may complicate the analysis,
the sample may be re-analysed inverting the diagnostic
iTRAQ reporter ion monitored by PIS analysis. Indeed
unspecific ions detected in PIS of 114 were not detected in
PIS of 117 and vice versa.
Identification of nitrated tyrosine residues was carried
out by taking advantage of the flexibility of the in house
MASCOT software. The software was properly modified by
adding in the ‘modification file’ the value of DM 159 for
iTRAQ labelled ammino-tyrosine residue. For MASCOT
analysis it was necessary to set the software supplying key
information, e.g. proteolytic enzyme, fixed modifications,
variable modifications, sample taxonomy, eventually
missed cleavage, etc. The data obtained from MS/MS anal-
ysis in PIS mode where exploited both to identify nitration
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FFigure 5. MS/MS spectra enlargement of characteristic iTRAQm/z region of nonspecifically detected BSA peptides. (A) Peptide AEFVEVTKwas detected in PIS 114 due the presence of an acetylated b1 ion of alanine residue atm/z 114.2. (B) Peptide VLASSARQR was detected inPIS114 mode because of the presence of an acetylated immonium ion of valine atm/z 114.0. (C) Peptide TVMENFVAFVDK was detected in
PIS 117 mode because of the presence of an acetylated immonium ion of threonine atm/z 116.3 or its isotope.
sites by using SwissProt database and to perform quanti-
tative analysis.
Nitration sites Y137, Y406, Y457 and Y337 were identified by
the detection and by MS/MS spectra interpretation from
MH2
21 ions atm/z 564.8, 841.0, 963.5, 885.3, respectively. As
an example, the MS/MS spectrum of modified peptide 137–
143 is shown in Fig. 6A. The derivatised product ions were
identified from either the corresponding b or y product ion
series. By using the Analyst software tool for calculation of
peaks area (Applied Biosystems) it was possible to compare
the areas signals relative to reporter ions atm/z 114 and 117.
As an example, for the MS/MS spectrum mentioned above a
ratio of 1.1 6 0.2 was calculated.
Figure 6B showed the MS/MS spectrum relative to the
peptide 444–457 for the mixture 1:4 molar ratios between N-
BSA labelled with iTRAQ 114 and N-BSA labelled with
iTRAQ 117. In this case nitration site was detectable from y
ions and the area ratios for the reporter ions at m/z 117 and
114 resulted to be 4.1 6 0.4, thus providing an accurate
measurement of the relative abundance of each nitrated
peptide.
Moreover, the presence of an intense iTRAQ-labelled
amino tyrosine immonium ion at 292.1 m/z could be
detected in both spectra (Fig. 6). This ionmight be used as an
indication for the occurrence of a nitration site in the pep-
tide.
3.1 Analysis of complex mixtures
In a proof of principle, to investigate the feasibility of apply-
ing the method to proteomic analysis, a model system was
constituted by adding 5 ng of protein mix containing BSA
and N-BSA to 30 mg of an E. coli entire soluble protein
extract. Aliquots of mix of BSA and N-BSA, as control, and E.
coli extract spiked with BSA mix were fractionated by SDS-
PAGE and submitted to a western blot analysis using anti-
nitrotyrosine antibody as indicated in Fig. 7. The analysis
showed that the amount of N-BSA was quite impossible to
differentiate from the other bacterial proteins. Moreover, in
lane D is possible to appreciate that the sample used could be
considered similar to a ‘dirty’ N-BSA E. coli protein extract,
thus being a good candidate for nitro-proteome study. The
total protein extract was then submitted to the procedure
described above. The mixture was hydrolysed with trypsin
and lysine residues were protected by acetylation. Nitroty-
rosines were then reduced with dithionite, and the newly
generated amino Tyr-containing peptides were submitted to
the iTRAQ labelling protocol, using 114 iTRAQ molecule.
After labelling reaction, LC-MS/MS analysis of the mix-
ture was performed by using 4000Q-Trap, as already de-
scribed. Figure 8 showed a 3-D graphic, defined as Counter
Plot, representing LC-MS/MS parameters, namely elution
time, m/z and ion intensity expressed in greyscale intensity.
This graphical view, obtained by the Analyst software tool,
showed the duty cycle and sensitivity improvement of the
strategy proposed. A full scan MS analysis of N-BSA spiked
with an entire digest of E. coli proteins extract is reported
Fig. 8A. As clearly shown in figure, this MS analysis is not
competitive for such complex peptide mixture. Indeed, due
to the large time spent by the spectrometer analysing the
most abundant peptides, only three out of four nitrated pep-
tides present in the mixture were detected. The high selec-
tivity of the optimised PIS analysis (Fig. 8B) greatly reduced
the number of analysed species, leading to a real increase in
sensitivity. Protein Identification of nitrated proteins was
carried out using the modified MASCOT software as descri-
bed above. These peptides corresponded to the same pep-
tides previously detected in the analysis of homogeneous
nitrated BSA. Thus, our results underscored the ability of the
proposed selective labelling strategy to discriminate nitro-
peptides from their unmodified counterparts in a complex
matrix.
ª 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
VCH Auftr.-Nr. 36264 Vers.: 6.06 1. Papierl. Seite 8 – MH –
S : / 3d / v c h / _ p ro t e om i c s / p r _ 09 _ 0 6 / p r _ 0 04 9 3 . 3 d Proteomics Montag, den 09. 02. 09, 12 Uhr 03
Proteomics 2009, 9, 0000–0000 9
GA
LL
EY
PR
OO
F
Figure 6. (A) MS/MS spectrum of nitrated BSA peptide 137–143 labelled by iTRAQ reagent in 1:1 ratio. (B) MS/MS spectrum of nitrated BSA
peptide 444–457 labelled by iTRAQ reagent in the ratio 1:4. Spectra enlargement showed iTRAQ signals allowing quantitative estimation.
The proposed strategy was finally employed to identify
unknown o-nitrotyrosine residues in a complex sample as
the entire bovine milk. Bovine milk was in vitro nitrated with
TNM [27] and the extent of nitration was monitored by SDS-
PAGE and western blot analysis as described above. Figure
9A (lane A) showed that the high difference of milk protein
abundance in the sample reflected the high dynamic range
features of the proteomic analysis. In addition the immuno-
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Figure 7. SDS-PAGE and Western blot analyses of E. coli protein
digest spiked with nitrated BSA (lane B) where N-BSA band was
indistinguishable by the others. Lane A: Standardmix of BSA and
N-BSA as control. Lanes C and D: Western blot analysis by using
antinitrotyrosine antibody of control and E. coli samples,
respectively.
detection (lane B) showed the low extent of protein nitration
thus indicating that this model system could be suitable for
proteomic analysis. The entire milk protein extract was then
dissolved in denaturant buffer, and cysteine alkylation and
nitro-groups reduction were performed ‘one pot’ as described
in Section 2. Two protein samples were then desalted and
digested with trypsin. The resulting peptide mixtures were
acetylated, differentially labelled with iTRAQ reagents (114
and 117) and mixed in molar ratios of 1:1 and 1:4. The sam-
ples were then selectively analysed by nanoLC-MS/MS in PIS
mode for the reporter ion at m/z 117.
Identification of nitrated milk proteins was carried out
using the modified MASCOT software as described. The
results obtained were mediated on triplicate analyses and are
summarised in the Table 2. As indicated in the table, besides
the high-abundant milk proteins (a-casein and b-lactoglobu-
lin), this procedure was also able to assess the nitration sites
occurring in low-abundant proteins, like Vimentin and
Integrin, thus, demonstrating the feasibility of this strategy
for the identification of protein nitration in proteomics. As for
the quantifications, we realised the quantitative estimation of
7/9 nitrated peptides. In fact, the spectra of low abundant
proteins let us to unequivocally identify the sequence; how-
ever, the quality of signals for the ions 114 and 117 were too
low tomake an accurate quantitative measure all over the sig-
nals. In Fig. 9B the MS/MS spectrum of a nitrated peptide
within a-casein is shown. It is interesting to note that the
occurrence of an acetylated threonine residue at N-terminal
position does not effect the quantitative estimation.
Finally, the proposed strategy was successfully applied to
the study of complex mixture of proteins in low abundance,
by using plasma samples where real protein nitration
changes are observed, thus representing a critical evaluation
of this methodology.
Table 2. Nitrated milk proteins detected by the selective iTRAQ labelling strategy coupled with a selective PIS-MS
analysis
Observed
m/z
Score Sequence Ratio
114:117
Protein, accession no.
740.2 59 (Ac)VLVDTY*K(Ac)K(Ac) 4.1 6 0.1
1.2 6 0.2
b-Lactoglobulin, P02754
796.5 49 (Ac)DMPIQAFLLY*QEPVLGPVR 3.8 6 0.4
0.9 6 0.2
b-Casein, P02666
573.5 44 (Ac)TVY*QHQK(Ac) 4.3 6 0.2
1.2 6 0.3
a-s1-Casein, P02663
568.8 42 (Ac)Y*LYEIAR 3.9 6 0.1
0.8 6 0.3
Albumin bovine, P02769
426.8 36 (Ac)ADLIAY*LK(Ac)K(Ac) 4.1 6 0.4
1.3 6 0.2
Cytochrome,c P62849
716.3 34 (Ac)STRTVSSSSY*R 4.1 6 0.4
1.2 6 0.4
Vimentin, P48616
617.4 30 (Ac)AY*PTPARSK(Ac) 4.2 6 0.7
1.4 6 0.3
Glycoprotein hormones a chain, P01217
565.9 29 (Ac)HFHLY*GR 5.2 6 1.6
1.8 6 0.9
Integrin a-L, P61625
559.8 29 (Ac)LELY*LPK(Ac) 7.1 6 3.4
1.8 6 1.2
Plasma serine protease inhibitor, Q9N212
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Figure 8. Counter plot representation of
a whole E. coli protein digest spiked with
nitrated BSA analysed, by a classical full
scan MS (A) and PIS (B) after iTRAQ
selective labelling.
Figure 9. (A) SDS-PAGE (lane A) and Western blot analysis using
anti-nitrotyrosine antibody (lane B) of in vitro nitrated milk pro-
teins. (B) MS/MS spectrum of a-Casein nitrated peptide
TVYQHQK detected in an in vitro nitrated milk proteins extract. In
the spectrum enlargement of iTRAQ mass region, the character-
istic signals of the reporter ions and a signal at m/z 116.1 of
acetylated threonine immonium ion are visible.
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Oxidative and nitrosative stress may cause post-translational
changes in plasma proteins that have been described to
accumulate in inflammatory and degenerative conditions.
Inflammation and oxidative/nitrosative stress (O/NS) are
exacerbated in uremia and hemodialysis (HD) patients [40].
Proteomics techniques, also described with the name of
‘redoxomics’ [41], have been tentatively used in these patients
to identify specific PTMs related with O/NS in plasma pro-
teins, and 3-nitro tyrosine is between the most investigated
ones.
Thus, the iTRAQ labelling procedure was successfully
applied to the qualitative and quantitative analysis of 3NT-
containing proteins with different relative abundance and
molecular mass, in 100 mL of plasma and dialysis fluids of
HD patients (Fig. 10). Our strategy let us to identify the
number and position of Tyr residues affected by this post-
translational change in individual proteins. Moreover,
iTRAQ selective labelling of nitration sites showed that
healthy control plasma contained much less nitrated pep-
tides and therefore nitrated proteins, with respect to the ure-
mic ones, and these findings were in agreement with lower
levels of biochemical indices of oxidative stress and inflam-
mation (manuscript in preparation).
Figure 10. Western blotting analysis of SDS-PAGE fractionation
of 3NT-containing proteins in 100 mL of pooled samples of uremic
and healthy control plasma (15 ug of proteins/lane). MW, molec-
ular weight markers stained by ponceau; 1, control plasma; 2,
uremic plasma, 3, uremic ultrafiltrate.
4 Concluding remarks
The iTRAQ approach has been successfully applied to a
variety of prokaryotic and eukaryotic samples including E.
coli, yeast, human saliva, human fibroblasts and mammary
epithelial cells to identify and quantify the proteins in these
samples [42–43]. Zhang et al. [44] combined the iTRAQ
labelling approach with immunoprecipitation to quantify ty-
rosine-phosphorylated peptides epithelial cells.
However, iTRAQ has been also applied to identify and
quantify protein level in shotgun proteomics approach
[45–46]. This work represents the first innovative applica-
tion of iTRAQ labelling strategy to the analysis of PTM.
In particular, we addressed the analysis of protein nitra-
tion, thus providing a powerful analytical method to
identify nitrated protein, localise tyrosine nitration sites
and to quantitate the extent of protein nitration in a sin-
gle experiment.
The newly developed procedure was successfully tested
on complex biological systems (manuscript in preparation),
to assess its feasibility for proteomic investigation of nitro-
proteins.
Here, the strategy proposed, taking in account the
availability of linear trap to select specific labelled peptides
giving rise to diagnostic MS/MS product ions, resulted to
be of interest in the selective detection of protein nitration.
Moreover, because of its operational simplicity, avoiding
long-lasting and time-consuming fractionation procedures,
this new strategy seems to be well suited for large-scale
quantitative profiling of nitration sites. Because of the cost
of iTRAQ kits, we would suggest to integrate our pre-
viously proposed method to selectively identify nitration
sites on a screening scale and further select the samples to
be of interest for quantitative analysis. The strategy report-
ed here was set up with a 4000QTrap mass spectrometer;
however, we believe that this approach may be realised also
using others mass spectrometer optics, with opportune
modifications. For example, Niggeweg et al. [47] showed
the possibility to perform PIS compatible with chromato-
graphic separations by a QTOF. Moreover, it would be very
interesting to evaluate possible improvements, in terms of
selectivity and quantitative estimation, by measuring with
high resolution and accuracy (,10 ppm) iTRAQ reporter
ions. This may be accomplished by a Thermo LIT/Orbitrap
performing MS/MS experiments in higher energy CID
(HCD) [15]. The optic and the electronics of this instru-
ment leads to perform analysis in an operation mode
called ‘Parent Ion Mapping’ that may be considered as
reconstructed PIS. However, our feeling is that, because of
the higher duty cycle of a triple quadrupole-based PIS,
eventual improvement would have real effectiveness in an
offline LC-MALDI-MS/MS analysis more than a classical
LC-ESI-MS/MS.
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